Bacillus thuringiensis toxins active against hymenopteran pests

ABSTRACT

Novel Bacillus thuringiensis toxins with hymenopteran activity are described.

CROSS-REFERENCE TO A RELATED APPLICATION

This is a continuation of application Ser. No. 08/158,232, filed Nov. 24, 1993 now U.S. Pat. No. 5,596,071, which is a continuation-in-part of application Ser. No. 07/887,980, filed on May 22, 1992, now abandoned which is a continuation-part of application Ser. No. 07/703,977, filed on May 22, 1991, now U.S. Pat. No. 5,260,058. Application Ser. No. 08/158,232 is also a continuation-in-part of application Ser. No. 07/797,645, filed on Nov. 25, 1991 now U.S. Pat. No. 5,268,297.

BACKGROUND OF THE INVENTION

The development of biological control agents as alternatives to chemical insecticides for the control of important pest species is a subject of increasing interest. Concerns for the environment and exposure of man to harmful substances in air, food and water have stimulated legislation and restrictions regarding the use of chemical pesticides, particularly for pests found in the urban environment. Control of insect pests in urban areas is highly desirable but exposure to chemical pesticides in the household and from lawns and gardens is of great concern to the public. If given a choice, most people would prefer to use a non-toxic biological control agent rather than a toxic chemical to control insects in the urban environment. The problem is that very few biological alternatives to chemical insecticides are available for purchase and use by the public.

The soil microbe Bacillus thuringiensis (B.t.) is a Gram-positive, spore-forming bacterium characterized by parasporal crystalline protein inclusions. These inclusions often appear microscopically as distinctively shaped crystals. The proteins can be highly toxic to pests and specific in their toxic activity. Certain B.t. toxin genes have been isolated and sequenced, and recombinant DNA-based B.t. products have been produced and approved for use. In addition, with the use of genetic engineering techniques, new approaches for delivering B.t. endotoxins to agricultural environments are under development, including the use of plants genetically engineered with endotoxin genes for insect resistance and the use of stabilized intact microbial cells as B.t. endotoxin delivery vehicles (Gaertner, F. H., L. Kim 1988! TIBTECH 6:S4-S7). Thus, isolated B.t. endotoxin genes are becoming commercially valuable.

Until the last ten years, commercial use of B.t. pesticides has been largely restricted to a narrow range of lepidopteran (caterpillar) pests. Preparations of the spores and crystals of B. thuringiensis subsp. kurstaki have been used for many years as commercial insecticides for lepidopteran pests. For example, B. thuringiensis var. kurstaki HD-1 produces a crystal called a δ-endotoxin which is toxic to the larvae of a number of lepidopteran insects.

In recent years, however, investigators have discovered B.t. pesticides with specificities for a much broader range of pests. For example, other species of B.t., namely israelensis and i tenebrionis (a.k.a. B.t. M-7, a.k.a. B.t. san diego), have been used commercially to control insects of the orders Diptera and Coleoptera, respectively (Gaertner, F. H. 1989! "Cellular Delivery Systems for Insecticidal Proteins: Living and Non-Living Microorganisms," in Controlled Delivery of Crop Protection Agents, R. M. Wilkins, ed., Taylor and Francis, New York and London, 1990, pp. 245-255). See also Couch, T. L. (1980) "Mosquito Pathogenicity of Bacillus thuringiensis var.israelensis," Developments in Industrial Microbiology 22:61-76; Beegle, C. C., (1978) "Use of Entomogenous Bacteria in Agroecosystems," Developments in Industrial Microbiology 20:97-104. Krieg, A., A. M. Huger, G. A. Langenbruch, W. Schnetter (1983) Z. ang. Ent. 96:500-508, describe Bacillus thuringiensis var. tenebrionis, which is reportedly active against two beetles in the order Coleoptera. These are the Colorado potato beetle, Leptinotarsa decemlineata, and Agelastica alni.

Recently, new subspecies of B.t. have been identified, and genes responsible for active δ-endotoxin proteins have been isolated (Hofte, H., H. R. Whiteley 1989! Microbiological Reviews 52(2):242-255). Hofte and Whiteley classified B.t. crystal protein genes into 4 major classes. The classes were CryI (Lepidoptera-specific), CryII (Lepidoptera- and Diptera-specific), CryIII (Coleoptera-specific), and CryIV (Diptera-specific). The discovery of strains specifically toxic to other pests has been reported. (Feitelson, J. S., J. Payne, L. Kim 1992! Bio/Technology 10:271-275).

The cloning and expression of a B.t. crystal protein gene in Escherichia coli has been described in the published literature (Schnepf, H. E., H. R. Whitely 1981! Proc. Natl. Acad. Sci. USA 78:2893-2897). U.S. Pat. No. 4,448,885 and U.S. Pat. No. 4,467,036 both disclose the expression of B.t. crystal protein in E. coli. U.S. Pat. Nos. 4,797,276 and 4,853,331 disclose B. thuringiensis strain san diego (a.k.a. B.t. tenebrionis, a.k.a. M-7) which can be used to control coleopteran pests in various envirorments. U.S. Pat. No. 4,918,006 discloses B.t. toxins having activity against Dipterans. U.S. Pat. No. 4,849,217 discloses B.t. isolates which have activity against the alfalfa weevil. U.S. Pat. No. 5,208,077 discloses coleopteran-active Bacillus thuringiensis isolates. U.S. Pat. No. 5,151,363 and U.S. Pat. No. 4,948,734 disclose certain isolates of B.t. which have activity against nematodes. As a result of extensive research and investment of resources, other patents have issued for new B.t. isolates and new uses of Bt. isolates. However, the discovery of new B.t. isolates and new uses of known B.t. isolates remains an empirical, unpredictable art.

Ants comprise a large group of insects (family Formicidae) from the taxonomic order, Hymenoptera. They are among the most common house pests. In many situations, ants are a nuisance pest. Foraging ants create problems with hygiene in hospitals and the food industry. Ants also create problems in agriculture. Damage can be caused by direct feeding on plants. Harvester and fire ants are commonly associated with this type of damage (Hoildobler, B., E. O. Wilson 1990! The Ants, Belkap Press, Cambridge, Mass. 732 pp.) Some ants cause indirect damage by nurturing and protecting sap feeding insects such as mealybugs and aphids. Ants, particularly in the genus Solenopsis are capable of producing extremely painful stings to humans. It has been estimated that approximately 10,000 stings occur each year (Habermehl, G. G. 1981! Venomous Animals and Their Toxins, Springer-Verlag, N.Y., 195 pp.). The pharaoh ant (Monomorium pharaonis) is primarily an urban pest. However, this species can also be an agricultural pest and damage to corn has been noted (Ebeling, W. 1978! Urban Entomology, UC Press, Berkeley, Calif., 695 pp.).

Carpenter ants, Camponotus spp., are distributed throughout North America. Some of the more common and/or studied species include C. modoc in the Pacific Northwest, C. clarithorax in southern California, and the black, red, and Florida carpenter ants, C. pennsylvanicus, C. noveboracensis and C. abdominalis, respectively, in the east (Ebeling, W. 1978! Urban Entomology, Univ. Calif.: Berkeley p. 209-213). Public concern over carpenter ants has been increasing due to the greater probability of structural infestations as suburban developments extend into the forest habitats of the ants.

Pestiferous species of carpenter ants may be considered nuisance pests because of their foraging activity inside homes. More significant damage occurs when carpenter ants extend their nests into sound wood. Nesting sites may be located in live and dead trees, sometimes resulting in damage to shade trees. Nests may also be established in walls and support beams of structures, or in voids within doors, walls, and furniture. Preference for moist or decaying wood has been reported, but nesting sites are not restricted to such areas. Carpenter ant populations develop relatively slowly with colonies of 300-2,000 workers being produced over a 2-year or longer period for various species. The presence of reproductives follows this slow development since their production has been reported only from well established colonies (Hansen, L. D., R. D. Akre 1985! Biology of carpenter ants in Washington state (Hymenoptera: Formicidae: Camponotus). Melanderia 43. 62 p.; Pricer, J. L. 1908! Biol. Bull. 14:177-218). Despite the slow colony growth, large colonies with satellite colonies have been found. Worker movement occurs between the main colony and the satellites, which serve as areas for further brood development and colony expansion (Hansen and Akre 1985!, supra).

Current methods for controlling structural infestations of carpenter ants include sanitation of potential and current nest sites, minimizing access to structures (eg. preventing the contact of tree branches with a structure), and the application of insecticides to repel (perimeter spray barriers) and/or eliminate carpenter ants. The use of boric acid dust in dry, wall voids is reported to be effective for up to 20 years (Hansen and Akre, supra).

Recommendations for the chemical control of established structural infestations in the home are often accompanied with warnings of possible hazards to the applicator as well as children and pets. Alternative control methods such as effective biological control agents have not been found (Akre, R. D., L. D. Hansen, A. L. Antonelli 1989! Ext. Bull. Washington State Univ. Coop. Ext. Serv. 1989 rev. no. EB 0818, 6 pp.). A need clearly exists for a safe, effective biological control agent for carpenter ants.

Pharaoh ants, Monomorium pharaonis, have been described as " . . . the most persistent and difficult of all our house-infesting ants to control or eradicate" (Smith, M. R. 1965! USDA-ARS Tech. Bull. No. 1326,105 pp.). It is a tropical species which has extended its range to more temperate regions by establishing colonies in heated buildings. Pharaoh ants frequently infests buildings where food is prepared, and have been found to carry pathogenic organisms (Beatson, S. H. 1972! Lancet 1:425-427).

The difficulty in controlling pharaoh ants may be attributed to their inaccessible nesting sites, rapid population growth, and dispersion of colonies. Their small size allows establishment of colonies in any suitable location, including unusual places such as between books and in stored clothing. With multiple queen colonies, and the warm (30° C.), humid (63-80% RH) conditions that favor pharaoh ants, large colonies can develop rapidly. Portions of these large colonies may disperse to form new colonies at any time, probably in response to overcrowding and unfavorable microenvironmental conditions. Unlike other ant species, pharaoh ants do not exhibit intercolony aggression. This permits the adoption of ants from other colonies and may further enhance the establishment of new colonies and reinfestations. Pharaoh ants also forage for food more than 35 m from the nest without distinct trail following, and thus make nests difficult to find and eradicate.

Control methods for pharaoh ants emphasize the use of insect growth regulators (IGR) or toxicants incorporated into baits. Properly implemented bait programs are effective, however it may take over a month to achieve control. Insecticide applications, while fast acting, usually do not eliminate colonies, and may be unacceptable in certain areas where toxic residues are a concern. In addition, insecticide applications are generally not compatible with bait programs.

A need exists for safe and effective biological control agents for pharaoh ants.

BRIEF SUMMARY OF THE INVENTION

The subject invention concerns novel Bacillus thuringiensis (B.t.) isolates and genes therefrom which encode novel hymenopteran-active proteins. The novel B.t. isolates, known herein as Bacillus thuringiensis PS140E2 (B.t. PS140E2), Bacillus thuringiensis PS86Q3 (B.t. PS86Q3) and Bacillus thuringiensis PS211B2 (B.t. PS211B2), as well as toxins from these isolates, can be used to control pests such as fire ants, carpenter ants, argentine ants, and pharaoh ants.

The subject invention also includes mutants of the above isolates which have substantially the same pesticidal properties as the parent isolate. Procedures for making mutants are well known in the microbiological art. Ultraviolet light and nitrosoguanidine are used extensively toward this end.

The subject invention also concerns novel toxins active against ants. A further aspect of the invention concerns genes encoding these formicidal toxins. The subject invention provides the person skilled in this art with a vast array of formicidal toxins, methods for using these toxins, and genes that encode the toxins. The genes or gene fragments of the invention encode Bacillus thuringiensis δ-endotoxins which have hymenopteran activity. The genes or gene fragments can be transferred to suitable hosts via a recombinant DNA vector.

One aspect of the invention is the discovery of a generalized chemical formula common to a wide range of formicidal toxins. This formula can be used by those skilled in this art to obtain and identify a wide variety of toxins having the desired formicidal activity. The subject invention provides other teachings which enable the skilled practitioner to identify and isolate ant-active toxins and the genes which code therefor. For example, characteristic features of ant-active toxin crystals are disclosed herein. Furthermore, characteristic levels of amino acid homology can be used to characterize the toxins of the subject invention. Yet another characterizing feature pertains to immunoreactivity of the toxins with certain antibodies. Also, nucleotide probes specific for genes encoding toxins with formicidal activity are described. Thus, the identification of toxins of the subject invention can be accomplished by sequence-specific motifs, overall sequence similarity, immunoreactivity, and ability to hybridize with specific probes.

In addition to the teachings of the subject invention which broadly define B.t. toxins with advantageous formicidal activity, a further aspect of the subject invention is the provision of specific formicidal toxins and the nucleotide sequences which encode these toxins. Examples of such specific toxins are the gene expression products of isolate PS86Q3.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a photograph of a standard SDS polyacrylamide gel of B.t. PS140E2, and B.t. PS86Q3.

FIG. 2 is a photograph of a standard SDS polyacrylamide gel showing alkali-soluble proteins of B.t. PS211B2 compared to a protein standard.

FIGS. 3-5 are transmission electron micrographs of ultrathin sections of the ant-active B.t. strains (FIG. 3 is B.t. PS140E2; FIG. 4 is B.t. PS86Q3; and FIG. 5 is B.t. PS211B2). Cells were embedded in an epoxy resin and stained with uranyl acetate and lead citrate.

BRIEF DESCRIPTION OF THE SEQUENCES

SEQ ID NO. 1 is the nucleotide sequence of gene 17a.

SEQ ID NO. 2 is the amino acid sequence of protein 17a.

SEQ ID NO. 3 is the nucleotide sequence of gene 17b.

SEQ ID NO. 4 is the amino acid sequence of protein 17b.

SEQ ID NO. 5 is the nucleotide sequence of gene 33F2.

SEQ ID NO. 6 is the amino acid sequence of protein 33F2.

SEQ ID NO. 7 is the nucleotide sequence of gene 86Q3a.

SEQ ID NO. 8 is the amino acid sequence of protein 86Q3a.

SEQ ID NO. 9 is the nucleotide sequence of gene 63B.

SEQ ID NO. 10 is the amino acid sequence of protein 63B.

SEQ ID NO. 11 is the amino acid sequence of a probe which can be used according to the subject invention.

SEQ ID NO. 12 is DNA coding for the amino acid sequence of SEQ ID NO. 11.

SEQ ID NO. 13 is DNA coding for the amino acid sequence of SEQ ID NO. 11.

SEQ ID NO. 14 is the amino acid sequence of a probe which can be used according to the subject invention.

SEQ ID NO. 15 is DNA coding for the amino acid sequence of SEQ ID NO. 14.

SEQ ID NO. 16 is DNA coding for the amino acid sequence of SEQ ID NO. 14.

SEQ ID NO. 17 is the N-terminal amino acid sequence of 17a.

SEQ ID NO. 18 is the N-terminal amino acid sequence of 17b.

SEQ ID NO. 19 is the N-terminal amino acid sequence of 86Q3a.

SEQ ID NO. 20 is the N-terminal amino acid sequence of 63B.

SEQ ID NO. 21 is the N-terminal amino acid sequence of 33F2.

SEQ ID NO. 22 is an internal amino acid sequence for 63B.

SEQ ID NO. 23 is a synthetic oligonucleotide derived from 17.

SEQ ID NO. 24 is the forward oligonucleotide primer from 63B.

SEQ ID NO. 25 is the reverse oligonucleotide primer from 63B.

SEQ ID NO. 26 is oligonucleotide probe 33F2A.

SEQ ID NO. 27 is oligonucleotide probe 33F2B.

SEQ ID NO. 28 is a reverse primer used according to the subject invention.

SEQ ID NO. 29 is an oligonucleotide derived from the N-terminal amino acid sequence of 86Q3a (SEQ ID NO. 19).

SEQ ID NO. 30 is the amino acid sequence coded for by an oligonucleotide used according to the subject invention (SEQ ID NO. 31).

SEQ ID NO. 31 is an oligonucleotide which codes for the amino acid sequence of SEQ ID NO. 30.

SEQ ID NO. 32 is the amino acid sequence coded for by the oligonucleotide of SEQ ID NO. 33.

SEQ ID NO. 33 is a DNA sequence coding for the peptide of SEQ ID NO. 32.

SEQ ID NO. 34 is the reverse complement primer to SEQ ID NO. 38, used according to the subject invention.

SEQ ID NO. 35 is a forward primer according to the subject invention.

SEQ ID NO. 36 is an amino acid sequence according to the subject invention.

SEQ ID NO. 37 is a reverse primer according to the subject invention.

SEQ ID NO. 38 is the nematode (NEMI) variant of region 5 of Hofte and Whiteley.

SEQ ID NO. 39 is the Generic Formula of the subject invention.

SEQ ID NO. 40 is an oligonucleotide derived from the N-terminal amino acid sequence of 86Q3c.

SEQ ID NO. 41 is the "protoxin T" oligonucleotide used as the reverse 3' primer.

SEQ ID NO. 42 is the nucleotide sequence of gene 86Q3c.

SEQ ID NO. 43 is the amino acid sequence of protein 86Q3c.

SEQ ID NO. 44 is the N-terminal amino acid sequence of 140E2.

SEQ ID NO. 45 is an oligonucleotide probe derived from the 35 kDa toxin of PS140E2.

SEQ ID NO. 46 is an internal amino acid sequence of 211B2.

SEQ ID NO. 47 is an N-terminal amino acid sequence of 211B2.

SEQ ID NO. 48 is a forward oligonucleotide primer used according to the subject invention.

SEQ ID NO. 49 is a reverse oligonucleotide primer used according to the subject invention.

SEQ ID NO. 50 is the nucleotide sequence of 211B2.

SEQ ID NO. 51 is the amino acid sequence of 211B2.

DETAILED DISCLOSURE OF THE INVENTION

One aspect of the subject invention is the discovery of Bacillus thuringiensis isolates having activity against ants.

A comparison of the characteristics of the Bacillus thuringiensis isolates of the subject invention is shown in Table 1.

                  TABLE 1                                                          ______________________________________                                         Comparison of B.t. PS140E2, B.t. PS86Q3, and B.t. PS211B2                               B.t. PS140E2                                                                            B.t. PS86Q3 B.t. PS211B2                                     ______________________________________                                         Inclusions:                                                                               Ellipse and 2                                                                             1 long and 1 or 2                                                                          Large amorphic                                          small      small inclusions                                                    inclusions                                                          Approximate                                                                               78,000     155,000     175,000                                      molecular wt. of                                                                          70,000     135,000     130,000                                      proteins by                                                                               35,000     98,000      100,000                                      SDS-PAGE              62,000      83,000                                                             58,000      69,000                                                                         43,000                                                                         40,000                                                                         36,000                                                                         35,000                                                                         34,000                                                                         27,000                                       Host range Hymenoptera                                                                               Hymenoptera Hymenoptera                                  Serovar    6, entomocidus                                                                            new         6, entomocidus                               ______________________________________                                    

The toxin genes or gene fragments exemplified according to the subject invention can be obtained from B. thuringiensis (B.t.) isolates designated PS17, PS33F2, PS63B, PS140E2, PS211B2, and PS86Q3. Subcultures of the E. coli host harboring the toxin genes of the invention were deposited in the permanent collection of the Northern Research Laboratory, U.S. Department of Agriculture, Peoria, Ill., USA. The accession numbers are as follows:

    ______________________________________                                         Culture         Repository No.                                                                             Deposit Date                                       ______________________________________                                         B.t. PS140E2    NRRL B-18812                                                                               April 23, 1991                                     B.t. PS86Q3     NRRL B-18765                                                                               February 6, 1991                                   B.t. PS211B2    NRRL B-18921                                                                               November 15, 1991                                  B.t. PS17       NRRL B-18243                                                                               July 28, 1987                                      B.t. PS33F2     NRRL B-18244                                                                               July 28, 1987                                      B.t. PS63B      NRRL B-18246                                                                               July 28, 1987                                      E. coli         NRRL B-18785                                                                               March 15, 1991                                     NM522(pMYC2316)(33F2)                                                          E. coli NM522(pMYC2321)                                                                        NRRL B-18770                                                                               February 14, 1991                                  E. coli NM522(pMYC2317)                                                                        NRRL B-18816                                                                               April 24, 1991                                     E. coli         NRRL B-18651                                                                               May 11, 1990                                       NM522(pMYC1627)(17a)                                                           E. coli         NRRL B-18652                                                                               May 11, 1990                                       NM522(pMYC1628)(17b)                                                           E. coli         NRRL B-18961                                                                               April 10, 1992                                     NM522(pMYC1642)(63B)                                                           E. coli         NRRL B-18970                                                                               April 29, 1992                                     MR618(pMYC1647)(86Q3a)                                                         E. coli         NRRL B-18992                                                                               August 25, 1992                                    NM625(pMYC1648)(86Q3c)                                                         E. coli         NRRL B-21149                                                                               October 20, 1993                                   NM522(pMYC2367)(140E2)                                                         E. coli         NRRL B-21150                                                                               October 20, 1993                                   NM522(pMYC2371)(211B2)                                                         ______________________________________                                    

The subject cultures have been deposited under conditions that assure that access to the cultures will be available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 CFR 1.14 and 35 USC 122. The deposits are available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny, are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action.

Further, the subject culture deposits will be stored and made available to the public in accord with the provisions of the Budapest Treaty for the Deposit of Microorganisms, i.e., they will be stored with all the care necessary to keep them viable and uncontaminated for a period of at least five years after the most recent request for the furnishing of a sample of the deposit, and in any case, for a period of at least 30 (thirty) years after the date of deposit or for the enforceable life of any patent which may issue disclosing the cultures. The depositor acknowledges the duty to replace the deposits should the depository be unable to furnish a sample when requested, due to the condition of the deposit(s). All restrictions on the availability to the public of the subject culture deposits will be irrevocably removed upon the granting of a patent disclosing them.

In addition to the hymenopteran-active B.t. isolates described herein, the subject invention concerns a vast array of B.t. δ-endotoxins having hymenopteran activity. In addition to having formicidal activity, the toxins of the subject invention will have one or more of the following characteristics:

1. An amino acid sequence according to the generic formula disclosed herein.

2. A high degree of amino acid homology with specific toxins disclosed herein.

3. A DNA sequence encoding the toxin wherein said sequence hybridizes with probes or genes disclosed herein.

4. A nucleotide sequence which can be amplified using primers disclosed herein.

5. A crystal toxin presentation as described herein.

6. Immunoreactivity to an antibody raised to a toxin disclosed herein.

Toxins and genes. The genes and toxins useful according to the subject invention include not only the full length sequences disclosed but also fragments of these sequences, variants, mutants, and fusion proteins which retain the characteristic pesticidal activity of the toxins specifically exemplified herein. As used herein, the terms "variants" or "variations" of genes refer to nucleotide sequences which encode the same toxins or which encode equivalent toxins having pesticidal activity. As used herein, the term "equivalent toxins" refers to toxins having the same or essentially the same biological activity against the target pests as the claimed toxins.

One aspect of the subject invention concerns the discovery of a generic chemical formula (hereinafter referred to as the Generic Formula; SEQ ID NO. 39) which can be used to identify toxins having activity against ants. This formula describes toxin proteins having molecular weights of about 130,000 daltons or more. The Generic Formula below covers those amino acids in the N-terminal region extending two amino acids past the invariant proline residue encountered at amino acid number 695 in the sequence of 86Q3a. The organization of the toxins within this class is delineated by the following generic sequence motif that is the ultimate determinant of structure and function.

    __________________________________________________________________________      1 MOXLUEBYPx                                                                             BXYUBLXxxx                                                                             xxxxXXXXXX                                                                             XXXXXBXXxX                                                                             EXXXKXXXKX                                     XxxxxxXJXX                                                                             XXBXXXXXXX                                                                             XXLXXXXXXX                                                                             XXLZBLZBxB                                                                             PXXXXXXXXX                                  101                                                                               XXBBXXBXXX                                                                             XXXXXXXXKX                                                                             xxLBXXBXXX                                                                             BXXBBXXXBX                                                                             XXXXXXXUXX                                     BXZLUXXXXX                                                                             XXXOBXXXX*                                                                             XXXXxxxxxx                                                                             xxxxxxxxxX                                                                             XX*xxxxxxx                                  201                                                                               xxxxxXXUZX                                                                             XOXXLXXBxx                                                                             xxXEXXXXXx                                                                             xxxxxxxxXL                                                                             PXYOXBOXXH                                     LBLXJXXLxx                                                                             xxxxxXKXXB                                                                             XXJXxBXXXK                                                                             XXLXXXLXXX                                                                             XLOBXXXBXX                                  301                                                                               XLXXXxXXXJ                                                                             xXZXXXXXXY                                                                             BJXBOXX*LE                                                                             BXXXXPOBEX                                                                             XXYXXxxxxx                                     XLXXOKXLXZ                                                                             XxxxxxXXXX                                                                             BXXXXXZXXX                                                                             ZXXXXXXxXX                                                                             XXXBXXXXXX                                  401                                                                               XXXXBxxxxx                                                                             xxxxXXXXXX                                                                             LXXXXXXXXX                                                                             XXX*xxXXXX                                                                             XxXXXXXXXX                                     XXZXUXXXBX                                                                             XXUXxxX*X                                                                              XXXXXXXXXX                                                                             XXXXXXXxKX                                                                             ZXXXXXXXxx                                  501                                                                               xxxxxxXXXZ                                                                             Z*X*XXXXxx                                                                             xXXPXXxxxx                                                                             xxxxXXLXXL                                                                             YXXXXXXXJX                                     XXxXBXxBBZ                                                                             XXXXXEXXXX                                                                             XBXZXXXXXX                                                                             XBXXXXBXxx                                                                             xXXKxxxxxX                                  601                                                                               xxxxxxxxEX                                                                             LUZXUXBXLX                                                                             XXUXBXBXBX                                                                             XXXXXXYXBK                                                                             *KYOZXXXXX                                     XXBXBEXXXx                                                                             UXBXXXXXXX                                                                             ZXXXXXXZxx                                                                             XXXXXYXBXZ                                                                             XXxxxxxxOx                                  701                                                                               XLXxxxxxxx                                                                             xxXUXXXXBB                                                                             LEKLEBBPXX                                                  __________________________________________________________________________

Numbering is for convenience and approximate location only.

    ______________________________________                                         Symbols used:                                                                  ______________________________________                                         A = ala        G = gly   M = met   S = ser                                     C = cys        H = his   N = asn   T = thr                                     D = asp        I = ile   P = pro   V = val                                     E = glu        K = lys   Q = gln   W = trp                                     F = phe        L = leu   R = arg   Y = tyr                                     K = K or R                                                                     E = E or D                                                                     L = L or I                                                                     B = M, L, I, V, or F                                                           J = K, R, E, or D                                                              O = A or T                                                                     U = N or Q                                                                     Z = G or S                                                                     X = any naturally occurring amino acid, except C.                              * = any naturally occurring amino acid.                                        x = any naturally occurring amino acid, except C (or complete                  omission of any amino acids).                                                  ______________________________________                                    

Where a stretch of wild-card amino acids are encountered (X(n) or x(n) where n>2), repetition of a given amino acid should be avoided. Similarly, P, C, E, D, K, or R utilization should be minimized.

Further guidance for characterizing the formicidal toxins of the subject invention is provided in Tables 3 and 4, which demonstrate the relatedness among formicidal toxins. These tables show a numeric score for the best matching alignment between two proteins that reflects: (1) positive scores for exact matches, (2) positive or negative scores reflecting the likelihood (or not) of one amino acid substituting for another in a related protein, and (3) negative scores for the introduction of gaps. A protein sequence aligned to itself will have the highest possible score--i.e., all exact matches and no gaps. However, an unrelated protein or a randomly generated sequence will typically have a low positive score. Related sequences have scores between the random background score and the perfect match score.

The sequence comparisons were made using the local homology algorithm of Smith and Waterman ( 1981! Advances in Applied Mathematics 2:482-489), implemented as the program "Bestfit" in the GCG Sequence Analysis Software Package Version 7 Apr. 1991. The sequences were compared with default parameter values (comparison table: Swgappep.Cmp, Gap weight:3.0, Length weight:0.1) except that gap limits of 250 residues were applied to each sequence compared. The program output value compared is referred to as the Quality score.

Tables 3 and 4 show the pairwise alignments between the indicated amino acids of the ant-active proteins and representatives of dipteran (CryIV; ISRH3 of Sen, K. et al. 1988! Agric. Biol. Chem. 52:873-878), lepidopteran and dipteran (CryIIA; CryB1 of Widner and Whiteley 1989! J. Bacteriol. 171:965-974), and lepidopteran (CryIA(c); Adang et al. 1981! Gene 36:289-300) proteins.

Table 2 shows which amino acids were compared from the proteins of interest.

The N-terminal portions of the molecules consisting of about 600-700 amino acids were compared. As can be seen from Table 2, the amino acids compared started with amino acid 1 at the N-terminus and continued about 600-700 amino acids toward the C-terminus. The exact length of the sequence to be compared is readily determined using the alignment program referred to above which takes into account regions of homology including those which exist in the portion of the toxins 600-700 amino acids from the N-terminus.

                  TABLE 2                                                          ______________________________________                                         Protein     Amino acids compared                                               ______________________________________                                         86Q3c       1-672                                                              86Q3a       1-697                                                              63B         1-692                                                              33F2        1-618                                                              17a         1-677                                                              17b         1-678                                                              CryIV       1-633                                                              CryIIA      1-633                                                              CryIIIA     1-644                                                              ______________________________________                                    

Table 3 shows the scores prior to adjustment for random sequence scores.

                                      TABLE 3                                      __________________________________________________________________________     86Q3c    86Q3a                                                                              63B                                                                               33F2                                                                              17b                                                                               17a CryIVA                                                                             CryIIA                                                                             CryIA(c)                                                                            CryIIIA                                 __________________________________________________________________________     86Q3c                                                                               1008                                                                               357.0                                                                              339.1                                                                             321.7                                                                             975.5                                                                             974.6                                                                              233.5                                                                              238.2                                                                              232.4                                                                               248.4                                   86Q3a    1045.5                                                                             388.8                                                                             310.5                                                                             341.5                                                                             339.7                                                                              236.3                                                                              235.6                                                                              238.1                                                                               256.6                                   63B          1038                                                                              273.8                                                                             339.4                                                                             338 235.2                                                                              227.8                                                                              232.3                                                                               243.6                                   33F2            927                                                                               323                                                                               321.5                                                                              250.9                                                                              232.5                                                                              250.9                                                                               270.4                                   17b                1017                                                                              1007                                                                               238.3                                                                              240.4                                                                              236  248.4                                   17a                   1015.5                                                                             239.6                                                                              240 236.6                                                                               248.9                                   CryIVA                    949.5                                                                              244.8                                                                              325.1                                                                               326.2                                   CryIIA                        949.5                                                                              243.6                                                                               241.3                                   CryIA(c)                          913.5                                                                               366.6                                   CryIIIA                                966                                     __________________________________________________________________________

Note that ant-active protein 86Q3a is more closely related to 63B, 17a, 17b, and 33F2 than it is to the CryIVA, CryIIA, and CryIA(c) toxins.

Table 4 shows the same analysis after subtraction of the average score of 50 alignments of random shuffles of the column sequences with the row sequences.

                                      TABLE 4                                      __________________________________________________________________________     86Q3c    86Q3a                                                                              63B                                                                               33F2                                                                              17b                                                                               17a CryIVA                                                                             CryIIA                                                                             CryIA(c)                                                                            CryIIIA                                 __________________________________________________________________________     86Q3c                                                                               803.5                                                                              155.8                                                                              133.5                                                                             128.7                                                                             769.0                                                                             767.6                                                                              39.2                                                                               42.6                                                                               43.3 53.8                                    86Q3a    841 183.5                                                                             118.2                                                                             136.4                                                                             134.6                                                                              40.8                                                                               39.8                                                                               49.8 60.1                                    63B          830.8                                                                             81.2                                                                              132.9                                                                             129.2                                                                              39.3                                                                               33.2                                                                               43.3 48.7                                    33F2            739.3                                                                             129.7                                                                             128 65.4                                                                               50.1                                                                               70.9 84.2                                    17b                810.9                                                                             797.7                                                                              42.5                                                                               44.3                                                                               46.7 55.5                                    17a                   808.3                                                                              42.8                                                                               43.7                                                                               44.5 53                                      CrIVA                     760.6                                                                              54  141.1                                                                               141.1                                   CryIIA                        755.4                                                                              54.7 51.2                                    CryIA(c)                          728.8                                                                               182                                     CryIIIA                                777.9                                   __________________________________________________________________________

Note that in Table 4 the same relationship holds as in Table 3, i.e., 86Q3a's highest score, aside from itself, is with 63B.

This degree of relatedness provides the basis for using common or similar sequence elements from the previously-described known genes to obtain related, but non-identical genes from an ant-active isolate.

Thus, certain toxins according to the subject invention can be defined as those which have formicidal activity and have an alignment value (according to the procedures of Table 4) greater than 100 with 86Q3a. As used herein, the term "alignment value" refers to the scores obtained using the methods described above which were used to create the scores reported in Table 4.

The toxins of the subject invention can also be characterized in terms of the shape and location of toxin inclusions.

Inclusion type

PS86Q3--Long amorphic inclusion and a small inclusion, both of which remain with the spore after lysis. See FIG. 3.

PS140E2--An elliptical coated inclusion situated outside the exosporium, and a long inclusion inside the exosporium. See FIG. 4.

PS211B2--Large round amorphic inclusion with coat, and an elliptical inclusion. See FIG. 5.

Formicidal toxins according to the Generic Formula (SEQ ID NO. 39) of the subject invention are specifically exemplified herein by the toxin encoded by the gene designated 86Q3a. Since this toxin is merely exemplary of the toxins represented by the Generic Formula (SEQ ID NO. 39) presented herein, it should be readily apparent that the subject invention comprises all toxins conforming to the Generic Formula (SEQ ID NO. 39) and further comprises equivalents of those toxins (and nucleotide sequences coding for equivalent toxins) having the same or similar biological activity to ants. Equivalent toxins will have amino acid homology with the original toxin. This amino acid homology will typically be greater than 75%, preferably be greater than 90%, and most preferably be greater than 95%. The amino acid homology will be highest in certain critical regions of the toxin which account for biological activity or are involved in the determination of three-dimensional configuration which ultimately is responsible for the biological activity. In this regard, certain amino acid substitutions are acceptable and can be expected if these substitutions are in regions which are not critical to activity or are conservative amino acid substitutions which do not affect the three-dimensional configuration of the molecule. For example, amino acids may be placed in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby an amino acid of one class is replaced with another amino acid of the same type fall within the scope of the subject invention so long as the substitution does not materially alter the biological activity of the compound. Table 5 provides a listing of examples of amino acids belonging to each class.

                  TABLE 5                                                          ______________________________________                                         Class of Amino Acid                                                                           Examples of Amino Acids                                         ______________________________________                                         Nonpolar       Ala, Val, Leu, Ile, Pro, Met, Phe, Trp                          Uncharged Polar                                                                               Gly, Ser, Thr, Cys, Tyr, Asn, Gln                               Acidic         Asp, Glu                                                        Basic          Lys, Arg, His                                                   ______________________________________                                    

In some instances, non-conservative substitutions can also be made. The critical factor is that these substitutions must not significantly detract from the biological activity of the toxin. The information presented in the Generic Formula of the subject invention provides clear guidance to the person skilled in this art in making various amino acid substitutions.

It should be apparent to a person skilled in this art that genes encoding active toxins can be identified and obtained through several means. The specific genes exemplified herein may be obtained from the isolates deposited at a culture depository as described above. These genes, or portions or variants thereof, may also be constructed synthetically, for example, by use of a gene synthesizer. Variations of genes may be readily constructed using standard techniques for making point mutations. Also, fragments of these genes can be made using commercially available exonucleases or endonucleases according to standard procedures. For example, enzymes such as Bal31 or site-directed mutagenesis can be used to systematically cut off nucleotides from the ends of these genes. Also, genes which encode active fragments may be obtained using a variety of restriction enzymes. Proteases may be used to directly obtain active fragments of these toxins.

Equivalent toxins and/or genes encoding these equivalent toxins can be derived from B.t. isolates and/or DNA libraries using the teachings provided herein. There are a number of methods for obtaining the pesticidal toxins of the instant invention. For example, antibodies to the pesticidal toxins disclosed and claimed herein can be used to identify and isolate other toxins from a mixture of proteins. Specifically, antibodies may be raised to the portions of the toxins which are most constant and most distinct from other B.t. toxins. These antibodies can then be used to specifically identify equivalent toxins with the characteristic activity by immunoprecipitation, enzyme linked immunosorbent assay (ELISA), or Western blotting. Antibodies to the toxins disclosed herein, or to equivalent toxins, or fragments of these toxins, can readily be prepared using standard procedures in this art. The genes which encode these toxins can then be obtained from the microorganism. Therefore, included within the scope of the subject invention are toxins which immunoreact with (i.e., bind with) antibodies to the toxins exemplified herein.

Fragments and equivalents which retain the pesticidal activity of the exemplified toxins would be within the scope of the subject invention. Also, because of the redundancy of the genetic code, a variety of different DNA sequences can encode the amino acid sequences disclosed herein. It is well within the skill of a person trained in the art to create these alternative DNA sequences encoding the same, or essentially the same, toxins. These variant DNA sequences are within the scope of the subject invention. As used herein, reference to "essentially the same" sequence refers to sequences which have amino acid substitutions, deletions, additions, or insertions which do not materially affect pesticidal activity. Fragments retaining pesticidal activity are also included in this definition.

A further method for identifying the toxins and genes of the subject invention is through the use of oligonucleotide probes. These probes are detectable nucleotide sequences. These sequences may be detectable by virtue of an appropriate label or may be made inherently fluorescent as described in International Application No. WO93/16094. As is well known in the art, if the probe molecule and nucleic acid sample hybridize by forming a strong bond between the two molecules, it can be reasonably assumed that the probe and sample have substantial homology. Detection of the probe provides a means for determining in a known manner whether hybridization has occurred. Such a probe analysis provides a rapid method for identifying toxin-encoding genes of the subject invention.

The nucleotide segments which are used as probes according to the invention can be synthesized by use of DNA synthesizers using standard procedures. In the use of labeled nucleotide segments as probes, the particular probe is labeled with any suitable label known to those skilled in the art, including radioactive and non-radioactive labels. Typical radioactive labels include ³² P, ¹²⁵ I, ³⁵ S, or the like. A probe labeled with a radioactive isotope can be constructed from a nucleotide sequence complementary to the DNA sample by a conventional nick translation reaction, using a DNase and DNA polymerase. The probe and sample can then be combined in a hybridization buffer solution and held at an appropriate temperature until annealing occurs. Preferably, hybridization is conducted under stringent conditions by techniques well known in the art, as described, for example, in Keller, G. H., M. M. Manak (1989) DNA Probes, Stockton Press, New York, N.Y., pp. 169-170. Thereafter, the membrane is washed free of extraneous materials, leaving the sample and bound probe molecules typically detected and quantified by autoradiography and/or liquid scintillation counting.

Non-radioactive labels include, for example, ligands such as biotin or thyroxine, as well as enzymes such as hydrolases or perixodases, or the various chemiluminescers such as luciferin, or fluorescent compounds like fluorescein and its derivatives. The probe may also be labeled at both ends with different types of labels for ease of separation, as, for example, by using an isotopic label at the end mentioned above and a biotin label at the other end.

Duplex formation and stability depend on substantial complementarity between the two strands of a hybrid, and, as noted above, a certain degree of mismatch can be tolerated. Therefore, the probes of the subject invention include mutations (both single and multiple), deletions, insertions of the described sequences, and combinations thereof, wherein said mutations, insertions and deletions permit formation of stable hybrids with the target polynucleotide of interest. Mutations, insertions, and deletions can be produced in a given polynucleotide sequence in many ways, and these methods are known to an ordinarily skilled artisan. Other methods may become known in the future.

The known methods include, but are not limited to:

(1) synthesizing chemically or otherwise an artificial sequence which is a mutation, insertion or deletion of the known sequence;

(2) using a probe of the present invention to obtain via hybridization a new sequence or a mutation, insertion or deletion of the probe sequence; and

(3) mutating, inserting or deleting a test sequence in vitro or in vivo.

It is important to note that the mutational, insertional, and deletional variants generated from a given probe may be more or less efficient than the original probe. Notwithstanding such differences in efficiency, these variants are within the scope of the present invention.

Thus, mutational, insertional, and deletional variants of the disclosed test sequences can be readily prepared by methods which are well known to those skilled in the art. These variants can be used in the same manner as the instant probes so long as the variants have substantial sequence homology with the probes. As used herein, substantial sequence homology refers to homology which is sufficient to enable the variant to function in the same capacity as the original probe. Preferably, this homology is greater than 50%; more preferably, this homology is greater than 75%; and most preferably, this homology is greater than 90%. The degree of homology needed for the variant to function in its intended capacity will depend upon the intended use of the sequence. It is well within the skill of a person trained in this art to make mutational, insertional, and deletional mutations which are designed to improve the function of the sequence or otherwise provide a methodological advantage.

Specific nucleotide probes useful, according to the subject invention, in the rapid identification of ant-active genes are

(i) DNA coding for a peptide sequence whose single letter amino acid designation is "REWINGAN" (SEQ ID NO. 11) or variations thereof which embody point mutations according to the following: position 1, R or K; position 3, W or Y; position 4, I or L; position 7, A or N; position 8, N or Q; a specific example of such a probe is "AGA(A or G)T(G or A)(G or T)(A or T)T(A or T)AATGG(A or T)GC(G or T)(A or C)A" (SEQ ID NO. 12); another example of such a probe is "GA(A or G)TGG(A or T)TAAATGGT(A or G)(A or C)(G or C)AA" (SEQ ID NO. 13);

(ii) DNA coding for a peptide sequence whose single letter amino acid designation is "PTFDPDLY" (SEQ ID NO. 14) or variations thereof which embody point mutations according to the following: position 3, F or L; position 4, D or Y; position 5, P or T; position 6, D or H; position 7, L or H or D or N; a specific example of such a probe is "CC(A or T)AC(C or T)TTT(T or G)ATCCAGAT(C or G)(T or A)(T or C)TAT" (SEQ ID NO. 15); another example of such a probe is "CC(T or A)AC(T or A)TT(T or C)GAT(C or A)CA(G or C)AT(C or A)(T or A)TTAT" (SEQ ID NO. 16);

(iii) additional useful probes for detecting ant-active B.t. genes include "GCAATTTTAA ATGAATTATA TCC" (SEQ ID NO. 23), "CAAYTACAAG CWCAACC" (SEQ ID NO. 24), "AATGAAGTWT ATCCWGTWAA T" (SEQ ID NO. 27), "GCAAGCGGCC GCTTATGGAA TAAATTCAAT TYKRTCWA" (SEQ ID NO. 28), "AGACTGGATC CATGGCWACW ATWAATGAAT TATAYCC" (SEQ ID NO.29), "TAACGTGTAT WCGSTTTTAA TTWGAYTC" (SEQ ID NO. 31), "TGGAATAAAT TCAATTYKRT CWA" (SEQ ID NO. 33), "AGGAACAAAY TCAAKWCGRT CTA" (SEQ ID NO. 34), and "TCTCCATCTT CTGARGWAAT" (SEQ ID NO. 37).

The potential variations in the probes listed is due, in part, to the redundancy of the genetic code. Because of the redundancy of the genetic code, i.e., more than one coding nucleotide triplet (codon) can be used for most of the amino acids used to make proteins. Therefore different nucleotide sequences can code for a particular amino acid. Thus, the amino acid sequences of the B.t. toxins and peptides can be prepared by equivalent nucleotide sequences encoding the same amino acid sequence of the protein or peptide. Accordingly, the subject invention includes such equivalent nucleotide sequences. Also, inverse or complement sequences are an aspect of the subject invention and can be readily used by a person skilled in this art. In addition it has been shown that proteins of identified structure and function may be constructed by changing the amino acid sequence if such changes do not alter the protein secondary structure (Kaiser, E. T., Kezdy, F. J. 1984! Science 223:249-255). Thus, the subject invention includes mutants of the amino acid sequence depicted herein which do not alter the protein secondary structure, or if the structure is altered, the biological activity is substantially retained. Further, the invention also includes mutants of organisms hosting all or part of a toxin encoding a gene of the invention. Such microbial mutants can be made by techniques well known to persons skilled in the art. For example, UV irradiation can be used to prepare mutants of host organisms. Likewise, such mutants may include asporogenous host cells which also can be prepared by procedures well known in the art.

Recombinant hosts. The toxin-encoding genes harbored by the isolates of the subject invention can be introduced into a wide variety of microbial or plant hosts. Expression of the toxin gene results, directly or indirectly, in the intracellular production and maintenance of the pesticide. With suitable microbial hosts, e.g., Pseudomonas, the microbes can be applied to the situs of the pest, where they will proliferate and be ingested. The result is a control of the pest. Alternatively, the microbe hosting the toxin gene can be treated under conditions that prolong the activity of the toxin and stabilize the cell. The treated cell, which retains the toxic activity, then can be applied to the environment of the target pest.

Where the B.t. toxin gene is introduced via a suitable vector into a microbial host, and said host is applied to the environment in a living state, it is essential that certain host microbes be used. Microorganism hosts are selected which are known to occupy the "phytosphere" (phylloplane, phyllosphere, rhizosphere, and/or rhizoplane) of one or more crops of interest. These microorganisms are selected so as to be capable of successfully competing in the particular environment (crop and other insect habitats) with the wild-type microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inactivation.

A large number of microorganisms are known to inhabit the phylloplane (the surface of the plant leaves) and/or the rhizosphere (the soil surrounding plant roots) of a wide variety of important crops. These microorganisms include bacteria, algae, and fungi. Of particular interest are microorganisms, such as bacteria, e.g., genera Pseudomonas, Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alcaligenes; fungi, particularly yeast, e.g., genera Saccharomyces, Cryptococcus, Kluyveromyces, Sporobolomyces, Rhodotorula, and Aureobasidium. Of particular interest are such phytosphere bacterial species as Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum, Agrobacterium tumefaciens, Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti, Alcaligenes entrophus, and Azotobacter vinlandii; and phytosphere yeast species such as Rhodotorula rubra, R. glutinis, R. marina, R. aurantiaca, Cryptococcus albidus, C. diffluens, C. laurentii, Saccharomyces rosei, S. pretoriensis, S. cerevisiae, Sporobolomyces roseus, S. odorus, Kluyveromyces veronae, and Aureobasidium pollulans. Of particular interest are the pigmented microorganisms.

A wide variety of ways are available for introducing a B.t. gene encoding a toxin into a microorganism host under conditions which allow for stable maintenance and expression of the gene. These methods are well known to those skilled in the art and are described, for example, in U.S. Pat. No. 5,135,867, which is incorporated herein by reference.

Treatment of cells. As mentioned above, B.t. or recombinant cells expressing a B.t. toxin can be treated to prolong the toxin activity and stabilize the cell for application to the environment of the target pest. Suitable host cells may include either prokaryotes or eukaryotes, normally being limited to those cells which do not produce substances toxic to higher organisms, such as mammals. However, organisms which produce substances toxic to higher organisms could be used, where the toxic substances are unstable or the level of application sufficiently low as to avoid any possibility of toxicity to a mammalian host. As hosts, of particular interest will be the prokaryotes and the lower eukaryotes, such as fungi.

The cell will usually be intact and be substantially in the proliferative form when treated, rather than in a spore form, although in some instances spores may be employed.

Treatment of the microbial cell, e.g., a microbe containing the B.t. toxin gene, can be by chemical or physical means, or by a combination of chemical and/or physical means, so long as the technique does not deleteriously affect the properties of the toxin, nor diminish the cellular capability of protecting the toxin. Examples of chemical reagents are halogenating agents, particularly halogens of atomic no. 17-80. More particularly, iodine can be used under mild conditions and for sufficient time to achieve the desired results. Other suitable techniques include treatment with aldehydes, such as glutaraldehyde; anti-infectives, such as zephiran chloride and cetylpyridinium chloride; alcohols, such as isopropyl and ethanol; various histologic fixatives, such as Lugol iodine, Bouin's fixative, various acids and Helly's fixative (See: Humason, Gretchen L., Animal Tissue Techniques, W. H. Freeman and Company, 1967); or a combination of physical (heat) and chemical agents that preserve and prolong the activity of the toxin produced in the cell when the cell is administered to the host environment. Examples of physical means are short wavelength radiation such as gamma-radiation and X-radiation, freezing, UV irradiation, lyophilization, and the like. Methods for treatment of microbial cells are disclosed in U.S. Pat. Nos. 4,695,455 and 4,695,462, which are incorporated herein by reference.

The cells generally will have enhanced structural stability which will enhance resistance to environmental conditions. Where the pesticide is in a proform, the method of cell treatment should be selected so as not to inhibit processing of the proform to the mature form of the pesticide by the target pest pathogen. For example, formaldehyde will crosslink proteins and could inhibit processing of the proform of a polypeptide pesticide. The method of treatment should retain at least a substantial portion of the bio-availability or bioactivity of the toxin.

Characteristics of particular interest in selecting a host cell for purposes of production include ease of introducing the B.t. gene into the host, availability of expression systems, efficiency of expression, stability of the pesticide in the host, and the presence of auxiliary genetic capabilities. Characteristics of interest for use as a pesticide microcapsule include protective qualities for the pesticide, such as thick cell walls, pigmentation, and intracellular packaging or formation of inclusion bodies; survival in aqueous environments; lack of mammalian toxicity; attractiveness to pests for ingestion; ease of killing and fixing without damage to the toxin; and the like. Other considerations include ease of formulation and handling, economics, storage stability, and the like.

Growth of cells. The cellular host containing the B.t. insecticidal gene may be grown in any convenient nutrient medium, where the DNA construct provides a selective advantage, providing for a selective medium so that substantially all or all of the cells retain the B.t. gene. These cells may then be harvested in accordance with conventional ways. Alternatively, the cells can be treated prior to harvesting.

The B.t. cells of the invention can be cultured using standard art media and fermentation techniques. Upon completion of the fermentation cycle the bacteria can be harvested by first separating the B.t. spores and crystals from the fermentation broth by means well known in the art. The recovered B.t. spores and crystals can be formulated into a wettable powder, liquid concentrate, granules or other formulations by the addition of surfactants, dispersants, inert carriers, and other components to facilitate handling and application for particular target pests. These formulations and application procedures are all well known in the art.

Formulations. Formulated bait granules containing an attractant and spores and crystals of the B.t. isolates, or recombinant microbes comprising the genes obtainable from the B.t. isolates disclosed herein, can be applied to the soil. Formulated product can also be applied as a seed-coating or root treatment or total plant treatment at later stages of the crop cycle. Plant and soil treatments of B.t. cells may be employed as wettable powders, granules or dusts, by mixing with various inert materials, such as inorganic minerals (phyllosilicates, carbonates, sulfates, phosphates, and the like) or botanical materials (powdered corncobs, rice hulls, walnut shells, and the like). The formulations may include spreader-sticker adjuvants, stabilizing agents, other pesticidal additives, or surfactants. Liquid formulations may be aqueous-based or non-aqueous and employed as foams, gels, suspensions, emulsifiable concentrates, or the like. The ingredients may include rheological agents, surfactants, emulsifiers, dispersants, or polymers.

As would be appreciated by a person skilled in the art, the pesticidal concentration will vary widely depending upon the nature of the particular formulation, particularly whether it is a concentrate or to be used directly. The pesticide will be present in at least 1% by weight and may be 100% by weight. The dry formulations will have from about 1-95% by weight of the pesticide while the liquid formulations will generally be from about 1-60% by weight of the solids in the liquid phase. The formulations will generally have from about 10² to about 10⁴ cells/mg. These formulations will be administered at about 50 mg (liquid or dry) to 1 kg or more per hectare.

The formulations can be applied to the environment of the lepidopteran pest, e.g., soil, foliage, or water, by spraying, dusting, sprinkling, or the like.

Mutants. Mutants of the isolates of the invention can be made by procedures well known in the art. For example, an asporogenous mutant can be obtained through ethylmethane sulfonate (EMS) mutagenesis of an isolate. The mutants can be made using ultraviolet light and nitrosoguanidine by procedures well known in the art.

A smaller percentage of the asporogenous mutants will remain intact and not lyse for extended fermentation periods; these strains are designated lysis minus (-). Lysis minus strains can be identified by screening asporogenous mutants in shake flask media and selecting those mutants that are still intact and contain toxin crystals at the end of the fermentation. Lysis minus strains are suitable for a cell treatment process that will yield a protected, encapsulated toxin protein.

To prepare a phage resistant variant of said asporogenous mutant, an aliquot of the phage lysate is spread onto nutrient agar and allowed to dry. An aliquot of the phage sensitive bacterial strain is then plated directly over the dried lysate and allowed to dry. The plates are incubated at 30° C. The plates are incubated for 2 days and, at that time, numerous colonies could be seen growing on the agar. Some of these colonies are picked and subcultured onto nutrient agar plates. These apparent resistant cultures are tested for resistance by cross streaking with the phage lysate. A line of the phage lysate is streaked on the plate and allowed to dry. The presumptive resistant cultures are then streaked across the phage line. Resistant bacterial cultures show no lysis anywhere in the streak across the phage line after overnight incubation at 30° C. The resistance to phage is then reconfirmed by plating a lawn of the resistant culture onto a nutrient agar plate. The sensitive strain is also plated in the same manner to serve as the positive control. After drying, a drop of the phage lysate is placed in the center of the plate and allowed to dry. Resistant cultures showed no lysis in the area where the phage lysate has been placed after incubation at 30° C. for 24 hours.

Following are examples which illustrate procedures, including the best mode, for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted.

EXAMPLE 1

Culturing B.t. Isolates of the Invention

A subculture of a B.t. isolate can be used to inoculate the following medium, a peptone, glucose, salts medium.

    ______________________________________                                         Bacto Peptone         7.5    g/l                                               Glucose               1.0    g/l                                               KH.sub.2 PO.sub.4     3.4    g/l                                               K.sub.2 HPO.sub.4     4.35   g/l                                               Salts Solution        5.0    ml/l                                              CaCl.sub.2 Solution   5.0    ml/l                                              Salts Solution (100 ml)                                                        MgSO.sub.4.7H.sub.2 O 2.46   g                                                 MnSO.sub.4.H.sub.2 O  0.04   g                                                 ZnSO.sub.4.7H.sub.2 O 0.28   g                                                 FeSO.sub.4.7H.sub.2 O 0.40   g                                                 CaCl.sub.2 Solution (100 ml)                                                   CaCl.sub.2.2H.sub.2 O 3.66   g                                                 pH 7.2                                                                         ______________________________________                                    

The salts solution and CaCl₂ solution are filter-sterilized and added to the autoclaved and cooked broth at the time of inoculation. Flasks are incubated at 30° C. on a rotary shaker at 200 rpm for 64 hr.

EXAMPLE 2

Purification of Protein and Amino Acid Sequencing

The B.t. isolates PS86Q3, PS17, PS63B, PS33F2, PS140E2, and PS211B2 were cultured as described in Example 1. The B.t. cells were harvested by standard sedimentation centrifugation. Parasporal inclusion bodies of some isolates were partially purified by sodium bromide (26-40%) isopycnic gradient centrifugation (Pfannenstiel, M. A., E. J. Ross, V. C. Kramer, K. W. Nickerson 1984! FEMS Microbiol. Lett. 21:39). Preparations containing proteins toxic to ants were bound to PVDF membranes (Millipore, Bedford, Mass.) by western blotting techniques (Towbin, H., T. Staehlelin, K. Gordon 1979! Proc. Natl. Acad. Sci. USA 76:4350) and the N-terminal amino acid sequences were determined by the standard Edman reaction with an automated gas-phase sequenator (Hunkapiller, M. W., R. M. Hewick, W. L. Dreyer, and L. E. Hood 1983! Meth. Enzymol. 91:399). The sequences obtained were:

17a: A I L N E L Y P S V P Y N V (SEQ ID NO. 17)

17b: A I L N E L Y P S V P Y N V (SEQ ID NO. 18)

86Q3a: M A T I N E L Y P N V P Y N V L (SEQ ID NO. 19)

63B: Q L Q A Q P L I P Y N V L A (SEQ ID NO. 20)

33F2: A T L N E V Y P V N (SEQ ID NO. 21)

140E2: A N T T Q S F H F S N I L D Y K (SEQ ID NO. 44)

211B2: A A S D Y I D P I F (SEQ ID NO. 47)

Internal amino acid sequence data were derived for 63B and PS211B2. The toxin protein was partially digested with Staphylococcus aureus V8 protease (Sigma Chem. Co., St. Louis, Mo.) essentially as described (Cleveland, D. W., S. G. Fischer, M. W. Kirschner, U. K. Laemmli 1977! J. Biol. Chem. 252:1102). The digested material was blotted onto PVDF membrane and a ca. 28 kDa limit peptide was selected for N-terminal sequencing as described above. The sequence obtained was:

63B(2) V Q R I L D E K L S F Q L I K (SEQ ID NO. 22)

An internal amino acid sequence was also determined for 211B2 by in situ enzymatic cleavage of the electroblotted protein (Abersold, R. H., J. Leavitt, R. A. Saavedra, L. E. Hood, S. B. Kent 1987! Proc. Natl. Acad. Sci. USA 84:6970). From this sequence data oligonucleotide probes were synthesized on an Applied Biosystems, Inc. DNA synthesis machine. The sequence obtained was:

211B2: G I G F E L D T Y A N A P E D E V (SEQ ID NO. 46)

From these sequence data oligonucleotide probes were designed by utilizing a codon frequency table assembled from available sequence data of other B.t. toxin genes. The probes were synthesized on an Applied Biosystems, Inc. DNA synthesis machine.

Protein purification and subsequent amino acid analysis of the N-terminal peptides listed above has led to the deduction of several oligonucleotide probes for the isolation of toxin genes from formicidal B.t. isolates. RFLP analysis of restricted total cellular DNA using radiolabeled oligonucleotide probes has elucidated different genes or gene fragments.

EXAMPLE 3

Cloning of Toxin Genes from Bacillus thuringiensis Strain PS17 and Transformation into Escherichia coli

Total cellular DNA was prepared by growing the cells B.t. PS17 to a low optical density (OD₆₀₀ =1.0) and recovering the cells by centrifugation. The cells were protoplasted in TES buffer (30 mM Tris-Cl, 10 mM EDTA, 50 mM NaCl, pH=8.0) containing 20% sucrose and 50 mg/ml lysozyme. The protoplasts were lysed by addition of SDS to a final concentration of 4%. The cellular material was precipitated overnight at 4° C. in 100 mM (final concentration) neutral potassium chloride. The supernate was extracted twice with phenol/chloroform (1:1). The DNA was precipitated with ethanol and purified by isopycnic banding on a cesium chloride-ethidium bromide gradient.

Total cellular DNA from PS17 was digested with EcoRI and separated by electrophoresis on a 0.8% (w/v) Agarose-TAE (50 mM Tris-HCl, 20 mM NaOAc, 2.5 mM EDTA, pH=8.0) buffered gel. A Southern blot of the gel was hybridized with a ³² P!-radiolabeled oligonucleotide probe derived from the N-terminal amino acid sequence of purified 130 kDa protein from PS17. The sequence of the oligonucleotide synthesized is (GCAATTTTAAATGAATTATATCC) (SEQ ID NO. 23). Results showed that the hybridizing EcoRI fragments of PS17 are 5.0 kb, 4.5 kb, 2.7 kb and 1.8 kb in size, presumptively identifying at least four new ant-active toxin genes, 17d, 17b, 17a and 17e, respectively.

A library was constructed from PS17 total cellular DNA partially digested with Sau3A and size fractionated by electrophoresis. The 9 to 23 kb region of the gel was excised and the DNA was electroeluted and then concentrated using an Elutip™ ion exchange column (Schleicher and Schuel, Keene N.H.). The isolated Sau3A fragments were ligated into LambdaGEM-11™ (PROMEGA). The packaged phage were plated on KW251 E. coli cells (PROMEGA) at a high titer and screened using the above radiolabeled synthetic oligonucleotide as a nucleic acid hybridization probe. Hybridizing plaques were purified and rescreened at a lower plaque density. Single isolated purified plaques that hybridized with the probe were used to infect KW251 E. coli cells in liquid culture for preparation of phage for DNA isolation. DNA was isolated by standard procedures.

Recovered recombinant phage DNA was digested with EcoRI and separated by electrophoresis on a 0.8% agarose-TAE gel. The gel was Southern blotted and hybridized with the oligonucleotide probe to characterize the toxin genes isolated from the lambda library. Two patterns were present, clones containing the 4.5 kb (17b) or the 2.7 kb (17a) EcoRI fragments. Preparative amounts of phage DNA were digested with SalI (to release the inserted DNA from lambda arms) and separated by electrophoresis on a 0.6% agarose-TAE gel. The large fragments, electroeluted and concentrated as described above, were ligated to SalI-digested and dephosphorylated pBClac, an E. coli/B.t. shuttle vector comprised of replication origins from pBC16 and pUC19. The ligation mix was introduced by transformation into NM522 competent E. coli cells and plated on LB agar containing ampicillin, isopropyl-(Beta)-D-thiogalactoside(IPTG)and5-Bromo-4-Chloro-3-indolyl-(Beta)-D-galactoside (XGAL). White colonies, with putative insertions in the (Beta)-galactosidase gene of pBClac, were subjected to standard rapid plasmid purification procedures to isolate the desired plasmids. The selected plasmid containing the 2.7 kb EcoRI fragment was named pMYC1627 and the plasmid containing the 4.5 kb EcoRI fragment was called pMYC1628.

The toxin genes were sequenced by the standard Sanger dideoxy chain termination method using the synthetic oligonucleotide probe, disclosed above, and by "walking" with primers made to the sequence of the new toxin genes.

The PS17 toxin genes were subcloned into the shuttle vector pHT3101 (Lereclus, D. et al. 1989! FEMS Microbiol. Lett. 60:211-218) using standard methods for expression in B.t. Briefly, SalI fragments containing the 17a and 17b toxin genes were isolated from pMYC1629 and pMYC1627, respectively, by preparative agarose gel electrophoresis, electroelution, and concentrated, as described above. These concentrated fragments were ligated into SalI-cleaved and dephosphorylated pHT3101. The ligation mixtures were used separately to transform frozen, competent E. coli NM522. Plasmids from each respective recombinant E. coli strain were prepared by alkaline lysis and analyzed by agarose gel electrophoresis. The resulting subclones, pMYC2311 and pMYC2309, harbored the 17a and 17b toxin genes, respectively. These plasmids were transformed into the acrystalliferous B.t. strain, HD-1 cryB (Aronson, A., Purdue University, West Lafayette, Ind.), by standard electroporation techniques (Instruction Manual, Biorad, Richmond, Calif.).

Recombinant B.t. strains HD-1 cryB pMYC2311! and pMYC2309! were grown to sporulation and the proteins purified by NaBr gradient centrifugation as described above for the wild-type B.t. proteins.

EXAMPLE 4

Molecular Cloning of a Gene Encoding a Toxin from Bacillus thuringiensis Strain PS63B

Example 2 shows the aminoterminal and internal polypeptide sequences of the 63B toxin protein as determined by standard Edman protein sequencing. From these sequences, two oligonucleotide primers were designed using a codon frequency table assembled from B.t. genes encoding δ-endotoxins. The sequence of the forward primer (63B-A) was complementary to the predicted DNA sequence at the 5' end of the gene:

63B-A--5' CAA T/CTA CAA GCA/T CAA CC 3' (SEQ ID NO. 24)

The sequence of the reverse primer (63B-INT) was complementary to the inverse of the internal predicted DNA sequence:

63B-INT--5' TTC ATC TAA AAT TCT TTG A/TAC 3' (SEQ ID NO. 25)

These primers were used in standard polymerase chain reactions (Cetus Corporation) to amplify an approximately 460 bp fragment of the 63B toxin gene for use as a DNA cloning probe. Standard Southern blots of total cellular DNA from 63B were hybridized with the radiolabeled PCR probe. Hybridizing bands included an approximately 4.4 kbp XbaI fragment, an approximately 2.0 kbp HindIII fragment, and an approximately 6.4 kbp SpeI fragment.

Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) cells grown to an optical density of 1.0 at 600 nm. The cells were recovered by centrifugation and protoplasts were prepared in lysis mix (300 mM sucrose, 25 mM Tris-HCl, 25 mM EDTA, pH=8.0) and lysozyme at a concentration of 20 mg/ml. The protoplasts were ruptured by addition of ten volumes of 0.1M NaCl, 0.1M Tris-HCl pH 8.0, and 0.1% SDS. The cellular material was quickly frozen at -70° C. and thawed to 37° C. twice. The supernatant was extracted twice with phenol/chloroform (1:1). The nucleic acids were precipitated with ethanol. To remove as much RNA as possible from the DNA preparation, RNase at final concentration of 200 μg/ml was added. After incubation at 37° C. for 1 hour, the solution was extracted once with phenol/chloroform and precipitated with ethanol.

A gene library was constructed from 63B total cellular DNA partially digested with NdeII and size fractioned by gel electrophoresis. The 9-23 kb region of the gel was excised and the DNA was electroeluted and then concentrated using an Elutip-d ion exchange column (Schleicher and Schuel, Keene, N.H.). The isolated NdeII fragments were ligated into BamHI-digested LambdaGEM-11 (PROMEGA). The packaged phage were plated on E. coli KW251 cells (PROMEGA) at a high titer and screened using the radiolabeled approximately 430 bp fragment probe amplified with the 63B-A and 63B internal primers (SEQ ID NOS. 27 and 28, respectively) by polymerase chain reaction. Hybridizing plaques were purified and rescreened at a lower plaque density. Single isolated, purified plaques that hybridized with the probe were used to infect KW251 cells in liquid culture for preparation of phage for DNA isolation. DNA was isolated by standard procedures (Maniatis, T., E. F. Fritsch, J. Sambrook 1982! Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, New York). Preparative amounts of DNA were digested with SalI (to release the inserted DNA from lambda sequences) and separated by electrophoresis on a 0.6% agarose-TAE gel. The large fragments were purified by ion exchange chromatography as above and ligated to SalI-digested, dephosphorylated pHTBlueII (an E. coli/B.t. shuttle vector comprised of pBlueScript S/K Stratagene, San Diego, Calif.! and the replication origin from a resident B.t. plasmid Lereclus, D. et al. (1989) FEMS Microbiol. Lett. 60:211-218!). The ligation mix was introduced by transformation into competent E. coli NM522 cells (ATCC 47000) and plated on LB agar containing ampicillin (100 μg/ml), IPTG (2%), and XGAL (2%). White colonies, with putative restriction fragment insertions in the (Beta)-galactosidase gene of pHTBlueII, were subjected to standard rapid plasmid purification procedures (Maniatis et al, supra). Plasmids ere analyzed by SalI digestion and agarose gel electrophoresis. The desired plasmid construct, pMYC1641, contains an approximately 14 kb SalI insert.

For subcloning, preparative amounts of DNA were digested with XbaI and electrophoresed on an agarose gel. The approximately 4.4 kbp band containing the toxin gene was excised from the gel, electroeluted from the gel slice, and purified by ion exchange chromatography as above. This fragment was ligated into XbaI cut pHTBlueII and the resultant plasmid was designated pMYC1642.

EXAMPLE 5

Cloning of a Toxin Gene From B.t. PS33F2 and Transformation into Escherichia coli

Total cellular DNA was prepared from B.t. PS33F2 cells grown to an optical density, at 600 nm, of 1.0. Cells were pelleted by centrifugation and resuspended in protoplast buffer (20 mg/ml lysozyme in 0.3M sucrose, 25 mM Tris-Cl pH 8.0!, 25 mM EDTA). After incubation at 37° C. for 1 hour, protoplasts were lysed by the addition of nine volumes of a solution of 0.1M NaCl, 0.1% SDS, 0.1M Tris-Cl followed by two cycles of freezing and thawing. The cleared lysate was extracted twice with phenol:chloroform (1:1). Nucleic acids were precipitated with two volumes of ethanol and pelleted by centrifugation. The pellet was resuspended in 10 mM Tris-Cl, 1 mM EDTA (TE) and RNase was added to a final concentration of 50 μg/ml. After incubation at 37° C. for 1 hour, the solution was extracted once each with phenol:chloroform (1:1) and TE-saturated chloroform. DNA was precipitated from the aqueous phase by the addition of one-tenth volume of 3M NaOAc and two volumes of ethanol. DNA was pelleted by centrifugation, washed with 70% ethanol, dried, and resuspended in TE.

Plasmid DNA was extracted from protoplasts prepared as described above. Protoplasts were lysed by the addition of nine volumes of a solution of 10 mM Tris-Cl, 1 mM EDTA, 0.085N NaOH, 0.1% SDS, pH=8.0. SDS was added to 1% final concentration to complete lysis. One-half volume of 3M KOAc was then added and the cellular material was precipitated overnight at 4° C. After centrifugation, the DNA was precipitated with ethanol and plasmids were purified by isopycnic centrifugation on cesium chloride-ethidium bromide gradients.

Restriction Fragment Length Polymorphism (RFLP) analyses were performed by standard hybridization of Southern blots of PS33F2 plasmid and total cellular DNA with ³² P-labelled oligonucleotide probes designed to the N-terminal amino acid sequence disclosed in Example 2.

Probe 33F2A: 5' GCA/T ACA/T TTA AAT GAA GTA/T TAT 3' (SEQ ID NO. 26)

Probe 33F2B: 5' AAT GAA GTA/T TAT CCA/T GTA/T AAT 3' (SEQ ID NO. 27)

Hybridizing bands included an approximately 5.85 kbp EcoRI fragment. Probe 33F2A and a reverse PCR primer were used to amplify a DNA fragment of approximately 1.8 kbp for use as a hybridization probe for cloning the 33F2 toxin gene. The sequence of the reverse primer was: 5' GCAAGCGGCCGCTTATGGAATAAATTCAATT C/T T/G A/G TC T/A A 3' (SEQ ID NO. 28).

A gene library was constructed from 33F2 plasmid DNA digested with EcoRI. Restriction digests were fractionated by agarose gel electrophoresis. DNA fragments 4.3-6.6 kbp were excised from the gel, electroeluted from the gel slice, and recovered by ethanol precipitation after purification on an Elutip-D ion exchange column (Schleicher and Schuel, Keene N.H.). The EcoRI inserts were ligated into EcoRI-digested pHTBlueII (an E. coli/B. thuringiensis shuttle vector comprised of pBluescript S/K Stratagene! and the replication origin from a resident B.t. plasmid (Lereclus et al., supra). The ligation mixture was transformed into frozen, competent NM522 cells (ATCC 47000). Transformants were plated on LB agar containing ampicillin, isopropyl-(Beta)-D-thiogalactoside(IPTG), and5-bromo-4-chloro-3-indolyl-(Beta)-D-galactoside (XGAL). Colonies were screened by hybridization with the radiolabeled PCR amplified probe described above. Plasmids were purified from putative toxin gene clones by alkaline lysis and analyzed by agarose gel electrophoresis of restriction digests. The desired plasmid construct, pMYC2316, contains an approximately 5.85 kbp Eco4RI insert; the toxin gene residing on this DNA fragment (33F2a) is novel compared to the DNA sequences of other toxin genes encoding formicidal proteins.

Plasmid pMYC2316 was introduced into the acrystalliferous (Cry⁻) B.t. host, HD-1 CryB (A. Aronson, Purdue University, West Lafayette, Ind.) by electroporation. Expression of an approximately 120-140 kDa crystal protein was verified by SDS-PAGE analysis. Crystals were purified on NaBr gradients (Pfannenstiel et al., supra) for determination of toxicity of the cloned gene product to Pratylenchus spp.

EXAMPLE 6

Cloning of a Novel Toxin Gene from B.t. Isolate PS86Q3

Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) cells as described in Example 5.

Total cellular DNA from isolate PS86Q3 was used as template for polymerase chain reaction (PCR) analysis according to protocols furnished by Perkin Elmer Cetus. An oligonucleotide derived from the N-terminal amino acid sequence of the toxin protein was used as a 5' primer. The sequence of this oligonucleotide is: 5'-AGACTGGATCCATGGC(A or T)AC(A or T)AT(A or T)AATGAATTATA (T or C)CC-3' (SEQ ID NO. 29).

An oligonucleotide coding for the amino acid sequence "ESKLKPNTRY" (SEQ ID NO. 30) can be used as the reverse 3' primer. The sequence of this oligonucleotide can be: "5'-TAACGTGTAT(A or T)CG(C or G)TTTTAATTT(T or A)GA(C or T)TC-3'" (SEQ ID NO. 31).

The reverse "YIDKIEFIP" (SEQ ID NO. 32) oligonucleotide was also used as a reverse 3' primer in conjunction with the above mentioned 5' primer. The sequence of the reverse primer can be: "5'-TGGAATAAATTCAATT(C or T)(T or G)(A or G)TC(T or A)A-3'" (SEQ ID NO. 33).

Amplification with the 5' primer and SEQ ID NO. 31 generates an approximately 2.3 kbp DNA fragment and an approximately 4.3 kbp DNA fragment. Amplification with the 5' primer and SEQ ID NO. 33 generates an approximate 1.8 kbp DNA fragment and an approximately 3.7 kbp DNA fragment. The approximately 2.3 kbp fragment was radiolabeled with ³² P and used as a hybridization probe to generate restriction fragment polymorphism (RFLP) patterns and to screen recombinant phage libraries.

A Southern blot of total cellular DNA digested with EcoRV was probed with the radiolabeled 2.3 kbp probe described above. The resultant RFLP includes 9.5 kbp, 6.4 kbp, and 4.5 kbp hybridizing fragments.

A gene library was constructed from PS86Q3 total cellular DNA partially digested with NdeII and size fractioned by gel electrophoresis. The 9-23 kb region of the gel was excised and the DNA was electroeluted and then concentrated using an Elutip-d ion exchange column (Schleicher and Schuel, Keene, N.H.). The isolated NdeII fragments were ligated into BamHI-digested LambdaGEM-11 (PROMEGA). The packaged phage were plated on E. coli KW251 cells (PROMEGA) at a high titer and screened using the radiolabeled probe described above. Hybridizing plaques were purified and rescreened at a lower plaque density. Single isolated, purified plaques that hybridized with the probe were used to infect KW251 cells in liquid culture for preparation of phage for DNA isolation. DNA was isolated by standard procedures (Maniatis et al., supra). Preparative amounts of DNA were digested with SalI (to release the inserted DNA from lambda sequences) and separated by electrophoresis on a 0.6% agarose-TAE gel. The large fragments were purified by ion exchange chromatography as above and ligated to SalI-digested, dephosphorylated pHTBlueII (an E. coli/B.t. shuttle vector comprised of pBluescript S/K Stratagene, San Diego, Calif.!) and the replication origin from a resident B.t. plasmid (Lereclus et al. 1989!, supra). The ligation mix was introduced by transformation into competent E. coli NM522 cells (ATCC 47000) and plated on LB agar containing ampicillin, IPTG, and XGAL. White colonies, with putative restriction fragment insertions in the (Beta)-galactosidase gene of pHTBlueII, were subjected to standard rapid plasmid purification procedures (Maniatis et al., supra). Plasmid DNA was analyzed by SalI digestion and agarose gel electrophoresis. The desired plasmid construct, pMYC1647, contains an approximately 12 kb SalI insert.

Plasmid pMYC1647 was introduced by electroporation into an acrystalliferous (Cry⁻) B.t., HD-1 CryB (A. I. Aronson, Purdue University) host to yield MR515, a recombinant B.t clone of 86Q3a. Expression of an approximately 155 kDa protein was verified by SDS-PAGE. Spores and crystals were removed from broth cultures and were used for determination of toxicity to pharaoh ants.

EXAMPLE 7

Cloning of a Second Novel Toxin Gene from B.t. Isolate PS86Q3

Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) cells grown to an optical density of 1.0 at 600 nm. The cells were recovered by centrifugation and protoplasts were prepared in lysis mix (300 mM sucrose, 25 mM Tris-HCl, 25 mM EDTA, pH=8.0) and lysozyme at a concentration of 20 mg/ml. The protoplasts were ruptured by addition of ten volumes of 1% SDS. The cellular material was quickly frozen at -70° C. and thawed to 37° C. twice. The supernate was extracted twice with phenol/chloroform (1:1). The nucleic acids were precipitated with ethanol. In order to remove as much RNA as possible from the DNA preparation, RNase at final concentration of 200 μg/ml was added and followed by phenol/chloroform extraction and ethanol precipitation.

Total cellular DNA from isolate PS86Q3 was used as template for polymerase chain reaction (PCR) analysis according to protocols furnished by Perkin Elmer Cetus. An oligonucleotide derived from the N-terminal amino acid sequence of the 135 kDa and 155 kDa proteins was used as a 5' primer. The sequence of this oligo is: 5'-AGACTGGATCC ATG GC(A or T) AC(A or T) AT(A or T) AAT GAA TTA TA(T or C) CC-3' (SEQ ID NO. 40). The "protoxin T" oligonucleotide (SEQ ID NO. 41) was used as the reverse 3' primer. The sequence of this oligo is: 5'-GACTGCGGCC GCGTCGAC TTA ACG TGT AT(A or T) CG(C or G) TTT TAA TTT (T or A)GA (C or T)TC-3'.

Amplification with these two primers generated an approximately 2.3 kbp DNA fragment. This fragment was then used as a hybridization probe. A Southern blot of 86Q3 total DNA digested with EcoRV and fractionated by electrophoresis on 0.8 (w/v) agarose-TAE buffered gel showed hybridizing fragments of approximately 6.4 kb and approximately 4.8 kb.

A library was constructed from PS86Q3 total cellular DNA as described in Example 6. The procedure varied from that used in Example 6 in that restriction enzyme XhoI was used to digest the DNA instead of SalI. The desired plasmid construct, pMYC1648, includes an approximately 14 kbp XhoI insert which contains the 86Q3c gene. Sequence analysis of the toxin gene revealed that it encodes a protein of approximately 134.5 kDa, deduced from the DNA sequence. The nucleotide and deduced amino acid sequences are shown in SEQ ID NOS. 42 and 43, respectively.

Plasmid pMYC1648 was introduced into an acrystalliferous (Cry⁻) B.t., HD-1 Cry B (A. I. Aronson, Purdue University), host by electroporation. Expression of an approximately 155 kDa protein was verified by SDS-PAGE. Broth containing spores and crystals was used for determination of toxicity to pharaoh ants (Monomorium phraonis).

EXAMPLE 8

Molecular Cloning and Expression of a Novel Toxin Gene from Bacillus thuringiensis Strain PS140E2

Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) cells as described in Example 5. A gene library was constructed from PS 1402 DNA partially digested with NdeII. Partial restriction digests were fractionated by agarose gel electrophoresis. DNA fragments 9.3 to 23 kbp in size were excised from the gel, electroeluted from the gel slice, purified on an Elutip-D ion exchange column (Schleicher and Schuell, Keene, N.H.), and recovered by ethanol precipitation. The NdeII inserts were ligated into BamHI-digested LambdaGem-11 (Promega, Madison, Wis.). Recombinant phage were packaged and plated on E. coli KW251 cells. Plaques were screened by hybridization to an oligonucleotide probe deduced from the amino acid sequence of the PS140E2 35 kDa toxin. The sequence of this probe was: 5' TTT CAT TTT TC(A/T) AAT ATT TTA GAT TAT AAA 3' (SEQ ID NO. 45).

Hybridizing phage were plaque-purified and used to infect liquid cultures of E. coli KW251 cells for isolation of DNA by standard procedures (Maniatis et al., supra).

For subcloning the gene encoding the approximately 35 kDa PS140E2 toxin, preparative amounts of phage DNA were digested with SalI and electrophoresed on an agarose gel. The approximately 13.5 kbp band containing the toxin gene was excised from the gel, electroeluted from the gel slice, and purified by ion exchange chromatography as described above. The purified DNA insert was ligated into XhoI-digested pHTBlueII (an E. coli/B. thuringiensis shuttle vector comprised of pBluescript S/K Stratagene, La Jolla, Calif.! and the replication origin from a resident B.t. plasmid Lereclus et al. (1989) FEMS Microbiology Letters 60:211-218!). The ligation mix was used to transform frozen, competent E. coli NM522 cells (ATCC 47000). β-galactosidase negative transformants were screened by restriction digestion of alkaline lysate plasmid minipreps as above. The desired plasmid construct, pMYC2367, contains a toxin gene that is novel compared to other toxin genes containing insecticidal proteins.

pMYC2367 was introduced into the acrystalliferous (Cry⁻) B.t. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. Expression of the 35 kDa toxin was demonstrated by SDS-PAGE analysis.

EXAMPLE 9

Molecular Cloning and Expression of a Novel Toxin Gene from Bacillus thuringiensis Strain PS211B2

Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) cells as described in Example 5.

An approximately 300 bp-sized fragment of the novel toxin gene (estimated size: 80 kDa) was obtained by polymerase chain reaction (PCR) amplification from PS211B2 cellular DNA using the following primers: "Forward": 5' GCAGGATCCGATTATATT (TA) GATAT (TA) A (CGA) TCC 3' (SEQ ID NO. 48), and "Reverse": 5' GCG GCC GCA CTT CAT CTT C(TA)G G(TA)G CAT T(TA)G CAT A(TA)G TAT C 3' (SEQ ID NO. 49). This DNA fragment was cloned into pBluescript II SK- (Stratagene, La Jolla, Calif.) and the DNA sequence determined by dideoxynucleotide sequencing methodology (Sanger et al. 1977! Proc. Natl. Acad. Sci. USA 74:5463-5467) using Sequenase (US Biochemical, Cleveland, Ohio). This fragment was subsequently radiolabelled with ³² P and used as a probe in standard hybridization screens of recombinant phage libraries.

A gene library was constructed from PS211B2 DNA partially digested with NdeII. Partial restriction digests were fractionated by agarose gel electrophoresis. DNA fragments 9.3 to 23 kbp in size were excised from the gel, electroeluted from the gel slice, purified on an Elutip-D ion exchange column (Schleicher and Schuell, Keene, N.H.), and recovered by ethanol precipitation. The NdeII inserts were ligated into BamHI-digested LambdaGem-11 (Promega, Madison, Wis.). Recombinant phage were packaged and plated on E. coli KW251 (Promega, Madison, Wis.) cells. Plaques were screened by hybridization with the probe described above. Hybridizing phage were plaque-purified and used to infect liquid cultures of E. coli KW251 cells for isolation of DNA by standard procedures (Maniatis et al., supra).

For subcloning the gene, preparative amounts of phage DNA were digested with SalI. The approximately 16 kbp band was ligated into XhoI-digested pHTBlueII (an E. coli/B. thuringiensis shuttle vector composed of pBluescript II SK- Stratagene, La Jolla, Calif.! and the replication origin from a resident B.t. plasmid Lereclus et al., supra!). The ligation mix was used to transform frozen, competent E. coli NM522 cells (ATCC 47000). β-galactosidase- transformants were screened by restriction digestion of alkaline lysate plasmid minipreps as above. The desired plasmid construct, pMYC2371, contains a toxin gene that is novel compared to other toxin genes containing insecticidal proteins. Sequence analysis of the toxin gene revealed that it encodes a protein of approximately 80,000 daltons, deduced from the DNA sequence. The nucleotide and deduced amino acid sequences are shown in SEQ ID NOS. 50 and 51, respectively. pMYC2371 was introduced into the acrystalliferous (Cry⁻) B.t. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. Expression of the approximately 80 kDa toxin was demonstrated by SDS-PAGE analysis.

EXAMPLE 10

Activity of the B.t. Toxin Protein and Gene Product Against Ants

Broths were tested for the presence of β-exotoxin by a larval house fly bioassay (Campbell, D. P., Dieball, D. E., Bracket, J. M. 1987! "Rapid HPLC assay for the β-exotoxin of Bacillus thuringiensis," J. Agric. Food Chem. 35:156-158). Only isolates which tested free of β-exotoxin were used in the assays against ants.

A bait was made consisting of 10% Bacillus thuringiensis isolates of the invention and Crosse and Blackwell mint apple jelly. Approximately 100 ants were placed in each plastic test chamber replicate with the baits. Control experiments were performed with untreated mint apple jelly. Each test was replicated a minimum of 10 times. Mortality was assessed at 21 days after introduction of the bait to the ants. Results are shown below:

                  TABLE 6                                                          ______________________________________                                         Toxicity of B. thuringiensis isolates to the pharaoh ant                       (Monomorium pharaonis)                                                         B.t. Isolate Percent Mortality                                                 ______________________________________                                         PS140E2      91                                                                PS 86Q3      84                                                                Control      11                                                                PS211B2      90.0                                                              Control      3.8                                                               ______________________________________                                    

EXAMPLE 11

Activity of the B.t. Toxin Protein and Gene Product Against Ants

Honey buffered with phosphate at pH 6.5 containing B.t. was fed to 5 replicates of approximately 100 worker ants for 21 days. Ants were provided water ad libitum. Totoal mortality (in %) over the test period was compared to controls.

                  TABLE 7                                                          ______________________________________                                         Three week mortality (%) on pharaoh ant workers                                                % toxin in final                                               Sample          bait       % mortality                                         ______________________________________                                         PS86Q3          20         100                                                 Honey only control                                                                             --         16                                                  PS211B2          5         100                                                 PS140E2         10         98                                                  Control rearing diet                                                                           --         61                                                  ______________________________________                                    

EXAMPLE 12

Cloning of Novel Ant-Active Genes Using Generic Oligonucleotide Primers

The formicidal gene of a new formicidal B.t. can be obtained from DNA of the strain by performing the standard polymerase chain reaction procedure as in Example 6 using the oligonucleotides of SEQ ID NO. 33 or AGGAACAAAYTCAAKWCGRTCTA (SEQ ID NO. 34) as reverse primers and SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 23, SEQ ID NO. 27, SEQ ID NO. 29, or SEQ ID NO. 24 as forward primers. The expected PCR fragments would be approximately 330 to 600 bp with either reverse primer and SEQ ID NO. 12 or SEQ ID NO. 13, 1000 to 1400 bp with either reverse primer and SEQ ID NO. 15 or SEQ ID NO. 16, and 1800 to 2100 bp with either reverse primer and any of the three N-terminal primers, SEQ ID NO. 27, SEQ ID NO. 23, SEQ ID NO. 29, and SEQ ID NO. 24. Alternatively, a complement from the primer family described by SEQ ID NO. 12 and SEQ ID NO. 13 can be used as reverse primer with SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 23, SEQ ID NO. 27, SEQ ID NO. 29, or SEQ ID NO. 24 as forward primers. The expected PCR fragments would be approximately 650 to 1000 bp with SEQ ID NO. 15 or SEQ ID NO. 16, and 1400 to 1800 bp for the four N-terminal primers (SEQ ID NO. 27, SEQ ID NO. 23, SEQ ID NO. 29, and SEQ ID NO. 24).

As another alternative, the reverse primer SEQ ID NO. 31 can be used with any of the four N-terminal forward primers to yield fragments of approximately 2550-3100 bp; 1750-2150 bp with the forward primers SEQ ID NOS. 15 or 16; 850-1400 bp with SEQ ID NOS. 12 or 13; and 550-1050 bp with the forward primer (TTTAGATCGT(A or C)TTGA(G or A)TTT(A or G)T(A or T)CC (SEQ ID NO. 35).

As yet another alternative, the ITSED (SEQ ID NO 36) reverse primer (TCTCCATCTTCTGA(G or A)G(T or A)AAT) (SEQ ID NO. 37) can be used with the N-terminal forward primers (SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 27, and SEQ ID NO. 29) to yield fragments of approximately 3550-4050 bp; 2600-3100 bp with forward primers SEQ ID NOS. 15 or 16; 1800-2400 bp with forward primers SEQ ID NOS. 12 or 13; and 1500-2050 bp with forward primer SEQ ID NO. 35.

Amplified DNA fragments of the indicated sizes can be radiolabeled and used as probes to clone the entire gene as in Example 6.

EXAMPLE 13

Insertion of Toxin Gene Into Plants

One aspect of the subject invention is the transformation of plants with genes coding for a formicidal toxin. The transformed plants are resistant to attack by ants.

Genes encoding formicidal toxins, as disclosed herein, can be inserted into plant cells using a variety of techniques which are well known in the art. For example, a large number of cloning vectors comprising a replication system in E. coli and a marker that permits selection of the transformed cells are available for preparation for the insertion of foreign genes into higher plants. The vectors comprise, for example, pBR322, pUC series, M13mp series, pACYC184, etc. Accordingly, the sequence encoding the B.t. toxin can be inserted into the vector at a suitable restriction site. The resulting plasmid is used for transformation into E. coli. The E. coli cells are cultivated in a suitable nutrient medium, then harvested and lysed. The plasmid is recovered. Sequence analysis, restriction analysis, electrophoresis, and other biochemical-molecular biological methods are generally carried out as methods of analysis. After each manipulation, the DNA sequence used can be cleaved and joined to the next DNA sequence. Each plasmid sequence can be cloned in the same or other plasmids. Depending on the method of inserting desired genes into the plant, other DNA sequences may be necessary. If, for example, the Ti or Ri plasmid is used for the transformation of the plant cell, then at least the right border, but often the right and the left border of the Ti or Ri plasmid T-DNA, has to be joined as the flanking region of the genes to be inserted.

The use of T-DNA for the transformation of plant cells has been intensively researched and sufficiently described in EP 120 516; Hoekema (1985) In: The Binary Plant Vector System, Offset-durkkerij Kanters B. V., Alblasserdam, Chapter 5; Fraley et al., Crit. Rev. Plant Sci. 4:1-46; and An et al. (1985) EMBO J. 4:277-287.

Once the inserted DNA has been integrated in the genome, it is relatively stable there and, as a rule, does not come out again. It normally contains a selection marker that confers on the transformed plant cells resistance to a biocide or an antibiotic, such as kanamycin, G 418, bleomycin, hygromycin, or chloramphenicol, inter alia. The individually employed marker should accordingly permit the selection of transformed cells rather than cells that do not contain the inserted DNA.

A large number of techniques are available for inserting DNA into a plant host cell. Those techniques include transformation with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agent, fusion, injection, or electroporation as well as other possible methods. If agrobacteria are used for the transformation, the DNA to be inserted has to be cloned into special plasmids, namely either into an intermediate vector or into a binary vector. The intermediate vectors can be integrated into the Ti or Ri plasmid by homologous recombination owing to sequences that are homologous to sequences in the T-DNA. The Ti or Ri plasmid also comprises the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate themselves in agrobacteria. The intermediate vector can be transferred into Agrobacterium tumefaciens by means of a helper plasmid (conjugation). Binary vectors can replicate themselves both in E. coli and in agrobacteria. They comprise a selection marker gene and a linker or polylinker which are framed by the right and left T-DNA border regions. They can be transformed directly into agrobacteria (Holsters et al. 1978! Mol. Gen. Genet. 163:181-187). The agrobacterium used as host cell is to comprise a plasmid carrying a vir region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be contained. The bacterium so transformed is used for the transformation of plant cells. Plant explants can advantageously be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes for the transfer of the DNA into the plant cell. Whole plants can then be regenerated from the infected plant material (for example, pieces of leaf, segments of stalk, roots, but also protoplasts or suspension-cultivated cells) in a suitable medium, which may contain antibiotics or biocides for selection. The plants so obtained can then be tested for the presence of the inserted DNA. No special demands are made of the plasmids in the case of injection and electroporation. It is possible to use ordinary plasmids, such as, for example, pUC derivatives.

The transformed cells grow inside the plants in the usual manner. They can form germ cells and transmit the transformed trait(s) to progeny plants. Such plants can be grown in the normal manner and crossed with plants that have the same transformed hereditary factors or other hereditary factors. The resulting hybrid individuals have the corresponding phenotypic properties.

In a preferred embodiment of the subject invention, plants will be transformed with genes wherein the codon usage has been optimized for plants. Also, advantageously, plants encoding a truncated toxin will be used. The truncated toxin typically will encode about 55% to about 80% of the full length toxin. Methods for creating synthetic B.t. genes for use in plants are known in the art.

EXAMPLE 14

Cloning of Novel B. thuringiensis Genes Into Insect Viruses

A number of viruses are known to infect insects. These viruses include, for example, baculoviruses and entomopoxviruses. In one embodiment of the subject invention, ant-active genes, as described herein, can be placed with the genome of the insect virus, thus enhancing the pathogenicity of the virus. Methods for constructing insect viruses which comprise B.t. toxin genes are well known and readily practiced by those skilled in the art. These procedures are described, for example, in Merryweather et al. (Merryweather, A. T., U. Weyer, M. P. G. Harris, M. Hirst, T. Booth, R. D. Possee (1990) J. Gen. Virol. 71:1535-1544) and Martens et al. (Martens, J. W. M., G. Honee, D. Zuidema, J. W. M. van Lent, B. Visser, J. M. Vlak (1990) Appl. Environmental Microbiol. 56(9):2764-2770).

It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims.

    __________________________________________________________________________     SEQUENCE LISTING                                                               (1) GENERAL INFORMATION:                                                       (iii) NUMBER OF SEQUENCES: 51                                                  (2) INFORMATION FOR SEQ ID NO:1:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 4155 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (iii) HYPOTHETICAL: NO                                                         (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (B) STRAIN: PS17                                                               (C) INDIVIDUAL ISOLATE: PS17a                                                  (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC1627) NRRL B-18651                                (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                                        ATGGCAATTTTAAATGAATTATATCCATCTGTACCTTATAATGTATTGGCGTATACGCCA60                 CCCTCTTTTTTACCTGATGCGGGTACACAAGCTACACCTGCTGACTTAACAGCTTATGAA120                CAATTGTTGAAAAATTTAGAAAAAGGGATAAATGCTGGAACTTATTCGAAAGCAATAGCT180                GATGTACTTAAAGGTATTTTTATAGATGATACAATAAATTATCAAACATATGTAAATATT240                GGTTTAAGTTTAATTACATTAGCTGTACCGGAAATTGGTATTTTTACACCTTTCATCGGT300                TTGTTTTTTGCTGCATTGAATAAACATGATGCTCCACCTCCTCCTAATGCAAAAGATATA360                TTTGAGGCTATGAAACCAGCGATTCAAGAGATGATTGATAGAACTTTAACTGCGGATGAG420                CAAACATTTTTAAATGGGGAAATAAGTGGTTTACAAAATTTAGCAGCAAGATACCAGTCT480                ACAATGGATGATATTCAAAGCCATGGAGGATTTAATAAGGTAGATTCTGGATTAATTAAA540                AAGTTTACAGATGAGGTACTATCTTTAAATAGTTTTTATACAGATCGTTTACCTGTATTT600                ATTACAGATAATACAGCGGATCGAACTTTGTTAGGTCTTCCTTATTATGCTATACTTGCG660                AGCATGCATCTTATGTTATTAAGAGATATCATTACTAAGGGTCCGACATGGGATTCTAAA720                ATTAATTTCACACCAGATGCAATTGATTCCTTTAAAACCGATATTAAAAATAATATAAAG780                CTTTACTCTAAAACTATTTATGACGTATTTCAGAAGGGACTTGCTTCATACGGAACGCCT840                TCTGATTTAGAGTCCTTTGCAAAAAAACAAAAATATATTGAAATTATGACAACACATTGT900                TTAGATTTTGCAAGATTGTTTCCTACTTTTGATCCAGATCTTTATCCAACAGGATCAGGT960                GATATAAGTTTACAAAAAACACGTAGAATTCTTTCTCCTTTTATCCCTATACGTACTGCA1020               GATGGGTTAACATTAAATAATACTTCAATTGATACTTCAAATTGGCCTAATTATGAAAAT1080               GGGAATGGCGCGTTTCCAAACCCAAAAGAAAGAATATTAAAACAATTCAAACTGTATCCT1140               AGTTGGAGAGCGGGACAGTACGGTGGGCTTTTACAACCTTATTTATGGGCAATAGAAGTC1200               CAAGATTCTGTAGAGACTCGTTTGTATGGGCAGCTTCCAGCTGTAGATCCACAGGCAGGG1260               CCTAATTATGTTTCCATAGATTCTTCTAATCCAATCATACAAATAAATATGGATACTTGG1320               AAAACACCACCACAAGGTGCGAGTGGGTGGAATACAAATTTAATGAGAGGAAGTGTAAGC1380               GGGTTAAGTTTTTTACAACGAGATGGTACGAGACTTAGTGCTGGTATGGGTGGTGGTTTT1440               GCTGATACAATATATAGTCTCCCTGCAACTCATTATCTTTCTTATCTCTATGGAACTCCT1500               TATCAAACTTCTGATAACTATTCTGGTCACGTTGGTGCATTGGTAGGTGTGAGTACGCCT1560               CAAGAGGCTACTCTTCCTAATATTATAGGTCAACCAGATGAACAGGGAAATGTATCTACA1620               ATGGGATTTCCGTTTGAAAAAGCTTCTTATGGAGGTACAGTTGTTAAAGAATGGTTAAAT1680               GGTGCGAATGCGATGAAGCTTTCTCCTGGGCAATCTATAGGTATTCCTATTACAAATGTA1740               ACAAGTGGAGAATATCAAATTCGTTGTCGTTATGCAAGTAATGATAATACTAACGTTTTC1800               TTTAATGTAGATACTGGTGGAGCAAATCCAATTTTCCAACAGATAAACTTTGCATCTACT1860               GTAGATAATAATACGGGAGTACAAGGAGCAAATGGTGTCTATGTAGTCAAATCTATTGCT1920               ACAACTGATAATTCTTTTACAGAAATTCCTGCGAAGACGATTAATGTTCATTTAACCAAC1980               CAAGGTTCTTCTGATGTCTTTTTAGACCGTATTGAATTTATACCTTTTTCTCTACCTCTT2040               ATATATCATGGAAGTTATAATACTTCATCAGGTGCAGATGATGTTTTATGGTCTTCTTCA2100               AATATGAATTACTACGATATAATAGTAAATGGTCAGGCCAATAGTAGTAGTATCGCTAGT2160               TCTATGCATTTGCTTAATAAAGGAAAAGTGATAAAAACAATTGATATTCCAGGGCATTCG2220               GAAACCTTCTTTGCTACGTTCCCAGTTCCAGAAGGATTTAATGAAGTTAGAATTCTTGCT2280               GGCCTTCCAGAAGTTAGTGGAAATATTACCGTACAATCTAATAATCCGCCTCAACCTAGT2340               AATAATGGTGGTGGTGATGGTGGTGGTAATGGTGGTGGTGATGGTGGTCAATACAATTTT2400               TCTTTAAGCGGATCTGATCATACGACTATTTATCATGGAAAACTTGAAACTGGGATTCAT2460               GTACAAGGTAATTATACCTATACAGGTACTCCCGTATTAATACTGAATGCTTACAGAAAT2520               AATACTGTAGTATCAAGCATTCCAGTATATTCTCCTTTTGATATAACTATACAGACAGAA2580               GCTGATAGCCTTGAGCTTGAACTACAACCTAGATATGGTTTTGCCACAGTGAATGGTACT2640               GCAACAGTAAAAAGTCCTAATGTAAATTACGATAGATCATTTAAACTCCCAATAGACTTA2700               CAAAATATCACAACACAAGTAAATGCATTATTCGCATCTGGAACACAAAATATGCTTGCT2760               CATAATGTAAGTGATCATGATATTGAAGAAGTTGTATTAAAAGTGGATGCCTTATCAGAT2820               GAAGTATTTGGAGATGAGAAGAAGGCTTTACGTAAATTGGTGAATCAAGCAAAACGTTTG2880               AGTAGAGCAAGAAATCTTCTGATAGGTGGGAGTTTTGAAAATTGGGATGCATGGTATAAA2940               GGAAGAAATGTAGTAACTGTATCTGATCATGAACTATTTAAGAGTGATCATGTATTATTA3000               CCACCACCAGGATTGTCTCCATCTTATATTTTCCAAAAAGTGGAGGAATCTAAATTAAAA3060               CCAAATACACGTTATATTGTTTCTGGATTCATCGCACATGGAAAAGACCTAGAAATTGTT3120               GTTTCACGTTATGGGCAAGAAGTGCAAAAGGTCGTGCAAGTTCCTTATGGAGAAGCATTC3180               CCGTTAACATCAAATGGACCAGTTTGTTGTCCCCCACGTTCTACAAGTAATGGAACCTTA3240               GGAGATCCACATTTCTTTAGTTACAGTATCGATGTAGGTGCACTAGATTTACAAGCAAAC3300               CCTGGTATTGAATTTGGTCTTCGTATTGTAAATCCAACTGGAATGGCACGCGTAAGCAAT3360               TTGGAAATTCGTGAAGATCGTCCATTAGCAGCAAATGAAATACGACAAGTACAACGTGTC3420               GCAAGAAATTGGAGAACCGAGTATGAGAAAGAACGTGCGGAAGTAACAAGTTTAATTCAA3480               CCTGTTATCAATCGAATCAACGGATTGTATGAAAATGGAAATTGGAACGGTTCTATTCGT3540               TCAGATATTTCGTATCAGAATATAGACGCGATTGTATTACCAACGTTACCAAAGTTACGC3600               CATTGGTTTATGTCAGATAGATTCAGTGAACAAGGAGATATAATGGCTAAATTCCAAGGT3660               GCATTAAATCGTGCGTATGCACAACTGGAACAAAGTACGCTTCTGCATAATGGTCATTTT3720               ACAAAAGATGCAGCTAATTGGACAATAGAAGGCGATGCACATCAGATAACACTAGAAGAT3780               GGTAGACGTGTATTGCGACTTCCAGATTGGTCTTCGAGTGTATCTCAAATGATTGAAATC3840               GAGAATTTTAATCCAGATAAAGAATACAACTTAGTATTCCATGGGCAAGGAGAAGGAACG3900               GTTACGTTGGAGCATGGAGAAGAAACAAAATATATAGAAACGCATACACATCATTTTGCG3960               AATTTTACAACTTCTCAACGTCAAGGACTCACGTTTGAATCAAATAAAGTGACAGTGACC4020               ATTTCTTCAGAAGATGGAGAATTCTTAGTGGATAATATTGCGCTTGTGGAAGCTCCTCTT4080               CCTACAGATGACCAAAATTCTGAGGGAAATACGGCTTCCAGTACGAATAGCGATACAAGT4140               ATGAACAACAATCAA4155                                                            (2) INFORMATION FOR SEQ ID NO:2:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1385 amino acids                                                   (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: protein                                                    (iii) HYPOTHETICAL: YES                                                        (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: BACILLUS THURINGIENSIS                                           (B) STRAIN: PS17                                                               (C) INDIVIDUAL ISOLATE: PS17a                                                  (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC1627) NRRL B-18651                                (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                                        MetAlaIleLeuAsnGluLeuTyrProSerValProTyrAsnValLeu                               151015                                                                         AlaTyrThrProProSerPheLeuProAspAlaGlyThrGlnAlaThr                               202530                                                                         ProAlaAspLeuThrAlaTyrGluGlnLeuLeuLysAsnLeuGluLys                               354045                                                                         GlyIleAsnAlaGlyThrTyrSerLysAlaIleAlaAspValLeuLys                               505560                                                                         GlyIlePheIleAspAspThrIleAsnTyrGlnThrTyrValAsnIle                               65707580                                                                       GlyLeuSerLeuIleThrLeuAlaValProGluIleGlyIlePheThr                               859095                                                                         ProPheIleGlyLeuPhePheAlaAlaLeuAsnLysHisAspAlaPro                               100105110                                                                      ProProProAsnAlaLysAspIlePheGluAlaMetLysProAlaIle                               115120125                                                                      GlnGluMetIleAspArgThrLeuThrAlaAspGluGlnThrPheLeu                               130135140                                                                      AsnGlyGluIleSerGlyLeuGlnAsnLeuAlaAlaArgTyrGlnSer                               145150155160                                                                   ThrMetAspAspIleGlnSerHisGlyGlyPheAsnLysValAspSer                               165170175                                                                      GlyLeuIleLysLysPheThrAspGluValLeuSerLeuAsnSerPhe                               180185190                                                                      TyrThrAspArgLeuProValPheIleThrAspAsnThrAlaAspArg                               195200205                                                                      ThrLeuLeuGlyLeuProTyrTyrAlaIleLeuAlaSerMetHisLeu                               210215220                                                                      MetLeuLeuArgAspIleIleThrLysGlyProThrTrpAspSerLys                               225230235240                                                                   IleAsnPheThrProAspAlaIleAspSerPheLysThrAspIleLys                               245250255                                                                      AsnAsnIleLysLeuTyrSerLysThrIleTyrAspValPheGlnLys                               260265270                                                                      GlyLeuAlaSerTyrGlyThrProSerAspLeuGluSerPheAlaLys                               275280285                                                                      LysGlnLysTyrIleGluIleMetThrThrHisCysLeuAspPheAla                               290295300                                                                      ArgLeuPheProThrPheAspProAspLeuTyrProThrGlySerGly                               305310315320                                                                   AspIleSerLeuGlnLysThrArgArgIleLeuSerProPheIlePro                               325330335                                                                      IleArgThrAlaAspGlyLeuThrLeuAsnAsnThrSerIleAspThr                               340345350                                                                      SerAsnTrpProAsnTyrGluAsnGlyAsnGlyAlaPheProAsnPro                               355360365                                                                      LysGluArgIleLeuLysGlnPheLysLeuTyrProSerTrpArgAla                               370375380                                                                      GlyGlnTyrGlyGlyLeuLeuGlnProTyrLeuTrpAlaIleGluVal                               385390395400                                                                   GlnAspSerValGluThrArgLeuTyrGlyGlnLeuProAlaValAsp                               405410415                                                                      ProGlnAlaGlyProAsnTyrValSerIleAspSerSerAsnProIle                               420425430                                                                      IleGlnIleAsnMetAspThrTrpLysThrProProGlnGlyAlaSer                               435440445                                                                      GlyTrpAsnThrAsnLeuMetArgGlySerValSerGlyLeuSerPhe                               450455460                                                                      LeuGlnArgAspGlyThrArgLeuSerAlaGlyMetGlyGlyGlyPhe                               465470475480                                                                   AlaAspThrIleTyrSerLeuProAlaThrHisTyrLeuSerTyrLeu                               485490495                                                                      TyrGlyThrProTyrGlnThrSerAspAsnTyrSerGlyHisValGly                               500505510                                                                      AlaLeuValGlyValSerThrProGlnGluAlaThrLeuProAsnIle                               515520525                                                                      IleGlyGlnProAspGluGlnGlyAsnValSerThrMetGlyPhePro                               530535540                                                                      PheGluLysAlaSerTyrGlyGlyThrValValLysGluTrpLeuAsn                               545550555560                                                                   GlyAlaAsnAlaMetLysLeuSerProGlyGlnSerIleGlyIlePro                               565570575                                                                      IleThrAsnValThrSerGlyGluTyrGlnIleArgCysArgTyrAla                               580585590                                                                      SerAsnAspAsnThrAsnValPhePheAsnValAspThrGlyGlyAla                               595600605                                                                      AsnProIlePheGlnGlnIleAsnPheAlaSerThrValAspAsnAsn                               610615620                                                                      ThrGlyValGlnGlyAlaAsnGlyValTyrValValLysSerIleAla                               625630635640                                                                   ThrThrAspAsnSerPheThrGluIleProAlaLysThrIleAsnVal                               645650655                                                                      HisLeuThrAsnGlnGlySerSerAspValPheLeuAspArgIleGlu                               660665670                                                                      PheIleProPheSerLeuProLeuIleTyrHisGlySerTyrAsnThr                               675680685                                                                      SerSerGlyAlaAspAspValLeuTrpSerSerSerAsnMetAsnTyr                               690695700                                                                      TyrAspIleIleValAsnGlyGlnAlaAsnSerSerSerIleAlaSer                               705710715720                                                                   SerMetHisLeuLeuAsnLysGlyLysValIleLysThrIleAspIle                               725730735                                                                      ProGlyHisSerGluThrPhePheAlaThrPheProValProGluGly                               740745750                                                                      PheAsnGluValArgIleLeuAlaGlyLeuProGluValSerGlyAsn                               755760765                                                                      IleThrValGlnSerAsnAsnProProGlnProSerAsnAsnGlyGly                               770775780                                                                      GlyAspGlyGlyGlyAsnGlyGlyGlyAspGlyGlyGlnTyrAsnPhe                               785790795800                                                                   SerLeuSerGlySerAspHisThrThrIleTyrHisGlyLysLeuGlu                               805810815                                                                      ThrGlyIleHisValGlnGlyAsnTyrThrTyrThrGlyThrProVal                               820825830                                                                      LeuIleLeuAsnAlaTyrArgAsnAsnThrValValSerSerIlePro                               835840845                                                                      ValTyrSerProPheAspIleThrIleGlnThrGluAlaAspSerLeu                               850855860                                                                      GluLeuGluLeuGlnProArgTyrGlyPheAlaThrValAsnGlyThr                               865870875880                                                                   AlaThrValLysSerProAsnValAsnTyrAspArgSerPheLysLeu                               885890895                                                                      ProIleAspLeuGlnAsnIleThrThrGlnValAsnAlaLeuPheAla                               900905910                                                                      SerGlyThrGlnAsnMetLeuAlaHisAsnValSerAspHisAspIle                               915920925                                                                      GluGluValValLeuLysValAspAlaLeuSerAspGluValPheGly                               930935940                                                                      AspGluLysLysAlaLeuArgLysLeuValAsnGlnAlaLysArgLeu                               945950955960                                                                   SerArgAlaArgAsnLeuLeuIleGlyGlySerPheGluAsnTrpAsp                               965970975                                                                      AlaTrpTyrLysGlyArgAsnValValThrValSerAspHisGluLeu                               980985990                                                                      PheLysSerAspHisValLeuLeuProProProGlyLeuSerProSer                               99510001005                                                                    TyrIlePheGlnLysValGluGluSerLysLeuLysProAsnThrArg                               101010151020                                                                   TyrIleValSerGlyPheIleAlaHisGlyLysAspLeuGluIleVal                               1025103010351040                                                               ValSerArgTyrGlyGlnGluValGlnLysValValGlnValProTyr                               104510501055                                                                   GlyGluAlaPheProLeuThrSerAsnGlyProValCysCysProPro                               106010651070                                                                   ArgSerThrSerAsnGlyThrLeuGlyAspProHisPhePheSerTyr                               107510801085                                                                   SerIleAspValGlyAlaLeuAspLeuGlnAlaAsnProGlyIleGlu                               109010951100                                                                   PheGlyLeuArgIleValAsnProThrGlyMetAlaArgValSerAsn                               1105111011151120                                                               LeuGluIleArgGluAspArgProLeuAlaAlaAsnGluIleArgGln                               112511301135                                                                   ValGlnArgValAlaArgAsnTrpArgThrGluTyrGluLysGluArg                               114011451150                                                                   AlaGluValThrSerLeuIleGlnProValIleAsnArgIleAsnGly                               115511601165                                                                   LeuTyrGluAsnGlyAsnTrpAsnGlySerIleArgSerAspIleSer                               117011751180                                                                   TyrGlnAsnIleAspAlaIleValLeuProThrLeuProLysLeuArg                               1185119011951200                                                               HisTrpPheMetSerAspArgPheSerGluGlnGlyAspIleMetAla                               120512101215                                                                   LysPheGlnGlyAlaLeuAsnArgAlaTyrAlaGlnLeuGluGlnSer                               122012251230                                                                   ThrLeuLeuHisAsnGlyHisPheThrLysAspAlaAlaAsnTrpThr                               123512401245                                                                   IleGluGlyAspAlaHisGlnIleThrLeuGluAspGlyArgArgVal                               125012551260                                                                   LeuArgLeuProAspTrpSerSerSerValSerGlnMetIleGluIle                               1265127012751280                                                               GluAsnPheAsnProAspLysGluTyrAsnLeuValPheHisGlyGln                               128512901295                                                                   GlyGluGlyThrValThrLeuGluHisGlyGluGluThrLysTyrIle                               130013051310                                                                   GluThrHisThrHisHisPheAlaAsnPheThrThrSerGlnArgGln                               131513201325                                                                   GlyLeuThrPheGluSerAsnLysValThrValThrIleSerSerGlu                               133013351340                                                                   AspGlyGluPheLeuValAspAsnIleAlaLeuValGluAlaProLeu                               1345135013551360                                                               ProThrAspAspGlnAsnSerGluGlyAsnThrAlaSerSerThrAsn                               136513701375                                                                   SerAspThrSerMetAsnAsnAsnGln                                                    13801385                                                                       (2) INFORMATION FOR SEQ ID NO:3:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 3867 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (iii) HYPOTHETICAL: NO                                                         (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (B) STRAIN: PS17                                                               (C) INDIVIDUAL ISOLATE: PS17b                                                  (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC1628) NRRL B-18652                                (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:                                        ATGGCAATTTTAAATGAATTATATCCATCTGTACCTTATAATGTATTGGCGTATACGCCA60                 CCCTCTTTTTTACCTGATGCGGGTACACAAGCTACACCTGCTGACTTAACAGCTTATGAA120                CAATTGTTGAAAAATTTAGAAAAAGGGATAAATGCTGGAACTTATTCGAAAGCAATAGCT180                GATGTACTTAAAGGTATTTTTATAGATGATACAATAAATTATCAAACATATGTAAATATT240                GGTTTAAGTTTAATTACATTAGCTGTACCGGAAATTGGTATTTTTACACCTTTCATCGGT300                TTGTTTTTTGCTGCATTGAATAAACATGATGCTCCACCTCCTCCTAATGCAAAAGATATA360                TTTGAGGCTATGAAACCAGCGATTCAAGAGATGATTGATAGAACTTTAACTGCGGATGAG420                CAAACATTTTTAAATGGGGAAATAAGTGGTTTACAAAATTTAGCAGCAAGATACCAGTCT480                ACAATGGATGATATTCAAAGCCATGGAGGATTTAATAAGGTAGATTCTGGATTAATTAAA540                AAGTTTACAGATGAGGTACTATCTTTAAATAGTTTTTATACAGATCGTTTACCTGTATTT600                ATTACAGATAATACAGCGGATCGAACTTTGTTAGGTCTTCCTTATTATGCTATACTTGCG660                AGCATGCATCTTATGTTATTAAGAGATATCATTACTAAGGGTCCGACATGGGATTCTAAA720                ATTAATTTCACACCAGATGCAATTGATTCCTTTAAAACCGATATTAAAAATAATATAAAG780                CTTTACTCTAAAACTATTTATGACGTATTTCAGAAGGGACTTGCTTCATACGGAACGCCT840                TCTGATTTAGAGTCCTTTGCAAAAAAACAAAAATATATTGAAATTATGACAACACATTGT900                TTAGATTTTGCAAGATTGTTTCCTACTTTTGATCCAGATCTTTATCCAACAGGATCAGGT960                GATATAAGTTTACAAAAAACACGTAGAATTCTTTCTCCTTTTATCCCTATACGTACTGCA1020               GATGGGTTAACATTAAATAATACTTCAATTGATACTTCAAATTGGCCTAATTATGAAAAT1080               GGGAATGGCGCGTTTCCAAACCCAAAAGAAAGAATATTAAAACAATTCAAACTGTATCCT1140               AGTTGGAGAGCGGCACAGTACGGTGGGCTTTTACAACCTTATTTATGGGCAATAGAAGTC1200               CAAGATTCTGTAGAGACTCGTTTGTATGGGCAGCTTCCAGCTGTAGATCCACAGGCAGGG1260               CCTAATTATGTTTCCATAGATTCTTCTAATCCAATCATACAAATAAATATGGATACTTGG1320               AAAACACCACCACAAGGTGCGAGTGGGTGGAATACAAATTTAATGAGAGGAAGTGTAAGC1380               GGGTTAAGTTTTTTACAACGAGATGGTACGAGACTTAGTGCTGGTATGGGTGGTGGTTTT1440               GCTGATACAATATATAGTCTCCCTGCAACTCATTATCTTTCTTATCTCTATGGAACTCCT1500               TATCAAACTTCTGATAACTATTCTGGTCACGTTGGTGCATTGGTAGGTGTGAGTACGCCT1560               CAAGAGGCTACTCTTCCTAATATTATAGGTCAACCAGATGAACAGGGAAATGTATCTACA1620               ATGGGATTTCCGTTTGAAAAAGCTTCTTATGGAGGTACAGTTGTTAAAGAATGGTTAAAT1680               GGTGCGAATGCGATGAAGCTTTCTCCTGGGCAATCTATAGGTATTCCTATTACAAATGTA1740               ACAAGTGGAGAATATCAAATTCGTTGTCGTTATGCAAGTAATGATAATACTAACGTTTTC1800               TTTAATGTAGATACTGGTGGAGCAAATCCAATTTTCCAACAGATAAACTTTGCATCTACT1860               GTAGATAATAATACGGGAGTACAAGGAGCAAATGGTGTCTATGTAGTCAAATCTATTGCT1920               ACAACTGATAATTCTTTTACAGTAAAAATTCCTGCGAAGACGATTAATGTTCATTTAACC1980               AACCAAGGTTCTTCTGATGTCTTTTTAGATCGTATTGAGTTTGTTCCAATTCTAGAATCA2040               AATACTGTAACTATATTCAACAATTCATATACTACAGGTTCAGCAAATCTTATACCAGCA2100               ATAGCTCCTCTTTGGAGTACTAGTTCAGATAAAGCCCTTACAGGTTCTATGTCAATAACA2160               GGTCGAACTACCCCTAACAGTGATGATGCTTTGCTTCGATTTTTTAAAACTAATTATGAT2220               ACACAAACCATTCCTATTCCGGGTTCCGGAAAAGATTTTACAAATACTCTAGAAATACAA2280               GACATAGTTTCTATTGATATTTTTGTCGGATCTGGTCTACATGGATCCGATGGATCTATA2340               AAATTAGATTTTACCAATAATAATAGTGGTAGTGGTGGCTCTCCAAAGAGTTTCACCGAG2400               CAAAATGATTTAGAGAATATCACAACACAAGTGAATGCTCTATTCACATCTAATACACAA2460               GATGCACTTGCAACAGATGTGAGTGATCATGATATTGAAGAAGTGGTTCTAAAAGTAGAT2520               GCATTATCTGATGAAGTGTTTGGAAAAGAGAAAAAAACATTGCGTAAATTTGTAAATCAA2580               GCGAAGCGCTTAAGCAAGGCGCGTAATCTCCTGGTAGGAGGCAATTTTGATAACTTGGAT2640               GCTTGGTATAGAGGAAGAAATGTAGTAAACGTATCTAATCACGAACTGTTGAAGAGTGAT2700               CATGTATTATTACCACCACCAGGATTGTCTCCATCTTATATTTTCCAAAAAGTGGAGGAA2760               TCTAAATTAAAACGAAATACACGTTATACGGTTTCTGGATTTATTGCGCATGCAACAGAT2820               TTAGAAATTGTGGTTTCTCGTTATGGGCAAGAAATAAAGAAAGTGGTGCAAGTTCCTTAT2880               GGAGAAGCATTCCCATTAACATCAAGTGGACCAGTTTGTTGTATCCCACATTCTACAAGT2940               AATGGAACTTTAGGCAATCCACATTTCTTTAGTTACAGTATTGATGTAGGTGCATTAGAT3000               GTAGACACAAACCCTGGTATTGAATTCGGTCTTCGTATTGTAAATCCAACTGGAATGGCA3060               CGCGTAAGCAATTTGGAAATTCGTGAAGATCGTCCATTAGCAGCAAATGAAATACGACAA3120               GTACAACGTGTCGCAAGAAATTGGAGAACCGAGTATGAGAAAGAACGTGCGGAAGTAACA3180               AGTTTAATTCAACCTGTTATCAATCGAATCAATGGATTGTATGACAATGGAAATTGGAAC3240               GGTTCTATTCGTTCAGATATTTCGTATCAGAATATAGACGCGATTGTATTACCAACGTTA3300               CCAAAGTTACGCCATTGGTTTATGTCAGATAGATTTAGTGAACAAGGAGATATCATGGCT3360               AAATTCCAAGGTGCATTAAATCGTGCGTATGCACAACTGGAACAAAATACGCTTCTGCAT3420               AATGGTCATTTTACAAAAGATGCAGCCAATTGGACGGTAGAAGGCGATGCACATCAGGTA3480               GTATTAGAAGATGGTAAACGTGTATTACGATTGCCAGATTGGTCTTCGAGTGTGTCTCAA3540               ACGATTGAAATCGAGAATTTTGATCCAGATAAAGAATATCAATTAGTATTTCATGGGCAA3600               GGAGAAGGAACGGTTACGTTGGAGCATGGAGAAGAAACAAAATATATAGAAACGCATACA3660               CATCATTTTGCGAATTTTACAACTTCTCAACGTCAAGGACTCACGTTTGAATCAAATAAA3720               GTGACAGTGACCATTTCTTCAGAAGATGGAGAATTCTTAGTGGATAATATTGCGCTTGTG3780               GAAGCTCCTCTTCCTACAGATGACCAAAATTCTGAGGGAAATACGGCTTCCAGTACGAAT3840               AGCGATACAAGTATGAACAACAATCAA3867                                                (2) INFORMATION FOR SEQ ID NO:4:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1289 amino acids                                                   (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: protein                                                    (iii) HYPOTHETICAL: YES                                                        (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: BACILLUS THURINGIENSIS                                           (B) STRAIN: PS17                                                               (C) INDIVIDUAL ISOLATE: PS17b                                                  (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC1628) NRRL B-18652                                (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:                                        MetAlaIleLeuAsnGluLeuTyrProSerValProTyrAsnValLeu                               151015                                                                         AlaTyrThrProProSerPheLeuProAspAlaGlyThrGlnAlaThr                               202530                                                                         ProAlaAspLeuThrAlaTyrGluGlnLeuLeuLysAsnLeuGluLys                               354045                                                                         GlyIleAsnAlaGlyThrTyrSerLysAlaIleAlaAspValLeuLys                               505560                                                                         GlyIlePheIleAspAspThrIleAsnTyrGlnThrTyrValAsnIle                               65707580                                                                       GlyLeuSerLeuIleThrLeuAlaValProGluIleGlyIlePheThr                               859095                                                                         ProPheIleGlyLeuPhePheAlaAlaLeuAsnLysHisAspAlaPro                               100105110                                                                      ProProProAsnAlaLysAspIlePheGluAlaMetLysProAlaIle                               115120125                                                                      GlnGluMetIleAspArgThrLeuThrAlaAspGluGlnThrPheLeu                               130135140                                                                      AsnGlyGluIleSerGlyLeuGlnAsnLeuAlaAlaArgTyrGlnSer                               145150155160                                                                   ThrMetAspAspIleGlnSerHisGlyGlyPheAsnLysValAspSer                               165170175                                                                      GlyLeuIleLysLysPheThrAspGluValLeuSerLeuAsnSerPhe                               180185190                                                                      TyrThrAspArgLeuProValPheIleThrAspAsnThrAlaAspArg                               195200205                                                                      ThrLeuLeuGlyLeuProTyrTyrAlaIleLeuAlaSerMetHisLeu                               210215220                                                                      MetLeuLeuArgAspIleIleThrLysGlyProThrTrpAspSerLys                               225230235240                                                                   IleAsnPheThrProAspAlaIleAspSerPheLysThrAspIleLys                               245250255                                                                      AsnAsnIleLysLeuTyrSerLysThrIleTyrAspValPheGlnLys                               260265270                                                                      GlyLeuAlaSerTyrGlyThrProSerAspLeuGluSerPheAlaLys                               275280285                                                                      LysGlnLysTyrIleGluIleMetThrThrHisCysLeuAspPheAla                               290295300                                                                      ArgLeuPheProThrPheAspProAspLeuTyrProThrGlySerGly                               305310315320                                                                   AspIleSerLeuGlnLysThrArgArgIleLeuSerProPheIlePro                               325330335                                                                      IleArgThrAlaAspGlyLeuThrLeuAsnAsnThrSerIleAspThr                               340345350                                                                      SerAsnTrpProAsnTyrGluAsnGlyAsnGlyAlaPheProAsnPro                               355360365                                                                      LysGluArgIleLeuLysGlnPheLysLeuTyrProSerTrpArgAla                               370375380                                                                      AlaGlnTyrGlyGlyLeuLeuGlnProTyrLeuTrpAlaIleGluVal                               385390395400                                                                   GlnAspSerValGluThrArgLeuTyrGlyGlnLeuProAlaValAsp                               405410415                                                                      ProGlnAlaGlyProAsnTyrValSerIleAspSerSerAsnProIle                               420425430                                                                      IleGlnIleAsnMetAspThrTrpLysThrProProGlnGlyAlaSer                               435440445                                                                      GlyTrpAsnThrAsnLeuMetArgGlySerValSerGlyLeuSerPhe                               450455460                                                                      LeuGlnArgAspGlyThrArgLeuSerAlaGlyMetGlyGlyGlyPhe                               465470475480                                                                   AlaAspThrIleTyrSerLeuProAlaThrHisTyrLeuSerTyrLeu                               485490495                                                                      TyrGlyThrProTyrGlnThrSerAspAsnTyrSerGlyHisValGly                               500505510                                                                      AlaLeuValGlyValSerThrProGlnGluAlaThrLeuProAsnIle                               515520525                                                                      IleGlyGlnProAspGluGlnGlyAsnValSerThrMetGlyPhePro                               530535540                                                                      PheGluLysAlaSerTyrGlyGlyThrValValLysGluTrpLeuAsn                               545550555560                                                                   GlyAlaAsnAlaMetLysLeuSerProGlyGlnSerIleGlyIlePro                               565570575                                                                      IleThrAsnValThrSerGlyGluTyrGlnIleArgCysArgTyrAla                               580585590                                                                      SerAsnAspAsnThrAsnValPhePheAsnValAspThrGlyGlyAla                               595600605                                                                      AsnProIlePheGlnGlnIleAsnPheAlaSerThrValAspAsnAsn                               610615620                                                                      ThrGlyValGlnGlyAlaAsnGlyValTyrValValLysSerIleAla                               625630635640                                                                   ThrThrAspAsnSerPheThrValLysIleProAlaLysThrIleAsn                               645650655                                                                      ValHisLeuThrAsnGlnGlySerSerAspValPheLeuAspArgIle                               660665670                                                                      GluPheValProIleLeuGluSerAsnThrValThrIlePheAsnAsn                               675680685                                                                      SerTyrThrThrGlySerAlaAsnLeuIleProAlaIleAlaProLeu                               690695700                                                                      TrpSerThrSerSerAspLysAlaLeuThrGlySerMetSerIleThr                               705710715720                                                                   GlyArgThrThrProAsnSerAspAspAlaLeuLeuArgPhePheLys                               725730735                                                                      ThrAsnTyrAspThrGlnThrIleProIleProGlySerGlyLysAsp                               740745750                                                                      PheThrAsnThrLeuGluIleGlnAspIleValSerIleAspIlePhe                               755760765                                                                      ValGlySerGlyLeuHisGlySerAspGlySerIleLysLeuAspPhe                               770775780                                                                      ThrAsnAsnAsnSerGlySerGlyGlySerProLysSerPheThrGlu                               785790795800                                                                   GlnAsnAspLeuGluAsnIleThrThrGlnValAsnAlaLeuPheThr                               805810815                                                                      SerAsnThrGlnAspAlaLeuAlaThrAspValSerAspHisAspIle                               820825830                                                                      GluGluValValLeuLysValAspAlaLeuSerAspGluValPheGly                               835840845                                                                      LysGluLysLysThrLeuArgLysPheValAsnGlnAlaLysArgLeu                               850855860                                                                      SerLysAlaArgAsnLeuLeuValGlyGlyAsnPheAspAsnLeuAsp                               865870875880                                                                   AlaTrpTyrArgGlyArgAsnValValAsnValSerAsnHisGluLeu                               885890895                                                                      LeuLysSerAspHisValLeuLeuProProProGlyLeuSerProSer                               900905910                                                                      TyrIlePheGlnLysValGluGluSerLysLeuLysArgAsnThrArg                               915920925                                                                      TyrThrValSerGlyPheIleAlaHisAlaThrAspLeuGluIleVal                               930935940                                                                      ValSerArgTyrGlyGlnGluIleLysLysValValGlnValProTyr                               945950955960                                                                   GlyGluAlaPheProLeuThrSerSerGlyProValCysCysIlePro                               965970975                                                                      HisSerThrSerAsnGlyThrLeuGlyAsnProHisPhePheSerTyr                               980985990                                                                      SerIleAspValGlyAlaLeuAspValAspThrAsnProGlyIleGlu                               99510001005                                                                    PheGlyLeuArgIleValAsnProThrGlyMetAlaArgValSerAsn                               101010151020                                                                   LeuGluIleArgGluAspArgProLeuAlaAlaAsnGluIleArgGln                               1025103010351040                                                               ValGlnArgValAlaArgAsnTrpArgThrGluTyrGluLysGluArg                               104510501055                                                                   AlaGluValThrSerLeuIleGlnProValIleAsnArgIleAsnGly                               106010651070                                                                   LeuTyrAspAsnGlyAsnTrpAsnGlySerIleArgSerAspIleSer                               107510801085                                                                   TyrGlnAsnIleAspAlaIleValLeuProThrLeuProLysLeuArg                               109010951100                                                                   HisTrpPheMetSerAspArgPheSerGluGlnGlyAspIleMetAla                               1105111011151120                                                               LysPheGlnGlyAlaLeuAsnArgAlaTyrAlaGlnLeuGluGlnAsn                               112511301135                                                                   ThrLeuLeuHisAsnGlyHisPheThrLysAspAlaAlaAsnTrpThr                               114011451150                                                                   ValGluGlyAspAlaHisGlnValValLeuGluAspGlyLysArgVal                               115511601165                                                                   LeuArgLeuProAspTrpSerSerSerValSerGlnThrIleGluIle                               117011751180                                                                   GluAsnPheAspProAspLysGluTyrGlnLeuValPheHisGlyGln                               1185119011951200                                                               GlyGluGlyThrValThrLeuGluHisGlyGluGluThrLysTyrIle                               120512101215                                                                   GluThrHisThrHisHisPheAlaAsnPheThrThrSerGlnArgGln                               122012251230                                                                   GlyLeuThrPheGluSerAsnLysValThrValThrIleSerSerGlu                               123512401245                                                                   AspGlyGluPheLeuValAspAsnIleAlaLeuValGluAlaProLeu                               125012551260                                                                   ProThrAspAspGlnAsnSerGluGlyAsnThrAlaSerSerThrAsn                               1265127012751280                                                               SerAspThrSerMetAsnAsnAsnGln                                                    1285                                                                           (2) INFORMATION FOR SEQ ID NO:5:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 3771 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (iii) HYPOTHETICAL: NO                                                         (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (C) INDIVIDUAL ISOLATE: 33F2                                                   (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC2316) B- 18785                                    (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- feature                                              (B) LOCATION: 4..24                                                            (D) OTHER INFORMATION: /function="oligonucleotide                              hybridization probe"                                                           /product= "GCA/T ACA/T TTA AAT GAA GTA/T TAT"                                  /standard.sub.-- name= "probe a"                                               /note= "Probe A"                                                               (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- feature                                              (B) LOCATION: 13..33                                                           (D) OTHER INFORMATION: /function="oligonucleotide                              hybridization probe"                                                           /product= "AAT GAA GTA/T TAT CCA/T GTA/T AAT"                                  /standard.sub.-- name= "Probe B"                                               /label= probe-b                                                                /note= "probe b"                                                               (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:                                        ATGGCTACACTTAATGAAGTATATCCTGTGAATTATAATGTATTATCTTCTGATGCTTTT60                 CAACAATTAGATACAACAGGTTTTAAAAGTAAATATGATGAAATGATAAAAGCATTCGAA120                AAAAAATGGAAAAAAGGGGCAAAAGGAAAAGACCTTTTAGATGTTGCATGGACTTATATA180                ACTACAGGAGAAATTGACCCTTTAAATGTAATTAAAGGTGTTTTATCTGTATTAACTTTA240                ATTCCTGAAGTTGGTACTGTGGCCTCTGCAGCAAGTACTATTGTAAGTTTTATTTGGCCT300                AAAATATTTGGAGATAAACCAAATGCAAAAAATATATTTGAAGAGCTCAAGCCTCAAATT360                GAAGCATTAATTCAACAAGATATAACAAACTATCAAGATGCAATTAATCAAAAAAAATTT420                GACAGTCTTCAGAAAACAATTAATCTATATACAGTAGCTATAGATAACAATGATTACGTA480                ACAGCAAAAACGCAACTCGAAAATCTAAATTCTATACTTACCTCAGATATCTCCATATTT540                ATTCCAGAAGGATATGAAACTGGAGGTTTACCTTATTATGCTATGGTTGCTAATGCTCAT600                ATATTATTGTTAAGAGACGCTATAGTTAATGCAGAGAAATTAGGCTTTAGTGATAAAGAA660                GTAGACACACATAAAAAATATATCAAAATGACAATACACAATCATACTGAAGCAGTAATA720                AAAGCATTCTTAAATGGACTTGACAAATTTAAGAGTTTAGATGTAAATAGCTATAATAAA780                AAAGCAAATTATATTAAAGGTATGACAGAAATGGTTCTTGATCTAGTTGCTCTATGGCCA840                ACTTTCGATCCAGATCATTATCAAAAAGAAGTAGAAATTGAATTTACAAGAACTATTTCT900                TCTCCAATTTACCAACCTGTACCTAAAAACATGCAAAATACCTCTAGCTCTATTGTACCT960                AGCGATCTATTTCACTATCAAGGAGATCTTGTAAAATTAGAATTTTCTACAAGAACGGAC1020               AACGATGGTCTTGCAAAAATTTTTACTGGTATTCGAAACACATTCTACAAATCGCCTAAT1080               ACTCATGAAACATACCATGTAGATTTTAGTTATAATACCCAATCTAGTGGTAATATTTCA1140               AGAGGCTCTTCAAATCCGATTCCAATTGATCTTAATAATCCCATTATTTCAACTTGTATT1200               AGAAATTCATTTTATAAGGCAATAGCGGGATCTTCTGTTTTAGTTAATTTTAAAGATGGC1260               ACTCAAGGGTATGCATTTGCCCAAGCACCAACAGGAGGTGCCTGGGACCATTCTTTTATT1320               GAATCTGATGGTGCCCCAGAAGGGCATAAATTAAACTATATTTATACTTCTCCAGGTGAT1380               ACATTAAGAGATTTCATCAATGTATATACTCTTATAAGTACTCCAACTATAAATGAACTA1440               TCAACAGAAAAAATCAAAGGCTTTCCTGCGGAAAAAGGATATATCAAAAATCAAGGGATC1500               ATGAAATATTACGGTAAACCAGAATATATTAATGGAGCTCAACCAGTTAATCTGGAAAAC1560               CAGCAAACATTAATATTCGAATTTCATGCTTCAAAAACAGCTCAATATACCATTCGTATA1620               CGTTATGCCAGTACCCAAGGAACAAAAGGTTATTTTCGTTTAGATAATCAGGAACTGCAA1680               ACGCTTAATATACCTACTTCACACAACGGTTATGTAACCGGTAATATTGGTGAAAATTAT1740               GATTTATATACAATAGGTTCATATACAATTACAGAAGGTAACCATACTCTTCAAATCCAA1800               CATAATGATAAAAATGGAATGGTTTTAGATCGTATTGAATTTGTTCCTAAAGATTCACTT1860               CAAGATTCACCTCAAGATTCACCTCCAGAAGTTCACGAATCAACAATTATTTTTGATAAA1920               TCATCTCCAACTATATGGTCTTCTAACAAACACTCATATAGCCATATACATTTAGAAGGA1980               TCATATACAAGTCAGGGAAGTTATCCACACAATTTATTAATTAATTTATTTCATCCTACA2040               GACCCTAACAGAAATCATACTATTCATGTTAACAATGGTGATATGAATGTTGATTATGGA2100               AAAGATTCTGTAGCCGATGGGTTAAATTTTAATAAAATAACTGCTACGATACCAAGTGAT2160               GCTTGGTATAGCGGTACTATTACTTCTATGCACTTATTTAATGATAATAATTTTAAAACA2220               ATAACTCCTAAATTTGAACTTTCTAATGAATTAGAAAACATCACAACTCAAGTAAATGCT2280               TTATTCGCATCTAGTGCACAAGATACTCTCGCAAGTAATGTAAGTGATTACTGGATTGAA2340               CAGGTCGTTATGAAAGTCGATGCCTTATCAGATGAAGTATTTGGAAAAGAGAAAAAAGCA2400               TTACGTAAATTGGTAAATCAAGCAAAACGTCTCAGTAAAATACGAAATCTTCTCATAGGT2460               GGTAATTTTGACAATTTAGTCGCTTGGTATATGGGAAAAGATGTAGTAAAAGAATCGGAT2520               CATGAATTATTTAAAAGTGATCATGTCTTACTACCTCCCCCAACATTCCATCCTTCTTAT2580               ATTTTCCAAAAGGTGGAAGAATCAAAACTAAAACCAAATACACGTTATACTATTTCTGGT2640               TTTATCGCACATGGAGAAGATGTAGAGCTTGTTGTCTCTCGTTATGGGCAAGAAATACAA2700               AAAGTGATGCAAGTGCCATATGAAGAAGCACTTCCTCTTACATCTGAATCTAATTCTAGT2760               TGTTGTGTTCCAAATTTAAATATAAATGAAACACTAGCTGATCCACATTTCTTTAGTTAT2820               AGCATCGATGTTGGTTCTCTGGAAATGGAAGCGAATCCTGGTATTGAATTTGGTCTCCGT2880               ATTGTCAAACCAACAGGTATGGCACGTGTAAGTAATTTAGAAATTCGAGAAGACCGTCCA2940               TTAACAGCAAAAGAAATTCGTCAAGTACAACGTGCAGCAAGAGATTGGAAACAAAACTAT3000               GAACAAGAACGAACAGAGATCACAGCTATAATTCAACCTGTTCTTAATCAAATTAATGCG3060               TTATACGAAAATGAAGATTGGAATGGTTCTATTCGTTCAAATGTTTCCTATCATGATCTA3120               GAGCAAATTATGCTTCCTACTTTATTAAAAACTGAGGAAATAAATTGTAATTATGATCAT3180               CCAGCTTTTTTATTAAAAGTATATCATTGGTTTATGACAGATCGTATAGGAGAACATGGT3240               ACTATTTTAGCACGTTTCCAAGAAGCATTAGATCGTGCATATACACAATTAGAAAGTCGT3300               AATCTCCTGCATAACGGTCATTTTACAACTGATACAGCGAATTGGACAATAGAAGGAGAT3360               GCCCATCATACAATCTTAGAAGATGGTAGACGTGTGTTACGTTTACCAGATTGGTCTTCT3420               AATGCAACTCAAACAATTGAAATTGAAGATTTTGACTTAGATCAAGAATACCAATTGCTC3480               ATTCATGCAAAAGGAAAAGGTTCCATTACTTTACAACATGGAGAAGAAAACGAATATGTG3540               GAAACACATACTCATCATACAAATGATTTTATAACATCCCAAAATATTCCTTTCACTTTT3600               AAAGGAAATCAAATTGAAGTCCATATTACTTCAGAAGATGGAGAGTTTTTAATCGATCAC3660               ATTACAGTAATAGAAGTTTCTAAAACAGACACAAATACAAATATTATTGAAAATTCACCA3720               ATCAATACAAGTATGAATAGTAATGTAAGAGTAGATATACCAAGAAGTCTC3771                        (2) INFORMATION FOR SEQ ID NO:6:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1257 amino acids                                                   (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: protein                                                    (iii) HYPOTHETICAL: YES                                                        (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (C) INDIVIDUAL ISOLATE: PS33F2                                                 (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC2316) B- 18785                                    (ix) FEATURE:                                                                  (A) NAME/KEY: Protein                                                          (B) LOCATION: 1..1257                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:                                        MetAlaThrLeuAsnGluValTyrProValAsnTyrAsnValLeuSer                               151015                                                                         SerAspAlaPheGlnGlnLeuAspThrThrGlyPheLysSerLysTyr                               202530                                                                         AspGluMetIleLysAlaPheGluLysLysTrpLysLysGlyAlaLys                               354045                                                                         GlyLysAspLeuLeuAspValAlaTrpThrTyrIleThrThrGlyGlu                               505560                                                                         IleAspProLeuAsnValIleLysGlyValLeuSerValLeuThrLeu                               65707580                                                                       IleProGluValGlyThrValAlaSerAlaAlaSerThrIleValSer                               859095                                                                         PheIleTrpProLysIlePheGlyAspLysProAsnAlaLysAsnIle                               100105110                                                                      PheGluGluLeuLysProGlnIleGluAlaLeuIleGlnGlnAspIle                               115120125                                                                      ThrAsnTyrGlnAspAlaIleAsnGlnLysLysPheAspSerLeuGln                               130135140                                                                      LysThrIleAsnLeuTyrThrValAlaIleAspAsnAsnAspTyrVal                               145150155160                                                                   ThrAlaLysThrGlnLeuGluAsnLeuAsnSerIleLeuThrSerAsp                               165170175                                                                      IleSerIlePheIleProGluGlyTyrGluThrGlyGlyLeuProTyr                               180185190                                                                      TyrAlaMetValAlaAsnAlaHisIleLeuLeuLeuArgAspAlaIle                               195200205                                                                      ValAsnAlaGluLysLeuGlyPheSerAspLysGluValAspThrHis                               210215220                                                                      LysLysTyrIleLysMetThrIleHisAsnHisThrGluAlaValIle                               225230235240                                                                   LysAlaPheLeuAsnGlyLeuAspLysPheLysSerLeuAspValAsn                               245250255                                                                      SerTyrAsnLysLysAlaAsnTyrIleLysGlyMetThrGluMetVal                               260265270                                                                      LeuAspLeuValAlaLeuTrpProThrPheAspProAspHisTyrGln                               275280285                                                                      LysGluValGluIleGluPheThrArgThrIleSerSerProIleTyr                               290295300                                                                      GlnProValProLysAsnMetGlnAsnThrSerSerSerIleValPro                               305310315320                                                                   SerAspLeuPheHisTyrGlnGlyAspLeuValLysLeuGluPheSer                               325330335                                                                      ThrArgThrAspAsnAspGlyLeuAlaLysIlePheThrGlyIleArg                               340345350                                                                      AsnThrPheTyrLysSerProAsnThrHisGluThrTyrHisValAsp                               355360365                                                                      PheSerTyrAsnThrGlnSerSerGlyAsnIleSerArgGlySerSer                               370375380                                                                      AsnProIleProIleAspLeuAsnAsnProIleIleSerThrCysIle                               385390395400                                                                   ArgAsnSerPheTyrLysAlaIleAlaGlySerSerValLeuValAsn                               405410415                                                                      PheLysAspGlyThrGlnGlyTyrAlaPheAlaGlnAlaProThrGly                               420425430                                                                      GlyAlaTrpAspHisSerPheIleGluSerAspGlyAlaProGluGly                               435440445                                                                      HisLysLeuAsnTyrIleTyrThrSerProGlyAspThrLeuArgAsp                               450455460                                                                      PheIleAsnValTyrThrLeuIleSerThrProThrIleAsnGluLeu                               465470475480                                                                   SerThrGluLysIleLysGlyPheProAlaGluLysGlyTyrIleLys                               485490495                                                                      AsnGlnGlyIleMetLysTyrTyrGlyLysProGluTyrIleAsnGly                               500505510                                                                      AlaGlnProValAsnLeuGluAsnGlnGlnThrLeuIlePheGluPhe                               515520525                                                                      HisAlaSerLysThrAlaGlnTyrThrIleArgIleArgTyrAlaSer                               530535540                                                                      ThrGlnGlyThrLysGlyTyrPheArgLeuAspAsnGlnGluLeuGln                               545550555560                                                                   ThrLeuAsnIleProThrSerHisAsnGlyTyrValThrGlyAsnIle                               565570575                                                                      GlyGluAsnTyrAspLeuTyrThrIleGlySerTyrThrIleThrGlu                               580585590                                                                      GlyAsnHisThrLeuGlnIleGlnHisAsnAspLysAsnGlyMetVal                               595600605                                                                      LeuAspArgIleGluPheValProLysAspSerLeuGlnAspSerPro                               610615620                                                                      GlnAspSerProProGluValHisGluSerThrIleIlePheAspLys                               625630635640                                                                   SerSerProThrIleTrpSerSerAsnLysHisSerTyrSerHisIle                               645650655                                                                      HisLeuGluGlySerTyrThrSerGlnGlySerTyrProHisAsnLeu                               660665670                                                                      LeuIleAsnLeuPheHisProThrAspProAsnArgAsnHisThrIle                               675680685                                                                      HisValAsnAsnGlyAspMetAsnValAspTyrGlyLysAspSerVal                               690695700                                                                      AlaAspGlyLeuAsnPheAsnLysIleThrAlaThrIleProSerAsp                               705710715720                                                                   AlaTrpTyrSerGlyThrIleThrSerMetHisLeuPheAsnAspAsn                               725730735                                                                      AsnPheLysThrIleThrProLysPheGluLeuSerAsnGluLeuGlu                               740745750                                                                      AsnIleThrThrGlnValAsnAlaLeuPheAlaSerSerAlaGlnAsp                               755760765                                                                      ThrLeuAlaSerAsnValSerAspTyrTrpIleGluGlnValValMet                               770775780                                                                      LysValAspAlaLeuSerAspGluValPheGlyLysGluLysLysAla                               785790795800                                                                   LeuArgLysLeuValAsnGlnAlaLysArgLeuSerLysIleArgAsn                               805810815                                                                      LeuLeuIleGlyGlyAsnPheAspAsnLeuValAlaTrpTyrMetGly                               820825830                                                                      LysAspValValLysGluSerAspHisGluLeuPheLysSerAspHis                               835840845                                                                      ValLeuLeuProProProThrPheHisProSerTyrIlePheGlnLys                               850855860                                                                      ValGluGluSerLysLeuLysProAsnThrArgTyrThrIleSerGly                               865870875880                                                                   PheIleAlaHisGlyGluAspValGluLeuValValSerArgTyrGly                               885890895                                                                      GlnGluIleGlnLysValMetGlnValProTyrGluGluAlaLeuPro                               900905910                                                                      LeuThrSerGluSerAsnSerSerCysCysValProAsnLeuAsnIle                               915920925                                                                      AsnGluThrLeuAlaAspProHisPhePheSerTyrSerIleAspVal                               930935940                                                                      GlySerLeuGluMetGluAlaAsnProGlyIleGluPheGlyLeuArg                               945950955960                                                                   IleValLysProThrGlyMetAlaArgValSerAsnLeuGluIleArg                               965970975                                                                      GluAspArgProLeuThrAlaLysGluIleArgGlnValGlnArgAla                               980985990                                                                      AlaArgAspTrpLysGlnAsnTyrGluGlnGluArgThrGluIleThr                               99510001005                                                                    AlaIleIleGlnProValLeuAsnGlnIleAsnAlaLeuTyrGluAsn                               101010151020                                                                   GluAspTrpAsnGlySerIleArgSerAsnValSerTyrHisAspLeu                               1025103010351040                                                               GluGlnIleMetLeuProThrLeuLeuLysThrGluGluIleAsnCys                               104510501055                                                                   AsnTyrAspHisProAlaPheLeuLeuLysValTyrHisTrpPheMet                               106010651070                                                                   ThrAspArgIleGlyGluHisGlyThrIleLeuAlaArgPheGlnGlu                               107510801085                                                                   AlaLeuAspArgAlaTyrThrGlnLeuGluSerArgAsnLeuLeuHis                               109010951100                                                                   AsnGlyHisPheThrThrAspThrAlaAsnTrpThrIleGluGlyAsp                               1105111011151120                                                               AlaHisHisThrIleLeuGluAspGlyArgArgValLeuArgLeuPro                               112511301135                                                                   AspTrpSerSerAsnAlaThrGlnThrIleGluIleGluAspPheAsp                               114011451150                                                                   LeuAspGlnGluTyrGlnLeuLeuIleHisAlaLysGlyLysGlySer                               115511601165                                                                   IleThrLeuGlnHisGlyGluGluAsnGluTyrValGluThrHisThr                               117011751180                                                                   HisHisThrAsnAspPheIleThrSerGlnAsnIleProPheThrPhe                               1185119011951200                                                               LysGlyAsnGlnIleGluValHisIleThrSerGluAspGlyGluPhe                               120512101215                                                                   LeuIleAspHisIleThrValIleGluValSerLysThrAspThrAsn                               122012251230                                                                   ThrAsnIleIleGluAsnSerProIleAsnThrSerMetAsnSerAsn                               123512401245                                                                   ValArgValAspIleProArgSerLeu                                                    12501255                                                                       (2) INFORMATION FOR SEQ ID NO:7:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 3738 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (iii) HYPOTHETICAL: NO                                                         (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (C) INDIVIDUAL ISOLATE: PS86Q3                                                 (vii) IMMEDIATE SOURCE:                                                        (A) LIBRARY: Lambdagem (TM) - 11 LIBRARY                                       (B) CLONE: 86Q3a                                                               (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:                                        ATGGCAACAATTAATGAGTTGTATCCAGTTCCTTATAATGTGCTAGCTCATCCAATTAAA60                 GAAGTCGATGATCCTTATTCTTGGTCAAATTTATTAAAGGGTATACAAGAAGGTTGGGAA120                GAATGGGGAAAAACAGGACAAAAAAAACTTTTTGAAGACCATCTTACGATTGCATGGAAT180                CTTTATAAAACAGGAAAATTAGATTATTTCGCTTTGACAAAAGCATCAATATCATTGATT240                GGATTTATTCCAGGGGCAGAAGCAGCAGTTCCCTTTATTAATATGTTTGTAGACTTTGTT300                TGGCCTAAATTATTTGGTGCGAATACAGAAGGAAAAGATCAACAGTTGTTTAATGCTATC360                ATGGATGCAGTTAATAAAATGGTAGATAATAAGTTCTTAAGTTATAATCTTAGTACACTT420                AATAAAACAATTGAAGGACTTCAAGGTAATTTAGGCCTATTTCAAAATGCTATACAAGTA480                GCCATTTGTCAAGGCAGTACACCAGAAAGAGTAAATTTTGATCAAAATTGTACACCATGT540                AATCCAAATCAACCTTGTAAAGATGATTTGGATAGAGTTGCTTCACGTTTTGATACGGCT600                AATTCTCAATTCACACAGCATTTACCAGAATTTAAAAATCCTTGGTCGGATGAAAACTCT660                ACTCAGGAATTTAAAAGAACATCTGTTGAATTAACTTTACCAATGTATACAACAGTAGCT720                ACGTTACATCTTTTATTATATGAAGGATATATAGAATTTATGACAAAATGGAATTTTCAC780                AATGAACAATATTTAAATAATTTAAAGGTAGAATTACAACAATTGATACACTCATATTCA840                GAAACTGTTCGTACAAGTTTCCTTCAATTTTTACCTACCTTGAATAATCGTTCAAAATCA900                TCCGTAAATGCTTATAACCGTTATGTCCGCAATATGACTGTTAACTGTTTAGATATTGCT960                GCTACATGGCCTACATTTGATACACATAATTATCATCAAGGTGGTAAATTAGATTTAACT1020               CGTATTATTCTTTCAGATACAGCAGGACCAATAGAAGAATATACTACTGGCGACAAAACT1080               TCAGGACCTGAACATAGTAACATTACACCAAATAATATTCTAGATACACCATCTCCAACA1140               TATCAGCACTCATTTGTATCTGTTGATTCTATTGTATATTCTAGAAAAGAATTACAACAA1200               TTAGACATAGCTACTTATAGTACAAATAATAGTAATAATTGTCACCCTTATGGATTACGA1260               CTTTCATATACAGATGGAAGCAGATATGATTATGGAGATAATCAACCTGATTTTACTACT1320               TCCAATAACAATTATTGTCATAATAGCTATACTGCCCCTATTACACTTGTGAATGCACGA1380               CATTTATATAATGCAAAAGGCTCTTTACAAAATGTAGAATCTTTAGTGGTTAGTACTGTA1440               AATGGTGGAAGTGGTTCATGCATTTGTGATGCATGGATTAATTATTTACGTCCTCCTCAA1500               ACAAGTAAAAATGAATCACGTCCTGATCAAAAAATTAATGTTTTGTATCCAATAACAGAA1560               ACTGTAAATAAGGGGACTGGAGGAAATTTAGGAGTTATTTCTGCCTATGTTCCAATGGAA1620               CTTGTACCAGAAAACGTTATTGGAGATGTTAATGCTGATACTAAATTGCCACTTACACAA1680               TTAAAGGGCTTTCCATTTGAAAAATATGGTTCTGAGTATAATAATCGGGGTATCTCTCTT1740               GTTCGCGAATGGATAAATGGTAACAATGCAGTTAAACTTTCTAATAGTCAATCTGTTGGC1800               ATACAAATTACGAATCAAACCAAACAAAAATATGAAATACGTTGCCGTTATGCGAGTAAA1860               GGAGATAATAATGTTTATTTTAATGTGGATTTAAGTGAAAATCCATTTAGAAATTCCATT1920               TCTTTTGGATCTACTGAAAGTTCTGTTGTAGGAGTACAAGGTGAAAATGGAAAGTATATA1980               TTGAAATCAATCACAACGGTAGAAATACCTGCTGGAAGTTTCTATGTTCATATAACAAAC2040               CAAGGTTCTTCAGATCTCTTTTTAGATCGTATTGAGTTTGTTCCAAAAATCCAATTCCAA2100               TTCTGTGATAATAATAATCTTCACTGTGATTGTAATAACCCTGTTGACACCGATTGTACA2160               TTTTGTTGCGTTTGCACTAGTCTTACTGATTGTGATTGTAATAACCCTCGTGGCCTAGAT2220               TGTACGCTATGTTGTCAGGTAGAAAATCAGCTACCTTCTTTTGTGACACTTACAGATTTA2280               CAAAATATTACGACACAAGTAAATGCATTAGTTGCATCGAGCGAACATGATACACTTGCA2340               ACAGACGTGAGTGATTATGAGATTGAAGAAGTTGTACTGAAAGTAGATGCATTATCTGGT2400               GAAGTGTTTGGAAAAGAGAAAAAAGCATTGCGTAAATTGGTAAATCACACAAAACGTTTA2460               AGCAAAGCGCGTAACCTCTTGATAGGAGGAAATTTTGATAACTTGGATGCTTGGTACAGA2520               GGCCGAAATGTAGTAAACGTATCTGATCATGAACTATTTAAGAGTGATCATGTATTATTG2580               CCACCACCAACACTGTACTCATCTTATATGTTCCAAAAAGTAGAGGAATCGAAATTAAAA2640               GCGAATACACGTTATACTGTGTCTGGTTTTATTGCACATGCAGAAGATTTAGAAATTGTT2700               GTGTCTCGTTATGGGCAAGAAGTGAAGAAAGTGGTTCAAGTTCCATATGGAGAAGCATTC2760               CCATTGACATCGAGGGGAGCGATTTGTTGCCCTCCACGTTCTACAAGTAATGGAAAACCT2820               GCTGATCCACATTTCTTTAGTTACAGTATTGATGTGGGAACATTAGATGTAGAAGCAAAC2880               CCTGGTATCGAATTGGGTCTTCGTATTGTAGAACGAACTGGAATGGCACGTGTAAGTAAT2940               TTAGAAATTCGTGAAGATCGTCCATTAAAGAAAAATGAACTCCGCAATGTACAACGTGCA3000               GCAAGAAATTGGAGAACAGCATATGACCAAGAACGTGCAGAAGTAACGGCCTTGATTCAA3060               CCTGTATTAAATCAAATCAATGCGTTGTATGAAAATGAAGATTGGAATGGAGCAATTCGT3120               TCTGGAGTTTCTTATCATGACTTAGAAGCAATTGTTTTACCAACATTACCAAAATTAAAT3180               CATTGGTTTATGTCTGATATGTTAGGGGAACAAGGTTCCATTTTAGCTCAATTTCAAGAA3240               GCATTAGATCGTGCGTATACGCAACTCGAAGAAAGTACAATTCTGCATAATGGTCATTTC3300               ACAACAGATGCAGCAAATTGGACGATAGAAGGCGATGCACATCATGCGATATTAGAAGAT3360               GGTAGACGCGTATTACGTCTTCCAGATTGGTCTTCTAGCGTTTCACAAACCATTGAAATA3420               GAAAATTTTGATCCAGATAAAGAATATCAGTTAGTTTTCCATGCACAAGGAGAAGGAACG3480               GTCTCCCTTCAACATGGTGAAGAAGGAGAATATGTGGAAACACACCCGCATAAGTCTGCG3540               AATTTTACAACTTCACACCGTCAAGGAGTCACATTTGAAACAAATAAAGTAACAGTTGAA3600               ATTACCTCAGAAGATGGAGAATTCCTAGTCGATCATATTGCTCTTGTGGAAGCTCCTCTT3660               CCTACAGATGACCAAAGTTCAGATGGAAATACGACTTCCAATACGAATAGCAATACAAGT3720               ATGAATAATAATCAATAA3738                                                         (2) INFORMATION FOR SEQ ID NO:8:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1245 amino acids                                                   (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: protein                                                    (iii) HYPOTHETICAL: YES                                                        (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: BACILLUS THURINGIENSIS                                           (C) INDIVIDUAL ISOLATE: PS86Q3                                                 (vii) IMMEDIATE SOURCE:                                                        (A) LIBRARY: LAMBDAGEM (tm) - 11 library                                       (B) CLONE: 86Q3A                                                               (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:                                        MetAlaThrIleAsnGluLeuTyrProValProTyrAsnValLeuAla                               151015                                                                         HisProIleLysGluValAspAspProTyrSerTrpSerAsnLeuLeu                               202530                                                                         LysGlyIleGlnGluGlyTrpGluGluTrpGlyLysThrGlyGlnLys                               354045                                                                         LysLeuPheGluAspHisLeuThrIleAlaTrpAsnLeuTyrLysThr                               505560                                                                         GlyLysLeuAspTyrPheAlaLeuThrLysAlaSerIleSerLeuIle                               65707580                                                                       GlyPheIleProGlyAlaGluAlaAlaValProPheIleAsnMetPhe                               859095                                                                         ValAspPheValTrpProLysLeuPheGlyAlaAsnThrGluGlyLys                               100105110                                                                      AspGlnGlnLeuPheAsnAlaIleMetAspAlaValAsnLysMetVal                               115120125                                                                      AspAsnLysPheLeuSerTyrAsnLeuSerThrLeuAsnLysThrIle                               130135140                                                                      GluGlyLeuGlnGlyAsnLeuGlyLeuPheGlnAsnAlaIleGlnVal                               145150155160                                                                   AlaIleCysGlnGlySerThrProGluArgValAsnPheAspGlnAsn                               165170175                                                                      CysThrProCysAsnProAsnGlnProCysLysAspAspLeuAspArg                               180185190                                                                      ValAlaSerArgPheAspThrAlaAsnSerGlnPheThrGlnHisLeu                               195200205                                                                      ProGluPheLysAsnProTrpSerAspGluAsnSerThrGlnGluPhe                               210215220                                                                      LysArgThrSerValGluLeuThrLeuProMetTyrThrThrValAla                               225230235240                                                                   ThrLeuHisLeuLeuLeuTyrGluGlyTyrIleGluPheMetThrLys                               245250255                                                                      TrpAsnPheHisAsnGluGlnTyrLeuAsnAsnLeuLysValGluLeu                               260265270                                                                      GlnGlnLeuIleHisSerTyrSerGluThrValArgThrSerPheLeu                               275280285                                                                      GlnPheLeuProThrLeuAsnAsnArgSerLysSerSerValAsnAla                               290295300                                                                      TyrAsnArgTyrValArgAsnMetThrValAsnCysLeuAspIleAla                               305310315320                                                                   AlaThrTrpProThrPheAspThrHisAsnTyrHisGlnGlyGlyLys                               325330335                                                                      LeuAspLeuThrArgIleIleLeuSerAspThrAlaGlyProIleGlu                               340345350                                                                      GluTyrThrThrGlyAspLysThrSerGlyProGluHisSerAsnIle                               355360365                                                                      ThrProAsnAsnIleLeuAspThrProSerProThrTyrGlnHisSer                               370375380                                                                      PheValSerValAspSerIleValTyrSerArgLysGluLeuGlnGln                               385390395400                                                                   LeuAspIleAlaThrTyrSerThrAsnAsnSerAsnAsnCysHisPro                               405410415                                                                      TyrGlyLeuArgLeuSerTyrThrAspGlySerArgTyrAspTyrGly                               420425430                                                                      AspAsnGlnProAspPheThrThrSerAsnAsnAsnTyrCysHisAsn                               435440445                                                                      SerTyrThrAlaProIleThrLeuValAsnAlaArgHisLeuTyrAsn                               450455460                                                                      AlaLysGlySerLeuGlnAsnValGluSerLeuValValSerThrVal                               465470475480                                                                   AsnGlyGlySerGlySerCysIleCysAspAlaTrpIleAsnTyrLeu                               485490495                                                                      ArgProProGlnThrSerLysAsnGluSerArgProAspGlnLysIle                               500505510                                                                      AsnValLeuTyrProIleThrGluThrValAsnLysGlyThrGlyGly                               515520525                                                                      AsnLeuGlyValIleSerAlaTyrValProMetGluLeuValProGlu                               530535540                                                                      AsnValIleGlyAspValAsnAlaAspThrLysLeuProLeuThrGln                               545550555560                                                                   LeuLysGlyPheProPheGluLysTyrGlySerGluTyrAsnAsnArg                               565570575                                                                      GlyIleSerLeuValArgGluTrpIleAsnGlyAsnAsnAlaValLys                               580585590                                                                      LeuSerAsnSerGlnSerValGlyIleGlnIleThrAsnGlnThrLys                               595600605                                                                      GlnLysTyrGluIleArgCysArgTyrAlaSerLysGlyAspAsnAsn                               610615620                                                                      ValTyrPheAsnValAspLeuSerGluAsnProPheArgAsnSerIle                               625630635640                                                                   SerPheGlySerThrGluSerSerValValGlyValGlnGlyGluAsn                               645650655                                                                      GlyLysTyrIleLeuLysSerIleThrThrValGluIleProAlaGly                               660665670                                                                      SerPheTyrValHisIleThrAsnGlnGlySerSerAspLeuPheLeu                               675680685                                                                      AspArgIleGluPheValProLysIleGlnPheGlnPheCysAspAsn                               690695700                                                                      AsnAsnLeuHisCysAspCysAsnAsnProValAspThrAspCysThr                               705710715720                                                                   PheCysCysValCysThrSerLeuThrAspCysAspCysAsnAsnPro                               725730735                                                                      ArgGlyLeuAspCysThrLeuCysCysGlnValGluAsnGlnLeuPro                               740745750                                                                      SerPheValThrLeuThrAspLeuGlnAsnIleThrThrGlnValAsn                               755760765                                                                      AlaLeuValAlaSerSerGluHisAspThrLeuAlaThrAspValSer                               770775780                                                                      AspTyrGluIleGluGluValValLeuLysValAspAlaLeuSerGly                               785790795800                                                                   GluValPheGlyLysGluLysLysAlaLeuArgLysLeuValAsnHis                               805810815                                                                      ThrLysArgLeuSerLysAlaArgAsnLeuLeuIleGlyGlyAsnPhe                               820825830                                                                      AspAsnLeuAspAlaTrpTyrArgGlyArgAsnValValAsnValSer                               835840845                                                                      AspHisGluLeuPheLysSerAspHisValLeuLeuProProProThr                               850855860                                                                      LeuTyrSerSerTyrMetPheGlnLysValGluGluSerLysLeuLys                               865870875880                                                                   AlaAsnThrArgTyrThrValSerGlyPheIleAlaHisAlaGluAsp                               885890895                                                                      LeuGluIleValValSerArgTyrGlyGlnGluValLysLysValVal                               900905910                                                                      GlnValProTyrGlyGluAlaPheProLeuThrSerArgGlyAlaIle                               915920925                                                                      CysCysProProArgSerThrSerAsnGlyLysProAlaAspProHis                               930935940                                                                      PhePheSerTyrSerIleAspValGlyThrLeuAspValGluAlaAsn                               945950955960                                                                   ProGlyIleGluLeuGlyLeuArgIleValGluArgThrGlyMetAla                               965970975                                                                      ArgValSerAsnLeuGluIleArgGluAspArgProLeuLysLysAsn                               980985990                                                                      GluLeuArgAsnValGlnArgAlaAlaArgAsnTrpArgThrAlaTyr                               99510001005                                                                    AspGlnGluArgAlaGluValThrAlaLeuIleGlnProValLeuAsn                               101010151020                                                                   GlnIleAsnAlaLeuTyrGluAsnGluAspTrpAsnGlyAlaIleArg                               1025103010351040                                                               SerGlyValSerTyrHisAspLeuGluAlaIleValLeuProThrLeu                               104510501055                                                                   ProLysLeuAsnHisTrpPheMetSerAspMetLeuGlyGluGlnGly                               106010651070                                                                   SerIleLeuAlaGlnPheGlnGluAlaLeuAspArgAlaTyrThrGln                               107510801085                                                                   LeuGluGluSerThrIleLeuHisAsnGlyHisPheThrThrAspAla                               109010951100                                                                   AlaAsnTrpThrIleGluGlyAspAlaHisHisAlaIleLeuGluAsp                               1105111011151120                                                               GlyArgArgValLeuArgLeuProAspTrpSerSerSerValSerGln                               112511301135                                                                   ThrIleGluIleGluAsnPheAspProAspLysGluTyrGlnLeuVal                               114011451150                                                                   PheHisAlaGlnGlyGluGlyThrValSerLeuGlnHisGlyGluGlu                               115511601165                                                                   GlyGluTyrValGluThrHisProHisLysSerAlaAsnPheThrThr                               117011751180                                                                   SerHisArgGlnGlyValThrPheGluThrAsnLysValThrValGlu                               1185119011951200                                                               IleThrSerGluAspGlyGluPheLeuValAspHisIleAlaLeuVal                               120512101215                                                                   GluAlaProLeuProThrAspAspGlnSerSerAspGlyAsnThrThr                               122012251230                                                                   SerAsnThrAsnSerAsnThrSerMetAsnAsnAsnGln                                        123512401245                                                                   (2) INFORMATION FOR SEQ ID NO:9:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 2412 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (iii) HYPOTHETICAL: NO                                                         (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (C) INDIVIDUAL ISOLATE: PS63B                                                  (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC1642) NRRL B-18961                                (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:                                        ATGACTTGTCAATTACAAGCGCAACCACTTATTCCCTATAACGTACTAGCAGGAGTTCCA60                 ACTAGTAATACAGGTAGTCCAATCGGCAATGCAGGTAATCAATTTGATCAGTTTGAGCAA120                ACCGTTAAAGAGCTCAAGGAAGCATGGGAAGCGTTCCAAAAAAACGGAAGTTTCTCATTA180                GCAGCTCTTGAAAAGGGATTTGATGCAGCAATCGGAGGAGGATCCTTTGATTATTTAGGT240                TTAGTTCAAGCCGGCCTAGGATTAGTTGGTACGCTAGGCGCCGCAATCCCTGGTGTTTCA300                GTGGCAGTGCCTCTTATTAGCATGCTTGTTGGTGTTTTTTGGCCAAAGGGCACAAACAAC360                CAAGAAAACCTTATTACAGTTATTGATAAGGAAGTTCAGAGAATACTAGATGAAAAGCTA420                TCTGATCAGTTAATAAAGAAATTGAACGCAGATTTAAATGCTTTTACGGACCTAGTAACT480                CGTTTGGAAGAAGTAATAATAGATGCAACTTTCGAGAATCACAAGCCTGTACTACAAGTA540                AGTAAATCAAATTATATGAAAGTGGATTCAGCATATTTCTCAACAGGAGGTATTCTTACT600                CTTGGCATGAGTGATTTTCTTACTGATACCTATTCAAAGCTTACCTTCCCATTATATGTA660                CTAGGCGCAACTATGAAACTTTCAGCATATCATAGTTATATACAATTCGGAAATACATGG720                CTTAATAAAGTTTATGATTTATCATCAGATGAGGGAAAAACAATGTCGCAGGCTTTAGCA780                CGAGCTAAACAGCATATGCGCCAAGACATAGCATTTTATACAAGCCAAGCTTTAAACATG840                TTTACTGGGAATCTCCCTTCATTATCATCTAATAAATATGCAATTAATGACTATAATGTA900                TACACTCGAGCAATGGTATTGAATGGCTTAGATATAGTAGCAACATGGCCTACCCTATAT960                CCAGATGACTATTCGTCTCAGATAAAACTGGAGAAAACACGCGTGATCTTTTCAGATATG1020               GTCGGGCAAAGTGAGAGTAGAGATGGCAGCGTAACGATTAAAAATATTTTTGACAATACA1080               GATTCACATCAACATGGATCCATAGGTCTCAATTCAATCTCTTATTTCCCAGATGAGTTA1140               CAGAAAGCACAACTTCGCATGTATGATTATAATCACAAACCTTATTGTACGGACTGTTTC1200               TGCTGGCCGTATGGAGTGATTTTAAACTATAACAAGAATACCTTTAGATATGGCGATAAT1260               GATCCAGGTCTTTCAGGAGACGTTCAACTCCCAGCACCTATGAGTGTAGTTAATGCCCAA1320               ACTCAAACAGCCCAATATACAGATGGAGAAAACATATGGACAGATACTGGCCGCAGTTGG1380               CTTTGTACTCTACGTGGCTACTGTACTACAAACTGTTTTCCAGGAAGAGGTTGTTATAAT1440               AATAGTACTGGATATGGAGAAAGTTGCAATCAATCACTTCCAGGTCAAAAAATACATGCA1500               CTATATCCTTTTACACAAACAAATGTGCTGGGACAATCAGGCAAACTAGGATTGCTAGCA1560               AGTCATATTCCATATGACCTAAGTCCGAACAATACGATTGGTGACAAAGATACAGATTCT1620               ACGAATATTGTCGCAAAAGGAATTCCAGTGGAAAAAGGGTATGCATCCAGTGGACAAAAA1680               GTTGAAATTATACGAGAGTGGATAAATGGTGCGAATGTAGTTCAATTATCTCCAGGCCAA1740               TCTTGGGGAATGGATTTTACCAATAGCACAGGTGGTCAATATATGGTCCGCTGTCGATAT1800               GCAAGTACAAACGATACTCCAATCTTTTTTAATTTAGTGTATGACGGGGGATCGAATCCT1860               ATTTATAACCAGATGACATTCCCTGCTACAAAAGAGACTCCAGCTCACGATTCAGTAGAT1920               AACAAGATACTAGGCATAAAAGGAATAAATGGAAATTATTCACTCATGAATGTAAAAGAT1980               TCTGTCGAACTTCCATCTGGGAAATTTCATGTTTTTTTCACAAATAATGGATCATCTGCT2040               ATTTATTTAGATCGACTTGAGTTTGTTCCTTTAGATCAACCAGCAGCGCCAACACAGTCA2100               ACACAACCAATTAATTATCCTATCACAAGTAGGTTACCTCATCGTTCCGGAGAACCACCT2160               GCAATAATATGGGAGAAATCAGGGAATGTTCGCGGGAATCAACTAACTATATCGGCACAA2220               GGTGTTCCAGAAAATTCCCAAATATATCTTTCGGTGGGTGGCGATCGCCAAATTTTAGAC2280               CGTAGCAACGGATTTAAATTAGTTAATTACTCACCTACTTATTCTTTCACTAACATTCAG2340               GCTAGCTCGTCAAATTTAGTAGATATTACAAGTGGTACCATCACTGGCCAAGTACAAGTA2400               TCTAATCTATAA2412                                                               (2) INFORMATION FOR SEQ ID NO:10:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 803 amino acids                                                    (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: protein                                                    (iii) HYPOTHETICAL: YES                                                        (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (C) INDIVIDUAL ISOLATE: PS63B                                                  (vii) IMMEDIATE SOURCE:                                                        (B) CLONE: E. coli NM522(pMYC1642) NRRL B-18961                                (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:                                       MetThrCysGlnLeuGlnAlaGlnProLeuIleProTyrAsnValLeu                               151015                                                                         AlaGlyValProThrSerAsnThrGlySerProIleGlyAsnAlaGly                               202530                                                                         AsnGlnPheAspGlnPheGluGlnThrValLysGluLeuLysGluAla                               354045                                                                         TrpGluAlaPheGlnLysAsnGlySerPheSerLeuAlaAlaLeuGlu                               505560                                                                         LysGlyPheAspAlaAlaIleGlyGlyGlySerPheAspTyrLeuGly                               65707580                                                                       LeuValGlnAlaGlyLeuGlyLeuValGlyThrLeuGlyAlaAlaIle                               859095                                                                         ProGlyValSerValAlaValProLeuIleSerMetLeuValGlyVal                               100105110                                                                      PheTrpProLysGlyThrAsnAsnGlnGluAsnLeuIleThrValIle                               115120125                                                                      AspLysGluValGlnArgIleLeuAspGluLysLeuSerAspGlnLeu                               130135140                                                                      IleLysLysLeuAsnAlaAspLeuAsnAlaPheThrAspLeuValThr                               145150155160                                                                   ArgLeuGluGluValIleIleAspAlaThrPheGluAsnHisLysPro                               165170175                                                                      ValLeuGlnValSerLysSerAsnTyrMetLysValAspSerAlaTyr                               180185190                                                                      PheSerThrGlyGlyIleLeuThrLeuGlyMetSerAspPheLeuThr                               195200205                                                                      AspThrTyrSerLysLeuThrPheProLeuTyrValLeuGlyAlaThr                               210215220                                                                      MetLysLeuSerAlaTyrHisSerTyrIleGlnPheGlyAsnThrTrp                               225230235240                                                                   LeuAsnLysValTyrAspLeuSerSerAspGluGlyLysThrMetSer                               245250255                                                                      GlnAlaLeuAlaArgAlaLysGlnHisMetArgGlnAspIleAlaPhe                               260265270                                                                      TyrThrSerGlnAlaLeuAsnMetPheThrGlyAsnLeuProSerLeu                               275280285                                                                      SerSerAsnLysTyrAlaIleAsnAspTyrAsnValTyrThrArgAla                               290295300                                                                      MetValLeuAsnGlyLeuAspIleValAlaThrTrpProThrLeuTyr                               305310315320                                                                   ProAspAspTyrSerSerGlnIleLysLeuGluLysThrArgValIle                               325330335                                                                      PheSerAspMetValGlyGlnSerGluSerArgAspGlySerValThr                               340345350                                                                      IleLysAsnIlePheAspAsnThrAspSerHisGlnHisGlySerIle                               355360365                                                                      GlyLeuAsnSerIleSerTyrPheProAspGluLeuGlnLysAlaGln                               370375380                                                                      LeuArgMetTyrAspTyrAsnHisLysProTyrCysThrAspCysPhe                               385390395400                                                                   CysTrpProTyrGlyValIleLeuAsnTyrAsnLysAsnThrPheArg                               405410415                                                                      TyrGlyAspAsnAspProGlyLeuSerGlyAspValGlnLeuProAla                               420425430                                                                      ProMetSerValValAsnAlaGlnThrGlnThrAlaGlnTyrThrAsp                               435440445                                                                      GlyGluAsnIleTrpThrAspThrGlyArgSerTrpLeuCysThrLeu                               450455460                                                                      ArgGlyTyrCysThrThrAsnCysPheProGlyArgGlyCysTyrAsn                               465470475480                                                                   AsnSerThrGlyTyrGlyGluSerCysAsnGlnSerLeuProGlyGln                               485490495                                                                      LysIleHisAlaLeuTyrProPheThrGlnThrAsnValLeuGlyGln                               500505510                                                                      SerGlyLysLeuGlyLeuLeuAlaSerHisIleProTyrAspLeuSer                               515520525                                                                      ProAsnAsnThrIleGlyAspLysAspThrAspSerThrAsnIleVal                               530535540                                                                      AlaLysGlyIleProValGluLysGlyTyrAlaSerSerGlyGlnLys                               545550555560                                                                   ValGluIleIleArgGluTrpIleAsnGlyAlaAsnValValGlnLeu                               565570575                                                                      SerProGlyGlnSerTrpGlyMetAspPheThrAsnSerThrGlyGly                               580585590                                                                      GlnTyrMetValArgCysArgTyrAlaSerThrAsnAspThrProIle                               595600605                                                                      PhePheAsnLeuValTyrAspGlyGlySerAsnProIleTyrAsnGln                               610615620                                                                      MetThrPheProAlaThrLysGluThrProAlaHisAspSerValAsp                               625630635640                                                                   AsnLysIleLeuGlyIleLysGlyIleAsnGlyAsnTyrSerLeuMet                               645650655                                                                      AsnValLysAspSerValGluLeuProSerGlyLysPheHisValPhe                               660665670                                                                      PheThrAsnAsnGlySerSerAlaIleTyrLeuAspArgLeuGluPhe                               675680685                                                                      ValProLeuAspGlnProAlaAlaProThrGlnSerThrGlnProIle                               690695700                                                                      AsnTyrProIleThrSerArgLeuProHisArgSerGlyGluProPro                               705710715720                                                                   AlaIleIleTrpGluLysSerGlyAsnValArgGlyAsnGlnLeuThr                               725730735                                                                      IleSerAlaGlnGlyValProGluAsnSerGlnIleTyrLeuSerVal                               740745750                                                                      GlyGlyAspArgGlnIleLeuAspArgSerAsnGlyPheLysLeuVal                               755760765                                                                      AsnTyrSerProThrTyrSerPheThrAsnIleGlnAlaSerSerSer                               770775780                                                                      AsnLeuValAspIleThrSerGlyThrIleThrGlyGlnValGlnVal                               785790795800                                                                   SerAsnLeu                                                                      (2) INFORMATION FOR SEQ ID NO:11:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 8 amino acids                                                      (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:                                       ArgGluTrpIleAsnGlyAlaAsn                                                       15                                                                             (2) INFORMATION FOR SEQ ID NO:12:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 21 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:                                       AGARTRKWTWAATGGWGCKMA21                                                        (2) INFORMATION FOR SEQ ID NO:13:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 20 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:                                       GARTGGWTAAATGGTRMSAA20                                                         (2) INFORMATION FOR SEQ ID NO:14:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 8 amino acids                                                      (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:                                       ProThrPheAspProAspLeuTyr                                                       15                                                                             (2) INFORMATION FOR SEQ ID NO:15:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 24 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:                                       CCNACYTTTKATCCAGATSWYTAT24                                                     (2) INFORMATION FOR SEQ ID NO:16:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 24 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:                                       CCWACWTTYGATMCASATMWTTAT24                                                     (2) INFORMATION FOR SEQ ID NO:17:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 14 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:                                       AlaIleLeuAsnGluLeuTyrProSerValProTyrAsnVal                                     1510                                                                           (2) INFORMATION FOR SEQ ID NO:18:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 14 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:                                       AlaIleLeuAsnGluLeuTyrProSerValProTyrAsnVal                                     1510                                                                           (2) INFORMATION FOR SEQ ID NO:19:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 16 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:                                       MetAlaThrIleAsnGluLeuTyrProAsnValProTyrAsnValLeu                               151015                                                                         (2) INFORMATION FOR SEQ ID NO:20:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 14 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:                                       GlnLeuGlnAlaGlnProLeuIleProTyrAsnValLeuAla                                     1510                                                                           (2) INFORMATION FOR SEQ ID NO:21:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 10 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:                                       AlaThrLeuAsnGluValTyrProValAsn                                                 1510                                                                           (2) INFORMATION FOR SEQ ID NO:22:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 15 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:                                       ValGlnArgIleLeuAspGluLysLeuSerPheGlnLeuIleLys                                  151015                                                                         (2) INFORMATION FOR SEQ ID NO:23:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 23 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:                                       GCAATTTTAAATGAATTATATCC23                                                      (2) INFORMATION FOR SEQ ID NO:24:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 17 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:                                       CAAYTACAAGCWCAACC17                                                            (2) INFORMATION FOR SEQ ID NO:25:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 21 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:                                       TTCATCTAAAATTCTTTGWAC21                                                        (2) INFORMATION FOR SEQ ID NO:26:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 21 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:                                       GCWACWTTAAATGAAGTWTAT21                                                        (2) INFORMATION FOR SEQ ID NO:27:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 21 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:                                       AATGAAGTWTATCCWGTWAAT21                                                        (2) INFORMATION FOR SEQ ID NO:28:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 38 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28:                                       GCAAGCGGCCGCTTATGGAATAAATTCAATTYKRTCWA38                                       (2) INFORMATION FOR SEQ ID NO:29:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 37 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:                                       AGACTGGATCCATGGCWACWATWAATGAATTATAYCC37                                        (2) INFORMATION FOR SEQ ID NO:30:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 10 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30:                                       GluSerLysLeuLysProAsnThrArgTyr                                                 1510                                                                           (2) INFORMATION FOR SEQ ID NO:31:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 29 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31:                                       TAACGTGTATWCGSTTTTAATTTWGAYTC29                                                (2) INFORMATION FOR SEQ ID NO:32:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 9 amino acids                                                      (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32:                                       TyrIleAspLysIleGluPheIlePro                                                    15                                                                             (2) INFORMATION FOR SEQ ID NO:33:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 23 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33:                                       TGGAATAAATTCAATTYKRTCWA23                                                      (2) INFORMATION FOR SEQ ID NO:34:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 23 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34:                                       AGGAACAAAYTCAAKWCGRTCTA23                                                      (2) INFORMATION FOR SEQ ID NO:35:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 24 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35:                                       TTTAGATCGTMTTGARTTTRTWCC24                                                     (2) INFORMATION FOR SEQ ID NO:36:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 5 amino acids                                                      (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36:                                       IleThrSerGluAsp                                                                15                                                                             (2) INFORMATION FOR SEQ ID NO:37:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 20 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:37:                                       TCTCCATCTTCTGARGWAAT20                                                         (2) INFORMATION FOR SEQ ID NO:38:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 8 amino acids                                                      (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:38:                                       LeuAspArgIleGluPheValPro                                                       15                                                                             (2) INFORMATION FOR SEQ ID NO:39:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 731 amino acids                                                    (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (iii) HYPOTHETICAL: YES                                                        (xi) SEQUENCE DESCRIPTION: SEQ ID NO:39:                                       MetXaaXaaXaaXaaXaaXaaTyrProXaaXaaXaaTyrXaaXaaXaa                               151015                                                                         XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               202530                                                                         XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               354045                                                                         XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               505560                                                                         XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               65707580                                                                       XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaProXaaXaaXaaXaaXaa                               859095                                                                         XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               100105110                                                                      XaaXaaXaaXaaXaaXaaLysXaaXaaXaaXaaXaaXaaXaaXaaXaa                               115120125                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               130135140                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               145150155160                                                                   XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               165170175                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               180185190                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               195200205                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               210215220                                                                      XaaXaaXaaXaaXaaGluXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               225230235240                                                                   ProXaaTyrXaaXaaXaaXaaXaaXaaHisXaaXaaXaaXaaXaaXaa                               245250255                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               260265270                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               275280285                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               290295300                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaTyr                               305310315320                                                                   XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaPro                               325330335                                                                      XaaXaaXaaXaaXaaXaaTyrXaaXaaXaaXaaXaaXaaXaaXaaXaa                               340345350                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               355360365                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               370375380                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               385390395400                                                                   XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               405410415                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               420425430                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               435440445                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               450455460                                                                      XaaXaaXaaXaaXaaXaaXaaXaaProXaaXaaXaaXaaXaaXaaXaa                               465470475480                                                                   XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               485490495                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               500505510                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               515520525                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaTyrXaaXaa                               530535540                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               545550555560                                                                   XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               565570575                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               580585590                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               595600605                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               610615620                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaTyrXaaXaa                               625630635640                                                                   XaaXaaXaaXaaProXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               645650655                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               660665670                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaTyrXaa                               675680685                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               690695700                                                                      XaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaaXaa                               705710715720                                                                   XaaXaaXaaXaaXaaXaaXaaXaaProXaaXaa                                              725730                                                                         (2) INFORMATION FOR SEQ ID NO:40:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 37 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40:                                       AGACTGGATCCATGGCWACWATWAATGAATTATAYCC37                                        (2) INFORMATION FOR SEQ ID NO:41:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 48 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:41:                                       GACTGCGGCCGCGTCGACTTAACGTGTATWCGSTTTTAATTTWGAYTC48                             (2) INFORMATION FOR SEQ ID NO:42:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 3660 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (iii) HYPOTHETICAL: NO                                                         (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (C) INDIVIDUAL ISOLATE: PS86Q3                                                 (vii) IMMEDIATE SOURCE:                                                        (A) LIBRARY: Lambdagem (TM) - 11 library of Luis                               Foncerrada                                                                     (B) CLONE: 86Q3c                                                               (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42:                                       ATGGCAATTTTAAATGAATTATATCCATCTGTACCTTATAATGTATTGGCGTATACGCCA60                 CCCTCTTTTTTACCTGATGCGGGTACACAAGCTACACCTGCTGACTTAACAGCTTATGAA120                CAATTGTTGAAAAATTTAGAAAAAGGGATAAATGCTGGAACTTATTCGAAAGCAATAGCT180                GATGTACTTAAAGGTATTTTTATAGATGATACAATAAATTATCAAACATATGTAAATATT240                GGTTTAAGTTTAATTACATTAGCTGTACCGGAAATTGGTATTTTTACACCTTTCATCGGT300                TTGTTTTTTGCTGCATTGAATAAACATGATGCTCCACCTCCTCCTAATGCAAAAGATATA360                TTTGAGGCTATGAAACCAGCGATTCAAGAGATGATTGATAGAACTTTAACTGCGGATGAG420                CAAACATTTTTAAATGGGGAAATAAGTGGTTTACAAAATTTAGCAGCAAGATACCAGTCT480                ACAATGGATGATATTCAAAGCCATGGAGGATTTAATAAGGTAGATTCTGGATTAATTAAA540                AAGTTTACAGATGAGGTACTATCTTTAAATAGTTTTTATACAGATCGTTTACCTGTATTT600                ATTACAGATAATACAGCGGATCGAACTTTGTTAGGTCTTCCTTATTATGCTATACTTGCG660                AGCATGCATCTTATGTTATTAAGAGATATAATTACTAAGGGTCCGACATGGGATTCTAAA720                ATTAATTTCACACCAGATGCAATTGATTCCTTTAAAACCGATATTAAAAATAATATAAAG780                CTTTACTCTAAAACTATTTATGACGTATTTCAGAAGGGACTTGCTTCATACGGAACGCCT840                TCTGATTTAGAGTCCTTTGCAAAAAAAAAAAAATATATTGAAATTATGACAACACATTGT900                TTAGATTTTGCAAGATTGTTTCCTACTTTTGATCCAGATCTTTATCCAACAGGATCAGGT960                GATATAAGTTTACAAAAAACACGTAGAATTCTTTCTCCTTTTATCCCTATACGTACTGCA1020               GATGGGTTAACATTAAATAATACTTCAATTGATACTTCAAATTGGCCTAATTATGAAAAT1080               GGGAATGGCGCGTTTCCAAACCCAAAAGAAAGAATATTAAAACAATTCAAACTGTATCCT1140               AGTTGGAGAGCGGGACAGTACGGTGGGCTTTTACAACCTTATTTATGGGCAATAGAAGTC1200               CAAGATTCTGTAGAGACTCGTTTGTATGGGCAGCTTCCAGCTGTAGATCCACAGGCAGGG1260               CCTAATTATGTTTCCATAGATTCTTCTAATCCAATCATACAAATAAATATGGATACTTGG1320               AAAACACCACCACAAGGTGCGAGTGGGTGGAATACAAATTTAATGAGAGGAAGTGTAAGC1380               GGGTTAAGTTTTTTACAACGAGATGGTACGAGACTTAGTGCTGGTATGGGTGGTGGTTTT1440               GCTGATACAATATATAGTCTCCCTGCAACTCATTATCTTTCTTATCTCTATGGAACTCCT1500               TATCAAACTTCTGATAACTATTCTGGTCACGTTGGTGCATTGGTAGGTGTGAGTACGCCT1560               CAAGAGGCTACTCTTCCTAATATTATAGGTCAACCAGATGAACAGGGAAATGTATCTACA1620               ATGGGATTTCCGTTTGAAAAAGCTTCTTATGGAGGTACAGTTGTTAAAGAATGGTTAAAT1680               GGTGCGAATGCGATGAAGCTTTCTCCTGGGCAATCTATAGGTATTCCTATTACAAATGTA1740               ACAAAACACAACTATCAAGTGCGTTGTCGTTATGCAAGTAATAGTGATAATCCTGTTTTC1800               TTTAATGTAGATACTGGTGGAGCGAATCCAATTTTCCAACAGATAAACTTTGCATCTACT1860               GTAGATAGTAATATGGGAGTAAAAGAAGAAAATGGCGTCTATGTTGTTAAATCTATAAAA1920               ACGGTAGAAATTCCTGCCGGAAGTTTCTATGTGCATGTAACAAACCAAGGTTCTTCAGAT1980               CTCTTTTTAGATCGTATTGAGTTTGTTCCAAAAATCCAATTCCAATTCTGTGATAATAAT2040               AATCTTCACTGTGATTGTAATAACCCTGTTGACACCGATTGTACATTTTGTTGCGTTTGC2100               ACTAGTCTTACTGATTGTGATTGTAATAACCCTCGTGGCATAGATTGTACGCTATGTTGT2160               CAGGTAGAAAATCAGCTACCTTCTTTTGTGACACTTACAGATTTACGAAATATCACATCC2220               CAAGTGAATGGTCTATTTGCACCTGGAACACAAAATAGGCTGGCTCAAAATATAAGTGAT2280               CATGATATTGAAGAAGTTGTATTGAAAGTGGATGCCTTATCAGATGAGATATTTGGAACA2340               AATAAGAAGGCTTTACGTAAATTGGTGAATCAAGCAAAACGTTTGAGTAGAGCAAGAAAT2400               CTTCTGATAGGTGGTAGTTTTGAAAATTGGGATGCATGGTATAAAGGAAGAAATGTAGTA2460               ACTGTATCTGATCATGAACTATTTAAGAGTGATCATGTATTATTACCACCACCAGGATTG2520               TCTCCATCTTATATTTTCCAAAAAGTGGAGGAATCTAAATTAAAAGCAAATACACGTTAT2580               ACGGTTTCTGGATTTATTGCGCATGCAACAGATTTAGAAATTGTGGTTTCTCGTTATGGG2640               CAAGAAATAAAGAAAGTGGTGCAAGTTCCTTATGGAGAAGCATTCCCATTAACATCAAGT2700               GGACCAGTTTGTTGTATCCCACATTCTACAAGTAATGGAACTTTAGGCAATCCACATTTC2760               TTTAGTTACAGTATTGATGTAGGTGCATTAGATGTAGACACAAACCCTGGTATTGAATTC2820               GGTCTTCGTATTGTAAATCCAACTGGAATGGCACGCGTAAGCAATTTGGAAATTCGTGAA2880               GATCGTCCATTAGCAGCAAATGAAATACGACAAGTACAACGTGTCGCAAGAAATTGGAGA2940               ACCGAGTATGAGAAAGAACGTGCGGAAGTAACAAGTTTAATTCAACCTGTTATCAATCGA3000               ATCAACGGATTGTATGAAAATGAAAATTGGAACGGTTCTATTCGTTCAGATATTTCGTAT3060               CAGAATATAGACGCGATTGTATTACCAACGTTACCAACGTTACGCCATTGGTTTATGTCA3120               GATAGATTCAGTGAACAAGGAGATATCATGGCTAAATTCCAAGGTGCATTAAATCGTGCG3180               TATGCACAACTGGAACAAAGTACGCTTCTGCATAATGGTCATTTTACAAAAGATGCAGCT3240               AATTGGACAATAGAAGGCGATGCACATCAGATAACACTAGAAGATGGTAGACGTGTATTG3300               CGACTTCCAGATTGGTCTTCGAGTGTATCTCAAATGATTGAAATCGAGAATTTTAATCCA3360               GATAAAGAATACAACTTAGTATTCCATGGGCAAGGAGAAGGAACGGTTACGTTGGAGCAT3420               GGAGAAGAAACAAAATATATAGAAACGCATACACATCATTTTGCGAATTTTACAACTTCT3480               CAACGTCAAGGACTCACGTTTGAATCAAATAAAGTGACAGTGACCATTTCTTCAGAAGAT3540               GGAGAATTCTTAGTGGATAATATTGCGCTTGTGGAAGCTCCTCTTCCTACAGATGACCAA3600               AATTCTGAGGGAAATACGGCTTTCAGTACGAATAGCGATACAAGTATGAACAACAATCAA3660               (2) INFORMATION FOR SEQ ID NO:43:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1220 amino acids                                                   (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: protein                                                    (iii) HYPOTHETICAL: YES                                                        (iv) ANTI-SENSE: NO                                                            (vi) ORIGINAL SOURCE:                                                          (A) ORGANISM: Bacillus thuringiensis                                           (C) INDIVIDUAL ISOLATE: 86Q3                                                   (vii) IMMEDIATE SOURCE:                                                        (A) LIBRARY: Lambdagem (TM) - 11 library of Luis                               Foncerrada                                                                     (B) CLONE: 86Q3c                                                               (xi) SEQUENCE DESCRIPTION: SEQ ID NO:43:                                       MetAlaIleLeuAsnGluLeuTyrProSerValProTyrAsnValLeu                               151015                                                                         AlaTyrThrProProSerPheLeuProAspAlaGlyThrGlnAlaThr                               202530                                                                         ProAlaAspLeuThrAlaTyrGluGlnLeuLeuLysAsnLeuGluLys                               354045                                                                         GlyIleAsnAlaGlyThrTyrSerLysAlaIleAlaAspValLeuLys                               505560                                                                         GlyIlePheIleAspAspThrIleAsnTyrGlnThrTyrValAsnIle                               65707580                                                                       GlyLeuSerLeuIleThrLeuAlaValProGluIleGlyIlePheThr                               859095                                                                         ProPheIleGlyLeuPhePheAlaAlaLeuAsnLysHisAspAlaPro                               100105110                                                                      ProProProAsnAlaLysAspIlePheGluAlaMetLysProAlaIle                               115120125                                                                      GlnGluMetIleAspArgThrLeuThrAlaAspGluGlnThrPheLeu                               130135140                                                                      AsnGlyGluIleSerGlyLeuGlnAsnLeuAlaAlaArgTyrGlnSer                               145150155160                                                                   ThrMetAspAspIleGlnSerHisGlyGlyPheAsnLysValAspSer                               165170175                                                                      GlyLeuIleLysLysPheThrAspGluValLeuSerLeuAsnSerPhe                               180185190                                                                      TyrThrAspArgLeuProValPheIleThrAspAsnThrAlaAspArg                               195200205                                                                      ThrLeuLeuGlyLeuProTyrTyrAlaIleLeuAlaSerMetHisLeu                               210215220                                                                      MetLeuLeuArgAspIleIleThrLysGlyProThrTrpAspSerLys                               225230235240                                                                   IleAsnPheThrProAspAlaIleAspSerPheLysThrAspIleLys                               245250255                                                                      AsnAsnIleLysLeuTyrSerLysThrIleTyrAspValPheGlnLys                               260265270                                                                      GlyLeuAlaSerTyrGlyThrProSerAspLeuGluSerPheAlaLys                               275280285                                                                      LysLysLysTyrIleGluIleMetThrThrHisCysLeuAspPheAla                               290295300                                                                      ArgLeuPheProThrPheAspProAspLeuTyrProThrGlySerGly                               305310315320                                                                   AspIleSerLeuGlnLysThrArgArgIleLeuSerProPheIlePro                               325330335                                                                      IleArgThrAlaAspGlyLeuThrLeuAsnAsnThrSerIleAspThr                               340345350                                                                      SerAsnTrpProAsnTyrGluAsnGlyAsnGlyAlaPheProAsnPro                               355360365                                                                      LysGluArgIleLeuLysGlnPheLysLeuTyrProSerTrpArgAla                               370375380                                                                      GlyGlnTyrGlyGlyLeuLeuGlnProTyrLeuTrpAlaIleGluVal                               385390395400                                                                   GlnAspSerValGluThrArgLeuTyrGlyGlnLeuProAlaValAsp                               405410415                                                                      ProGlnAlaGlyProAsnTyrValSerIleAspSerSerAsnProIle                               420425430                                                                      IleGlnIleAsnMetAspThrTrpLysThrProProGlnGlyAlaSer                               435440445                                                                      GlyTrpAsnThrAsnLeuMetArgGlySerValSerGlyLeuSerPhe                               450455460                                                                      LeuGlnArgAspGlyThrArgLeuSerAlaGlyMetGlyGlyGlyPhe                               465470475480                                                                   AlaAspThrIleTyrSerLeuProAlaThrHisTyrLeuSerTyrLeu                               485490495                                                                      TyrGlyThrProTyrGlnThrSerAspAsnTyrSerGlyHisValGly                               500505510                                                                      AlaLeuValGlyValSerThrProGlnGluAlaThrLeuProAsnIle                               515520525                                                                      IleGlyGlnProAspGluGlnGlyAsnValSerThrMetGlyPhePro                               530535540                                                                      PheGluLysAlaSerTyrGlyGlyThrValValLysGluTrpLeuAsn                               545550555560                                                                   GlyAlaAsnAlaMetLysLeuSerProGlyGlnSerIleGlyIlePro                               565570575                                                                      IleThrAsnValThrLysHisAsnTyrGlnValArgCysArgTyrAla                               580585590                                                                      SerAsnSerAspAsnProValPhePheAsnValAspThrGlyGlyAla                               595600605                                                                      AsnProIlePheGlnGlnIleAsnPheAlaSerThrValAspSerAsn                               610615620                                                                      MetGlyValLysGluGluAsnGlyValTyrValValLysSerIleLys                               625630635640                                                                   ThrValGluIleProAlaGlySerPheTyrValHisValThrAsnGln                               645650655                                                                      GlySerSerAspLeuPheLeuAspArgIleGluPheValProLysIle                               660665670                                                                      GlnPheGlnPheCysAspAsnAsnAsnLeuHisCysAspCysAsnAsn                               675680685                                                                      ProValAspThrAspCysThrPheCysCysValCysThrSerLeuThr                               690695700                                                                      AspCysAspCysAsnAsnProArgGlyIleAspCysThrLeuCysCys                               705710715720                                                                   GlnValGluAsnGlnLeuProSerPheValThrLeuThrAspLeuArg                               725730735                                                                      AsnIleThrSerGlnValAsnGlyLeuPheAlaProGlyThrGlnAsn                               740745750                                                                      ArgLeuAlaGlnAsnIleSerAspHisAspIleGluGluValValLeu                               755760765                                                                      LysValAspAlaLeuSerAspGluIlePheGlyThrAsnLysLysAla                               770775780                                                                      LeuArgLysLeuValAsnGlnAlaLysArgLeuSerArgAlaArgAsn                               785790795800                                                                   LeuLeuIleGlyGlySerPheGluAsnTrpAspAlaTrpTyrLysGly                               805810815                                                                      ArgAsnValValThrValSerAspHisGluLeuPheLysSerAspHis                               820825830                                                                      ValLeuLeuProProProGlyLeuSerProSerTyrIlePheGlnLys                               835840845                                                                      ValGluGluSerLysLeuLysAlaAsnThrArgTyrThrValSerGly                               850855860                                                                      PheIleAlaHisAlaThrAspLeuGluIleValValSerArgTyrGly                               865870875880                                                                   GlnGluIleLysLysValValGlnValProTyrGlyGluAlaPhePro                               885890895                                                                      LeuThrSerSerGlyProValCysCysIleProHisSerThrSerAsn                               900905910                                                                      GlyThrLeuGlyAsnProHisPhePheSerTyrSerIleAspValGly                               915920925                                                                      AlaLeuAspValAspThrAsnProGlyIleGluPheGlyLeuArgIle                               930935940                                                                      ValAsnProThrGlyMetAlaArgValSerAsnLeuGluIleArgGlu                               945950955960                                                                   AspArgProLeuAlaAlaAsnGluIleArgGlnValGlnArgValAla                               965970975                                                                      ArgAsnTrpArgThrGluTyrGluLysGluArgAlaGluValThrSer                               980985990                                                                      LeuIleGlnProValIleAsnArgIleAsnGlyLeuTyrGluAsnGlu                               99510001005                                                                    AsnTrpAsnGlySerIleArgSerAspIleSerTyrGlnAsnIleAsp                               101010151020                                                                   AlaIleValLeuProThrLeuProThrLeuArgHisTrpPheMetSer                               1025103010351040                                                               AspArgPheSerGluGlnGlyAspIleMetAlaLysPheGlnGlyAla                               104510501055                                                                   LeuAsnArgAlaTyrAlaGlnLeuGluGlnSerThrLeuLeuHisAsn                               106010651070                                                                   GlyHisPheThrLysAspAlaAlaAsnTrpThrIleGluGlyAspAla                               107510801085                                                                   HisGlnIleThrLeuGluAspGlyArgArgValLeuArgLeuProAsp                               109010951100                                                                   TrpSerSerSerValSerGlnMetIleGluIleGluAsnPheAsnPro                               1105111011151120                                                               AspLysGluTyrAsnLeuValPheHisGlyGlnGlyGluGlyThrVal                               112511301135                                                                   ThrLeuGluHisGlyGluGluThrLysTyrIleGluThrHisThrHis                               114011451150                                                                   HisPheAlaAsnPheThrThrSerGlnArgGlnGlyLeuThrPheGlu                               115511601165                                                                   SerAsnLysValThrValThrIleSerSerGluAspGlyGluPheLeu                               117011751180                                                                   ValAspAsnIleAlaLeuValGluAlaProLeuProThrAspAspGln                               1185119011951200                                                               AsnSerGluGlyAsnThrAlaPheSerThrAsnSerAspThrSerMet                               120512101215                                                                   AsnAsnAsnGln                                                                   1220                                                                           (2) INFORMATION FOR SEQ ID NO:44:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 16 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44:                                       AlaAsnThrThrGlnSerPheHisPheSerAsnIleLeuAspTyrLys                               151015                                                                         (2) INFORMATION FOR SEQ ID NO:45:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 30 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:45:                                       TTTCATTTTTCWAATATTTTAGATTATAAA30                                               (2) INFORMATION FOR SEQ ID NO:46:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 17 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:46:                                       GlyIleGlyPheGluLeuAspThrTyrAlaAsnAlaProGluAspGlu                               151015                                                                         Val                                                                            (2) INFORMATION FOR SEQ ID NO:47:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 10 amino acids                                                     (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:47:                                       AlaAlaSerAspTyrIleAspProIlePhe                                                 1510                                                                           (2) INFORMATION FOR SEQ ID NO:48:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 30 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:48:                                       GCAGGATCCGATTATATTWGATATWAVTCC30                                               (2) INFORMATION FOR SEQ ID NO:49:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 40 bases                                                           (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (synthetic)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:49:                                       GCGGCCGCACTTCATCTTCWGGWGCATTWGCATAWGTATC40                                     (2) INFORMATION FOR SEQ ID NO:50:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 2172 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (xi) SEQUENCE DESCRIPTION: SEQ ID NO:50:                                       ATGAAAGAACAAAATCTAAATAAATATGATGAAATAACTGTACAAGCAGCAAGCGATTAT60                 ATCGACATTCGTCCGATTTTTCAAACAAATGGATCTGCTACATTTAATTCTAATACCAAT120                ATTACAACTTTAACACAAGCTATAAATAGTCAAGCAGGAGCAATTGCAGGAAAGACTGCT180                CTAGATATGAGACATGACTTTACTTTTAGAGCAGATATTTTTCTTGGAACTAAAAGTAAC240                GGAGCAGACGGTATTGCAATCGCATTTCATAGAGGATCAATTGGGTTTGTTGGAACAAAA300                GGCGGAGGACTTGGAATATTAGGTGCACCTAAAGGGATAGGGTTTGAATTAGACACATAT360                GCGAATGCACCTGAGGACGAAGTAGGCGATTCGTTTGGGCATGGGGCAATGAAAGGATCA420                TTCCCTAGTTTCCCAAATGGATATCCCCATGCTGGCTTTGTAAGTACTGATAAAAATAGT480                AGATGGTTATCAGCTCTAGCTCAGATGCAGCGAATCGCTGCTCCAAACGGGCGTTGGAGA540                CGTCTGGAGATTCGTTGGGATGCTCGTAATAAAGAGTTAACTGCAAATCTTCAGGATTTA600                ACTTTTAATGACATAACTGTTGGAGAGAAGCCACGTACTCCAAGAACTGCAACTTGGAGG660                TTAGTAAATCCTGCATTTGAACTTGATCAGAAGTATACTTTTGTTATTGGTTCGGCGACG720                GGTGCATCTAATAACCTACATCAGATTGGGATTATAGAATTTGATGCATACTTTACTAAA780                CCGACAATAGAAGCGAATAATGTAAATGTCCCAGTGGGAGCAACATTTAATCCAAAAACA840                TATCCAGGAATAAATTTAAGAGCAACAGATGAGATAGATGGGGATTTGACATCGAAGATT900                ATTGTGAAAGCAAACAATGTTAATACGTCGAAAACGGGTGTGTATTATGTGACGTATTAT960                GTAGAGAATAGTTATGGGGAAAGTGATGAAAAAACAATCGAAGTAACTGTGTTTTCAAAC1020               CCTACAATTATTGCAAGTGATGTTGAAATTGAAAAAGGGGAATCTTTTAACCCACTAACT1080               GATTCAAGAGTAGGTCTTTCTGCACAGGATTCATTAGGCAATGATATTACCCAAAATGTA1140               AAGGTAAAATCGAGTAATGTGGATACTTCAAAGCCAGGGGAATATGAAGTTGTATTTGAA1200               GTGACAGATAGCTTTGGTGGAAAAGCAGAAAAAGATTTCAAGGTTACAGTTTTAGGACAG1260               CCAAGTATAGAAGCGAATAATGTTGAATTAGAAATAGATGATTCATTGGATCCATTAACA1320               GATGCAAAAGTAGGTCTCCGTGCAAAGGATTCATTAGGTAATGATATTACGAAAGACATA1380               AAAGTAAAGTTCAATAACGTAGATACTTCAAATTCAGGAAAGTATGAAGTTATATTTGAA1440               GTGACGGACCGTTTTGGAAAAAAAGCAGAAAAAAGTATTGAAGTCCTTGTTCTAGGAGAA1500               CCAAGCATTGAAGCAAATGATGTTGAGGTTAATAAAGGTGAAACGTTTGAACCATTAACA1560               GATTCAAGAGTTGGCCTCCGTGCAAAAGACTCATTAGGTAATGATATTACGAAAGATGTG1620               AAAATAAAATCAAGTAATGTGGATACTTCAAAACCAGGTGAATATGAAGTTGTATTTGAA1680               GTGACAGATCGTTTTGGTAAATATGTAGAAAAAACAATTGGAGTTATAGTGCCAGTAATT1740               GATGATGAATGGGAAGATGGAAATGTGAATGGTTGGAAATTCTATGCTGGGCAAGATATT1800               AAACTGTTGAAGGATCCTGATAAAGCCTATAAAGGCGATTATGTATTCTATGATTCTAGA1860               CACGTTGCTATTTCTAAAACAATTCCACTAACGGATTTGCAAATAAATACAAACTATGAA1920               ATTACAGTGTATGCTAAAGCAGAAAGCGGCGATCATCACTTAAAAGTGACGTATAAGAAA1980               GACCCGGCAGGTCCAGAAGAGCCGCCAGTTTTCAATAGACTGATTAGCACAGGCACATTG2040               GTAGAAAAAGATTATAGAGAATTAAAAGGGACGTTCCGCGTAACAGAATTAAACAAAGCA2100               CCATTGATAATCGTAGAGAATTTTGGAGCTGGATATATAGGTGGAATTAGAATTGTGAAA2160               ATATCGTAATAA2172                                                               (2) INFORMATION FOR SEQ ID NO:51:                                              (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 722 amino acids                                                    (B) TYPE: amino acid                                                           (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: peptide                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:51:                                       MetLysGluGlnAsnLeuAsnLysTyrAspGluIleThrValGlnAla                               151015                                                                         AlaSerAspTyrIleAspIleArgProIlePheGlnThrAsnGlySer                               202530                                                                         AlaThrPheAsnSerAsnThrAsnIleThrThrLeuThrGlnAlaIle                               354045                                                                         AsnSerGlnAlaGlyAlaIleAlaGlyLysThrAlaLeuAspMetArg                               505560                                                                         HisAspPheThrPheArgAlaAspIlePheLeuGlyThrLysSerAsn                               65707580                                                                       GlyAlaAspGlyIleAlaIleAlaPheHisArgGlySerIleGlyPhe                               859095                                                                         ValGlyThrLysGlyGlyGlyLeuGlyIleLeuGlyAlaProLysGly                               100105110                                                                      IleGlyPheGluLeuAspThrTyrAlaAsnAlaProGluAspGluVal                               115120125                                                                      GlyAspSerPheGlyHisGlyAlaMetLysGlySerPheProSerPhe                               130135140                                                                      ProAsnGlyTyrProHisAlaGlyPheValSerThrAspLysAsnSer                               145150155160                                                                   ArgTrpLeuSerAlaLeuAlaGlnMetGlnArgIleAlaAlaProAsn                               165170175                                                                      GlyArgTrpArgArgLeuGluIleArgTrpAspAlaArgAsnLysGlu                               180185190                                                                      LeuThrAlaAsnLeuGlnAspLeuThrPheAsnAspIleThrValGly                               195200205                                                                      GluLysProArgThrProArgThrAlaThrTrpArgLeuValAsnPro                               210215220                                                                      AlaPheGluLeuAspGlnLysTyrThrPheValIleGlySerAlaThr                               225230235240                                                                   GlyAlaSerAsnAsnLeuHisGlnIleGlyIleIleGluPheAspAla                               245250255                                                                      TyrPheThrLysProThrIleGluAlaAsnAsnValAsnValProVal                               260265270                                                                      GlyAlaThrPheAsnProLysThrTyrProGlyIleAsnLeuArgAla                               275280285                                                                      ThrAspGluIleAspGlyAspLeuThrSerLysIleIleValLysAla                               290295300                                                                      AsnAsnValAsnThrSerLysThrGlyValTyrTyrValThrTyrTyr                               305310315320                                                                   ValGluAsnSerTyrGlyGluSerAspGluLysThrIleGluValThr                               325330335                                                                      ValPheSerAsnProThrIleIleAlaSerAspValGluIleGluLys                               340345350                                                                      GlyGluSerPheAsnProLeuThrAspSerArgValGlyLeuSerAla                               355360365                                                                      GlnAspSerLeuGlyAsnAspIleThrGlnAsnValLysValLysSer                               370375380                                                                      SerAsnValAspThrSerLysProGlyGluTyrGluValValPheGlu                               385390395400                                                                   ValThrAspSerPheGlyGlyLysAlaGluLysAspPheLysValThr                               405410415                                                                      ValLeuGlyGlnProSerIleGluAlaAsnAsnValGluLeuGluIle                               420425430                                                                      AspAspSerLeuAspProLeuThrAspAlaLysValGlyLeuArgAla                               435440445                                                                      LysAspSerLeuGlyAsnAspIleThrLysAspIleLysValLysPhe                               450455460                                                                      AsnAsnValAspThrSerAsnSerGlyLysTyrGluValIlePheGlu                               465470475480                                                                   ValThrAspArgPheGlyLysLysAlaGluLysSerIleGluValLeu                               485490495                                                                      ValLeuGlyGluProSerIleGluAlaAsnAspValGluValAsnLys                               500505510                                                                      GlyGluThrPheGluProLeuThrAspSerArgValGlyLeuArgAla                               515520525                                                                      LysAspSerLeuGlyAsnAspIleThrLysAspValLysIleLysSer                               530535540                                                                      SerAsnValAspThrSerLysProGlyGluTyrGluValValPheGlu                               545550555560                                                                   ValThrAspArgPheGlyLysTyrValGluLysThrIleGlyValIle                               565570575                                                                      ValProValIleAspAspGluTrpGluAspGlyAsnValAsnGlyTrp                               580585590                                                                      LysPheTyrAlaGlyGlnAspIleLysLeuLeuLysAspProAspLys                               595600605                                                                      AlaTyrLysGlyAspTyrValPheTyrAspSerArgHisValAlaIle                               610615620                                                                      SerLysThrIleProLeuThrAspLeuGlnIleAsnThrAsnTyrGlu                               625630635640                                                                   IleThrValTyrAlaLysAlaGluSerGlyAspHisHisLeuLysVal                               645650655                                                                      ThrTyrLysLysAspProAlaGlyProGluGluProProValPheAsn                               660665670                                                                      ArgLeuIleSerThrGlyThrLeuValGluLysAspTyrArgGluLeu                               675680685                                                                      LysGlyThrPheArgValThrGluLeuAsnLysAlaProLeuIleIle                               690695700                                                                      ValGluAsnPheGlyAlaGlyTyrIleGlyGlyIleArgIleValLys                               705710715720                                                                   IleSer                                                                         __________________________________________________________________________ 

We claim:
 1. An isolated polynucleotide encoding a B.t. toxin wherein said toxin is lethal to a hymenopteran pest wherein the amino acid sequence of said toxin is at least 75% the same as the amino acid sequence shown in SEQ ID NO.
 8. 2. An isolated polynucleotide encoding a B.t. toxin wherein said toxin is lethal to a hymenopteran pest wherein the amino acid sequence of said toxin is at least 75% the same as the amino acid sequence shown in SEQ ID NO. 43, wherein said toxin has an amino acid sequence that is other than the amino acid sequence of SEQ ID NO. 2, and wherein said toxin has an amino acid sequence that is other than the amino acid sequence of SEQ ID NO.
 4. 3. The polynucleotide sequence, according to claim 2, wherein said toxin is at least 95% the same as the amino acid sequence shown in SEQ ID NO.
 43. 4. The polynucleotide sequence, according to claim 2, encoding the amino acid sequence shown in SEQ ID NO.
 43. 5. The polynucleotide sequence, according to claim 2, wherein said polynucleotide sequence has the nucleotide sequence shown in SEQ ID NO.
 42. 6. An isolated polynucleotide encoding a B.t. toxin wherein said toxin is lethal to a hymenopteran pest wherein the amino acid sequence of said toxin is at least 75% the same as the amino acid sequence of SEQ ID NO.
 51. 7. The polynucleotide, according to claim 6, encoding the amino acid sequence shown in SEQ ID NO.
 51. 8. The polynucleotide sequence, according to claim 6, wherein said polynucleotide has the sequence shown in SEQ ID NO.
 50. 9. An isolated polynucleotide encoding a B.t. toxin from B.t. isolate PS140E2 wherein said toxin is lethal to a hymenopteran pest.
 10. An isolated polynucleotide encoding a B.t. toxin, wherein said toxin is lethal to a hymenopteran pest, and wherein said polynucleotide hybridizes under stringent conditions with SEQ ID NO.
 45. 11. An isolated polynucleotide sequence encoding a B.t. toxin, wherein said toxin is lethal to a hymenopteran pest, and wherein said toxin comprises the amino acid sequence shown in SEQ ID NO
 44. 12. An isolated polynucleotide encoding a B.t. toxin that is lethal to a hymenopteran pest, wherein said polynucleotide hybridizes under stringent conditions with a probe selected from the group consisting of SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 27, SEQ ID NO. 29, and SEQ ID NO. 37; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 8; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 2; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 4; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 6; and wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO.
 10. 13. An isolated polynucleotide encoding a B.t. toxin that is lethal to a hymenopteran pest, wherein a portion of said polynucleotide sequence can be amplified from total cellular DNA from a Bacillus thuringiensis strain using polymerase chain reaction with a reverse primer selected from the group consisting of SEQ ID NO. 33 and SEQ ID NO. 34; and with a forward primer selected from the group consisting of SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 27, SEQ ID NO. 23, SEQ ID NO. 24, and SEQ ID NO. 29; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 8; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 2; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 4; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 6; and wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO.
 10. 14. An isolated polynucleotide encoding a B.t. toxin that is lethal to a hymenopteran pest, wherein a portion of said polynucleotide sequence can be amplified from total cellular DNA from a Bacillus thuringiensis strain using polymerase chain reaction with a reverse primer selected from the group consisting of a complement of SEQ ID NO. 12 and SEQ ID NO. 13 and with a forward primer selected from the group consisting of SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 27, SEQ ID NO. 23, SEQ ID NO. 24, and SEQ ID NO. 29; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 8; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 2; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 4; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 6; and wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO.
 10. 15. An isolated polynucleotide encoding a B.t. toxin that is lethal to a hymenopteran pest, wherein a portion of said polynucleotide sequence can be amplified from total cellular DNA from a Bacillus thuringiensis strain using polymerase chain reaction with a reverse primer having the sequence of SEQ ID NO. 31 and with a forward primer selected from the group consisting of SEQ ID NO. 27, SEQ ID NO. 23, SEQ ID NO. 29, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 12, SEQ ID NO. 13, and SEQ ID NO. 35; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 8; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 2; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 4; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 6; and wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO.
 10. 16. An isolated polynucleotide encoding a B.t. toxin that is lethal to a hymenopteran pest, wherein a portion of said polynucleotide sequence can be amplified from total cellular DNA from a Bacillus thuringiensis strain using polymerase chain reaction with a reverse primer having the sequence of SEQ ID NO. 37 and with a forward primer selected from the group consisting of SEQ ID NO. 27, SEQ ID NO. 23, SEQ ID NO. 29, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 12, SEQ ID NO. 13, and SEQ ID NO. 35; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 8; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 2; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 4; wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO. 6; and wherein said polynucleotide is other than a polynucleotide encoding SEQ ID NO.
 10. 